Biovisionalex 2008.Pdf

BioVisionAlexandria 2008 12-16 April Bibliotheca Alexandrina

Conference Booklet Organizing Committee

Serageldin, Ismail Director, Bibliotheca Alexandrina and Conference Chairman 2008

International Scientiﬁc Committee Alberts, Bruce ( USA) Nutti, Marilia (Brazil) Bouis, Howarth ( USA) Omi, Koji (Japan) Daar, Abdallah (Canada) Rabbinge, Raoelf ( Netherlands) Gros, Francois ( France) Schneider, Cynthia ( USA) Hassan, Mohamed (Sudan) Singer, Peter (Canada) Huanming, Yang ( China) Swaminathan, Monkombu Sambasivan ( India) McConnell, David ( Ireland) Van Montagu, Marc ( Belgium) International Steering Committee

Anhoury, Pierre (France) Degget , Jens (Spain) Cunningham, Patrick (Ireland) Flanagan, Jim (Ireland) BA Steering/Scientiﬁc Committee Abdelhady, Layla El-Faham, Mohamed Adly, Nefertiti El-Wakil, Marwa Aly, Sahar Madkour, Magdy Ashour, Fayrouz Massoud, Amani Darwish, Omneya Nakhla, Raﬁk El Beltagy, Adel Soliman, Salah Technical and Logistics Committee Abdallah, Sara Farouk, Mustafa Moussa, Mariam Abdel El-Rassoul, Marwa Gad, Mohamed Nafea, Mohamed

BioVisionAlexandria BioVisionAlexandria Abdel Latif, Inas Gafour, Olfat Nassar, Hadeer AbdelHamid, Riham Gomaa, Mohamed Nofal, Khaled Abdel-Nasser, Mohamed Gowayed, Menattallah Omnia, Abd Eltawab Abdelrazek, Hanan Hamdy, Heba Ossama, Nehal Abdelwahab, Hala Hassan, Karim Ragab, Esraa Adly, Noha Helmy, Mona Refay, Galal Ali, Alyaa Hosni, Gamal Riad, Sherif Allam, Mohamed Ibrahim, Shymaa Sakr, Ashraf 2 Ammar, Sherif Kamal, Islam Salah, Mohamed Anas, Nagy Kamel, Omneya Samir, Yasmine Ata, Nermine Maamoun, Yasmin Seoud, Samar Azab, Khaled Magdy, Doha Shoushan, Mohamed El Amir, Radwa Magdy, Sally Soccar, Peter El-Borgy, Dina Mahdy, Khaled Soliman, Asmaa El-Saadany, Aly Mahdy, Marwa Soudi, Marwa El-Sammak, Mohamed Maram, Heba Talaat, Sherouk El-Shobaky, Sara Merzeban, Faten Wassef, Mayada Essalmawi, Hala Mounir, Hanan Zaky, Nihal Farid, Mona Moussa, Heba Alexandria, 12 April 2008 Dear Participant,

Welcome to Alexandria and to this international event organized by the Bibliotheca Alexandrina in partnership with the World Life Sciences Forum, BioVision. 2008

BioVisionAlexandria and the World Life Sciences Forum, BioVision, are important gatherings that bring distinguished speakers in discussions commemorating science and the ﬁnest achievements of the human intellect. They include members of academia, industry, research, institutions, media, and society. The ultimate goal is to provide a platform for exchange of information and for dialogue to explore the diﬀerent ways in which the life sciences can help to meet the challenges facing us in the 21st century, a vital step for economic development leading to global improvement of quality of life for all.

BioVisionAlexandria aims to increase the participation of developing countries in this important global dialogue. BioVisionAlexandria 2008 is dedicated to the eﬀective translation of the best knowledge available into new approaches and to encouraging scientiﬁc research that holds great promise to tackle the problems of the developing countries.

We welcome you to this important conference, meeting on the very spot where the ancient Bibliotheca Alexandrina once stood, once again gathering the best minds from around the world to discuss issues of importance. We hope that you will also take some time to visit the remarkable tourist sites of Egypt. We wish you a productive and pleasant stay in Alexandria!

Ismail Serageldin

Librarian of Alexandria Director of the Bibliotheca Alexandrina BioVisionAlexandria

3 I n d e x 2008

1. Provisional Program ...... 5

2. Speaker List ...... 26

3. Nobel Laureates ...... 42

4. Speakers` Biographies & Abstracts ...... 48

5. Partners, Sponsors and Exhibitors ...... 147 BioVisionAlexandria BioVisionAlexandria

In this publication, you will ﬁnd all documents and useful information that you may need for the BioVisionAlexandria 2008 Conference. It is prepared by the conference organizing committee to accompany you during your stay in Alexandria. BioVisionAlexandria April 2008 2008

Provisional Program BioVisionAlexandria BioVisionAlexandria

5 6 BioVisionAlexandria 2008

Monday, 14 April 2008 Sunday, 13 April 2008 Saturday, 12 Plenary Sessions Nobel Day April 2008 14:30-15:30 13:00-14:30 12:30-13:00 11:00-12:30 17:00-17:30 15:30-17:00 17:30-19:00 12:30-13:30 11:00-12:30 10:30-11:00 09:00-10:30 13:30-15:00 15:00-15:30 17:30-19:30 17:00-17:30 15:30-17:00 08:00 08:00 08:00 Bioinformatics andComputationalBiology:Wideningthe The DevelopingWorld’sTechnologyDivide Conference ataGlance Bioenergy andBiofuels:theNewCleanEra (Featuring internationalandnationaleminentﬁgures) EAGLES FoodSymposium (Subject tochange) Grand GlobalChallenges Session 2:ScienceVersusGlobalChallenges Evening Event1:NobelRoundTable Plenary Session2: Plenary Session1: Plenary Session3: Plenary Session5: Plenary Session4: (During alldaysoftheConference) (During alldaysoftheConference) Session 1:ScienceforInnovation Perspective Conference OpeningSession Registration Lunch Break Lunch Break Registration Registration Break Break Break Break Break Diabetes Supercourse Commission Funded Research in the Arab Research in the Arab Problems Hindering Problems Hindering Programmes for for the MENA Biotechnology Biotechnology Provisional Program Provisional Research and IPR Serving Innovation Innovation Plenum 2 Plenum 1 European Track2 : Track4 : Track1 : Track3 : Track4 : Region Region Region BioVisionAlexandria April 2008

Registration 08:00 (During all days of the Conference) Panel B-1: Natural Resource Panel A-1: Management Panel C-1: 2008 Nanotechnology: Building Public Global Convergence Track 5 : 09:00-10:30 Supercourse Smaller Resilience, in Food Supply 1 Technology… Rebuilding Lives (EAGLES) Bigger Impact

(Health) (Environment) (Food and Agriculture)

10:30-11:00 Break

Panel C- 2: Track 6 : Project on Global Convergence Panel B-2: South-to-South 11:00-12:30 Panel A-2: in Food Supply 2 Collaboration Viral Hepatitis: Water Resources: (EAGLES) for Genomics Promise Awaits the the Global Concern Innovation Stealth Epidemic Plenum 1 (Health) (Environment) (Food and Agriculture)

12:30-13:30 Lunch Break

Panel C-3: Track 6 : April 2008 Panel B-3: European Research Project on Panel A-3: Climate Change: Policy and Global South-to-South Collaboration 13:30-15:00 Tuberculosis: Impacts and Food Security Parallel Sessions Comprehensive for Genomics Responses (EAGLES) Tuesday, 15 Overview and Innovation Challenges (Environment) Plenum 2 (Health) (Food and Agriculture)

15:00-15:30 Break BioVisionAlexandria BioVisionAlexandria Panel B-4: Panel C-4: Environmental EAGLES Food Track 7 : Panel A-4: Safety and Symposium 15:30-17:00 Scientiﬁc Egyptian New Tools in Biotechnology: Conclusions and Partnerships Medicine: A World Trusting Recommendations of Possibilities (Health) Biotechnology (Environment) (Food and Agriculture)

17:00-17:30 Break 7 Track 8 : PRRI Participation of Evening Event 2: CEO Panel: Public Researchers 17:30-19:00 The Outbreak in Drug Discoveries and Vaccine Technologies in Cartagena Protocol and the Biodiversity Convention 8 BioVisionAlexandria 2008

Wednesday, 16 April 2008 11:00-14:00 10:30-11:00 09:00-10:30 Free time Evening Event Track 9:Bio-ethics Track 8:PRRI-ParticipationofPublicResearchersinCartagenaProtocol Track 7:ScientiﬁcEgyptianPartnerships Track 6:ProjectonSouth-to-SouthCollaborationforGenomicsInnovati Track 5:Supercourse Track 4:ProblemsHinderingBiotechnologyResearchintheArabRegion Track 3:EuropeanCommissionFundedProgrammesforResearchandInnovation Track 2:IPRServingInnovation Track 1:DiabetesSupercoursefortheMENARegion Theme C:FoodandAgriculture Theme B:Environment Theme A:Health Plenary Session Nobel DaySession 08:00 Gene Modiﬁcations in Recombinant and Advances Technologies Panel A-5: (Health) (Environment) Home Grown Biotech Firms (During alldaysoftheConference) Panel B-5: Reporting andClosingSession Plenary Session7: Registration Break (Food and Agriculture) Biotechnology: Food for aBetterWorld Agricultural Panel C-5: andtheBiodiversityConvention Bio-ethics: Racing up theRoadto Provisional Program Provisional Track 9: Research BioVisionAlexandria April 2008

Detailed Program (Subject to change)

Saturday, 12 April 2008

08:00 Registration 2008

Sunday, 13 April 2008

08:00 Registration (registration will remain open throughout the conference) 11:00-12:30 Opening Addresses Great Hall Special Inauguration Session where world renowned international political, social and scientiﬁc leaders will introduce BioVisionAlexandria 2008, presenting their views on the implications of the life sciences revolution in today's world (in order of presentation) Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) Philippe Desmarescaux, Chairman, The World Life Sciences Forum, BioVision (France) Mohamed Hassan, Executive Director, The Academy of Sciences for the Developing Day 1 World (TWAS) (Sudan) Koji Omi, Former Japanese Minister of State for Science and Technology Policy (Japan) Janez Potocnik, European Commissioner for Science and Research, European Commission (Belgium) Hany Helal, Minister of Higher Education (Egypt) Ahmed Nazif, Prime Minister (Egypt) 12:30-13:00 Break (Visit BioFair@BioVisionAlexandria and Posters Area!) Nobel Laureates' Day 13:00-14:30 Session 1: Science for Innovation Great Hall

Chair: Julia Marton-Lefevre, Director General, The World Conservation Union (IUCN)(Switzerland) Rapporteur: Pierre Anhoury, Senior Vice President, Business Leader Europe, Day 1 MattsonJack (France)

Richard R. Ernst, Chemistry 1991(Switzerland) BioVisionAlexandria BioVisionAlexandria Today's Providence for Tomorrow's Survival Torsten N. Wiesel, Physiology or Medicine 1981 (USA) John Fenn, Chemistry 2002 (USA) 14:30:-15:30 Lunch Break 15:30-17:00 Session 2: Science Versus Global Challenges Great Hall Chair: Margaret Catley-Carlson, Chair, Global Water Partnership (USA) Rapporteur:: Pierre Anhoury, Senior Vice President, Business Leader Europe, MattsonJack (France) 9 Day 1 F. Sherwood Rowland, Chemistry 1995 (USA) The Greenhouse Gases and Global Climate Change Erling Norrby, Secretary General, the Royal Swedish Academy of Sciences (Sweden) Jeﬀrey D. Sachs, Director, Earth Institute (USA) 17:00-17:30 Break (Visit BioFair @BioVisionAlexandria and Posters Area) 17:30-19:00 Evening Event 1 Great Hall Round Table Discussions: Nobel Views and Perceptions Day 1 Moderator: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) 10 BioVisionAlexandria 2008 09:00-10:30 10:30-11:00 09:00-10:30 Day 2 Day 2 IPR MediatedBridgingoftheTechnologyDivide…Exploring Options Our main objective is to report on the project’s achievement and to discuss Diabetes as an as Diabetes discuss to and achievement project’s the on report to is objective main Our (WDF). Its main goal is to raise public awareness is of the prevention and control of diabetes. (MENA) Region Foundation Diabetes World the by supported is It Pittsburgh. of University the at Center African Collaborating WHO North the and (BA) and Alexandrina Bibliotheca East the between collaboration Middle the for Supercourse Diabetes Track 1:DiabetesSupercoursefortheMENARegion Ismail Serageldin, Prabuddha Ganguli, in success additional for momentum give could that models successful with challenges and holds collaboration South-South hopes holds approach conventional non This trap’. ‘low-technology the escaping of promise countries, developed from down trickle to technology for waiting Not decades. few last the in concern major a been and has countries, developed developing between capacity, scientiﬁc and evolution technical in gap growing The Rapporteur: Diabetes andMetabolism,FacultyofMedicine,AlexandriaUniversity(Egypt) Chair: SamirAssaad-Khalil,Head,DepartmentofInternalMedicine;Head,Unit ongoing epidemic. (Denmark) Boerge Diderichsen, Morsi Arab, University ofPittsburgh(USA) Ronald Laporte,ProfessorofEpidemiology,GraduateSchoolPublic Health, Alexandrina Fayrouz Ashour, The DevelopingWorld’s"TechnologyDivide”:IsthereHope toClosetheGap? John Kilama Ichiro Kitsato, Accelerating HealthInnovationinAfrica Joint CentreforBioethics(Canada) Rapporteur: Science the Chair, University; Council oftheCGIAR(Netherlands) Wageningen Professor, Rabbinge, Raoelf Chair: the future. "The DevelopingWorld’sTechnologyDivide" Plenary Session1:GreatHall Sun Life Financial Chair in Bioethics; Director, University of Toronto of University Director, Bioethics; in Chair Financial Life Sun Singer, Peter

Break (VisitBioFair@BioVisionAlexandriaandPostersArea) (Egypt) IDFRegionalChairDiabetes,EMMEregion(Egypt). RaﬁkNakhla,BibliothecaAlexandrina(Egypt) Quentin Cooper,BroadcasterandScienceJournalist(UK) President, GlobalBioscienceDevelopmentInstitute(USA) President, JapanBioindustryAssociation(JBA) Diabetes SupercourseProjectCoordinator,Bibliotheca Director,BibliothecaAlexandrina(Egypt) CEO,Vision-IPR(India) Monday, 14April2008 Vice President,CorporateResearchAﬀairs,NovoNordisk

LectureHall

(Japan) Provisional Program Provisional BioVisionAlexandria April 2008

11:00-12:30 Plenary Session 2: Great Hall "Grand Global Challenges"

The Grand Global Challenges for global health can be faced by exploiting the advances in science and technology in order to signiﬁcantly improve health in the world’s poorest 2008 countries. Many initiatives have been developed to support groundbreaking research projects to discover and develop scientiﬁc breakthroughs for preventing, treating, and curing various diseases as well as malnutrition problems that kill millions of people each year in developing countries.

Chair: Yehia Zaky, Head, Academic and Cultural Aﬀairs Sector, Bibliotheca Alexandrina (Egypt) Rapporteur: Raﬁk Nakhla, Bibliotheca Alexandrina (Egypt)

Day 2 Abdallah Daar, Professor of Public Health, University of Toronto (Canada) Grand Challenges in Chronic Non-Communicable Diseases-Priorities for Developing Countries Howarth Bouis, Director, HarvestPlus (USA), Marilia Nutti, Researcher, National Research Center on Food Technology, Embrapa (Brazil) Biofortification - Using Agriculture to Improve Human Nutrition: Progress Under HarvestPlus Institutionalizing the Biofortification Strategy in a Sustainable Way: The Case of Brazil Joel Breman, Senior Scientific Advisor, Fogarty International Center, National Institutes of Health (USA) Conquering the Intolerable Burden of Malaria: Promises to Practice...to Scale Up Michael Oborne, Director, International Futures Programme, OECD (France), Iain Gillespie, Head, Biotechnology Division, Science, Technology and Industry, OECD (France) Key Findings of the OECD’s Bioeconomy to 2030 project

11:00-12:30 Track 2: IPR Serving Innovation Lecture Hall

The impacts of the new Intellectual Property Rights (IPR) environment are perceived mostly BioVisionAlexandria BioVisionAlexandria through projects linking scientists and teams in high-income countries with their peers in low-income countries, technology transfer, and joint ventures between universities, firms and research labs in these countries. This impact on scientific activities is amplified by the specific manner in which science is carried out in developing countries.

Chair: Magdy Madkour, Professor, Arid Lands Agricultural Research Institute (ALARI), Faculty of Agriculture, Ain Shams University (Egypt) Rapporteur: Perihan Abu Zeid, Private Lawyer and Lecturer, the Arab Academy for Day 2 Science, Technology and Maritime Transport (Egypt) 11 Anatole Krattiger, Research Professor, Arizona State University (USA) Intellectual Property Management Strategies as an Essential Element in Public- Private Partnerships to Enable Global Access Prabuddha Ganguli, CEO, Vision-IPR. (India) IPR Internalise™ A Pathway to Seamless Integration of IPR into Innovation Processes Ahmed Abdel Latif, Program Manager, IP programs, ICTSD (Switzerland) Mohamed Raouf Hamed, Professor of Pharmacology and Toxicology, National Organization for Drug Control and Research (Egypt)

12:30-13:30 Lunch Break 12 BioVisionAlexandria 2008 13:30-15:00 13:30-15:00 15:00-15:30 Day 2 Day 2 Oligonucleotide Signatures of Pathogenic Microorganisms for Diagnostic Genetic Diagnostic for Microorganisms Pathogenic of Signatures Oligonucleotide and ComputationalBiologyUnitUniversityofPretoria(SouthAfrica). Oleg Reva, Understanding InnateImmuneRegulationwithHelpfrom FunctionalGenomics Immunology andHygiene,TechnicalUniversityofMunich(Germany) physicists crossingtraditionalacademicboundarieswillleadtoapplicablesolutions. medicine. Therefore, only the joint efforts of biologists, chemists, statisticians, engineers, and performance computing are key utilities in solving today's pressing problems in biology and high- and analysis biological of makingsignificant combination The sciences. environmental and forensics, agriculture is design, drug detection, disease as Biology such areas andComputational scientific various to contributions ofBioinformatics field novel The Hall Great "Bioinformatics andComputationalBiology:Wideningthe Perspective" 3: Session Plenary Innovation Track 3:EuropeanCommissionFundedProgrammesforResearchand Huanming Yang, Ta Lae o te iifrais em Gnm Exploration Genome Team, Research Group,GenomicScienceCenter,RIKENYokohamaInstitute(Japan) Bioinformatics the of Leader Team Daub , Carsten Chips andMetagenomics Unit, Core Micorarray Director, Lang, Roland in Developing Countries Genomics for Tools Important and Infrastructure Essential Bioinformatics: (China) Rapporteur Biotechnology Unit,EuropeanCommission(Belgium) Elisabetta Balzi, Commission (Belgium) Indridi Benediktsson, Alexandrina (Egypt) Rapporteur : in Egypt(Belgium) Chair: Chair National focalPointforFP7inEgypt: Hamid El-Zoheiry, : ElenaSachez,ScienceCounselor,DelegationoftheEuropeanCommission Jane Morris, National Bioinformatics Network Node Manager, ACGT Bioinformatics : Break (VisitBioFair@BioVisionAlexandriaandPostersArea!) RafikNakhla, HalaAbdElWahab,Head,ResourceDevelopmentUnit,Bibliotheca Directorate-General forResearch,FoodAgricultureand Director, Beijing Genomics Institute, Chinese Academy of Sciences Director,AfricanCentreforGeneTechnologies(SouthAfrica) Coordinator, EuropeanCommission(Egypt) Directorate-General forResearch,Health,European

BibliothecaAlexandrina(Egypt)

TBA

Institute of Medical Microbiology, Medical of Institute

Lecture Hall Provisional Program Provisional BioVisionAlexandria April 2008

15:30-17:00 Plenary Session 4: Great Hall "Bioenergy and Biofuels : the New Clean Era"

Will the production of bio-energy and bio-fuel be the upcoming solution for an existing

problem and help prevent the predicted relapse of the world’s future back to dark cold 2008 centuries that could be deprived from usable energy due to consumed resources?. Will it require a global awareness of potential impacts on health, food and environment mostly for the deprived ones?

Chair: Raoelf Rabbinge, Professor, Wageningen University; Chair, the Science Council of the CGIAR (The Netherlands) Day 2 Rapporteur: Raﬁk Nakhla, Bibliotheca Alexandrina (Egypt) Birte Holst Joergensen, Managing Director, Nordic Energy Research (Denmark) Nordic Perspectives on Bioenergy João Paes de Carvalho, Principal, BiznessBrazil (Brazil) Bioenergy to Illuminate the Dark Age Geoﬀrey Hamer, Honorary Secretary, Biofocus Foundation (UK) Methanotrophy: From Single Cell Protein Production to Gaseous Emissions from Wetland Agriculture and Engineered Aquatic Environments Salah Hassouna, Professor, High Institute of Graduate Studies and Research, Alexandria University, Alexandria (Egypt) Biofuels: Where Do We Stand? Weber Amaral, Professor; CEO, Brazilian Biofuels Programme (Brazil)

15:30-17:00 Track 4: Problems Hindering Biotechnology Research in the Arab Region: Lessons Learned and Possible Solutions Lecture Hall "Plenum1"

Chair: Mohamed El-Awadi, Professor, Faculty of Pharmacy, Tanta University (Egypt) Rapporteur: Mariam Moussa, Research Specialist, Center for Special Studies and Programs, Bibliotheca Alexandrina (Egypt) Day 2 Ibrahim Badran, Former Minister of Health (Egypt)

John Hillman, Former Director, Scottish Crop Research Institute (SCRI) (UK) BioVisionAlexandria Elias Baydoun, Professor of Biology, American University of Beirut (Lebanon) Opportunities for Biotechnology Research and Development in the Arab Region Mona K. Marei, Professor of Prosthetic Dentistry and Head, Tissue Engineering Laboratories, Faculty of Dentistry, Alexandria University (Egypt) Visions for Regenerative Medicine: Addressing the Challenges of Health Burden for Future Development Mohsen Shoukry, Professor, Academy of Scientific Research and Technology (Egypt) 13 17:00-17:30 Break (Visit BioFair@BioVisionAlexandria and Posters Area!) 14 BioVisionAlexandria 2008 17:30-19:30 17:30-19:30 Day 2 Day 2 GM Technology: GM rc 4 Polm Hneig itcnlg Rsac i te rb Region: Arab the in Research Biotechnology Hindering Problems 4: Track University Conferences on Innovation and Technology Transfer for Global Health Global for Transfer Technology and Innovation on Conferences University Oxford Co-Chair, USA; EPOS Development, Business Director, Derhak, Dianna of University Medicine, Veterinary of School Immunology, and Microbiology Animal Vaccines: Soybeans inArgentina:BenefitsandLessonsfortheFuture of theArgentineGovernment(Argentina) Realities? Current and Ambitions Research between Gaps the Cover World Arab the Did Sultan QaboosUniversity(Oman) Bayoumi, Riad the Practice, to Promise From Challenges World: Muslim the in Technology and Science Department ofPediatrics,Riyadh MilitaryHospital(SaudiArabia) Aqeel, Al Aida Brian Clark,VicePresident,EuropeanFederationofBiotechnology (Denmark) (USA) Lessons fromHealthBiotechnologyInnovationSystems of Emerging Economies Abdallah Daar, Professor of Public Health Sciences, University of Toronto (Canada) Programs, BibliothecaAlexandrina(Egypt) Rapporteur: Chair: Mohamed El-Awadi, Professor, Faculty of Pharmacy, Tanta University (Egypt) "Plenum 2" Lessons LearnedandPossibleSolutions California (USA) Innovation and Technology Science, for Secretariat the of Directorate International Soybeans: Rapporteur: Keynote Address: public interestorganizationswillbeinvitedtoattend. of leaders and humanitarians writers, journalists, and editors servants, civil national parliaments, and Parliament European the of members Commission, European the of staff and Members world. developing the and Europe from fromthe disciplines other and formers sciences opinion life together bring will Symposium The improved. be can DECs and in food to forums related policies and international programmes European how on other recommendations provide meetings, EAGLES previous from recommendations and reports on draw will symposium The (DECs). countries emerging safety and developing and in quality security, sufficiency, food of challenges the meeting are and biotechnology agriculture food, major on programmes European how consider to is objective The the direction of Dr. Ismail Serageldin, Director General, Bibliotheca Alexandrina, Egypt. This EAGLES Food Symposium, funded by the European Commission, is being held under "EAGLES FoodSymposium" Plenary Session5:GreatHall Genetics andDevelopmentalBiology,ChineseAcademyofSciences(CAS)(China) Chu, Chengcai Rice: Federation ofTechnology(Belgium) Center for Research and Advanced Studies, the National Polytechnic Institute Chair: Luis Herrera Estrella, Head, National Laboratory of Genomics for Biodiversity, Success StoriesintheDECsandLessonsforFuture Drco, rp CO n Sinic die, the Adviser, Scientific and CEO Grupo Director, Trigo, Eduardo RubinEcheverria,

Mariam Moussa, Research Specialist, Center for Special Studies and Studies Special for Center Specialist, Research Moussa, Mariam

Professor and Head of Clinical Biochemistry, the College of Medicine, of College the Biochemistry, Clinical of Head and Professor eir oslat eiti Mdcl eeiit Endocrinologist, Geneticist; Medical Pediatric Consultant Senior Tilahun Yilma, Distinguished Professor, Department of Pathology,

Ismail Serageldin , Elected and Acting President, the European the President, Acting and Elected Montagu, van Marc rnil Ivsiao ad aoaoy ed Isiue of Institute Head, Laboratory and Investigator Principle

Director, theCGIARScienceCouncil(Italy) ,

Director, BibliothecaAlexandrina LectureHall Provisional Program Provisional (Egypt)

(Mexico)

BioVisionAlexandria April 2008

Tuesday 15 April 2008

09:00-10:30 Health Stream: Panel A -1 Great Hall "Nanotechnology: Smaller Technology… Bigger Impact" 2008 The emerging science of nanotechnology raises high expectations for millions of patients for better, more efficient and affordable health care and has the potential of delivering promising solutions to many illnesses such as cancer, cardiovascular diseases and others.The promising possibilities that nanomedicine might offer in the future have to be counterweighted against potential hazards of this new technology to human beings as well as to the environment and the ethical concerns arising from nanoapplications.

Chair: Ahmed Massoud, Professor, Faculty of Dentistry, Alexandria University and Director, Egyptian Association for Continuing Education and Training (Egypt) Rapporteur: Raﬁk Nakhla, Bibliotheca Alexandrina (Egypt) Day 3 Dennis E. Discher, Professor, Chemical and Biomolecular, Mechanical, and Bio- Engineering, University of Pennsylvania (USA) 'NanoBiology' - Natural or Engineered Particles of Diverse Shape and Their Interactions with Cells Hassan Azzazy, Chairman and Associate Professor, Department of Chemistry, American University in Cairo (Egypt) Nanoparticles: Emerging Diagnostic and Therapeutic Applications Gilbert Rios, Coordinator, NanoMemPro Network of Excellence (France) Nanoscale-Designed Membrane Materials for Health Applications Takaaki Kurasaki, Director, Division of Advanced Medical and Radiological Science, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Japan) Japan’s Research and Development Policy in Life Science

09:00-10:30 Environment Stream: Panel B-1: Small Theater "Natural Resource Management: Building Public Resilience, Rebuilding Lives"

National initiatives addressing issues related to managing and using sustainable resources as well as building community level resilience are urgently needed for natural resource BioVisionAlexandria BioVisionAlexandria management. Expanding global research collaboration will not only have a signiﬁcant impact on NRM but will highly encourage adoption of sustainable natural resource management practices.

Day 3 Chair: Eric Huttner, General Manager, Diversity Arrays Technology Pty Limited (Australia) Rapporteur: Salah Soliman, Professor, Faculty of Agriculture, Alexandria University (Egypt) Adel El- Beltagy, Chair, Global Forum on Agricultural Research (Egypt) 15 Ewald Schnug, Head, Institute for Plant Nutrition and Soil Science (Germany) Agricultures Contribution to Natural Resource Management - The Promise of Sustainability Hani El-Nokrashi, CEO, Nokrashi Engineering GmbH (Germany) The Desert of Egypt as Everlasting Power House Pat Mooney, Executive Director, ETC Group (Canada) 16 BioVisionAlexandria 2008 11:00-12:30 10:30-11:00 09:00-10:30 09:00-10:30 Day 3 Day 3 Day 3 Health Stream:PanelA-2: Solidarity andSubsidiaritybetweenAcademicSciencesBusinesstoImprove Track 5:Supercourse Food and Agriculture Stream: Panel C-1: Panel Stream: Agriculture and Food rfso, h Dprmn o Mlclr n Cl Biology, Cell and Molecular of Department the Professor, Thompson, Jennifer Cancer Institute(USA) Faina Linkov,ResearchAssistantProfessorofMedicine,UniversityPittsburgh (Russia) Improvement (UK) Drco, eerh n Development and Research Director, Araki, Kazuhiro Shubnikov, Eugene Scientific Supercourse,WhiskingSciencetoClassroom Health, Public of University ofPittsburgh(USA) School Graduate Epidemiology, of Professor Laporte, Ronald Prosperity andHealth“fromCoexistencetoConviviality” Francois Sauer, Ismail Serageldin, Rapporteur: Chair: forCrop Institute Borlaug Norman The Director, Executive Elliot, Malcolm University ofCapeTown(SouthAfrica) Roger Beachy, Samuel Jutzi,Director,AnimalProductionandHealthDivision,FAO(Italy) Pretoria (SouthAfrica). Rapporteur: Chair, IdentiGENLtd(Ireland) Chair: "Global ConvergenceinFoodSupply1(EAGLES)" may be possible to develop new affordable and available therapies especially to those who those to especially therapies available and affordable new develop to possible be may it research, not further with However, available. do currently are that still treatments illnessesare the to respond patients hepatic many made, chronic been and has progress acute significant though from Even significant. that result mortality and morbidity preventive The offer to and hepatitis of increase. to causes continues infection hepatitis of cases diagnosed newly of number the regimens, viral many diagnose to ability our Despite “Viral Hepatitis:PromiseAwaitstheStealthEpidemic” ei Zaky, Yehia Chair: are sufferinginhepatitisendemicareas. Medicine, Ain ShamsUniversityandDirector, CairoLiverCenter El-Zayadi, Rahman Abdel Wahid Doss, Rapporteur: Alexandrina (Egypt) Hepatitis Band HepatitisC:FaceTo Bureau, MinistryofHealth, WelfareandLabour(Japan Medicine, MansouraUniversity (Egypt) ah Ad El-Aziz, Abd Farha idie cecs Fcly f aua ad giutrl cecs te nvriy of University the Sciences, Agricultural and Natural of Faculty Sciences, Wildlife

TBA Patrick Cunningham Professor of Animal Genetics, Trinity College, Dublin; College, Trinity Genetics, Animal of Professor Cunningham Patrick Break (VisitBioFair@BioVisionAlexandriaandPostersArea!)

TBA Raﬁk Nakhla,BibliothecaAlexandrina(Egypt) omn ae, rfso ad ed Dprmn o Aia and Animal of Department Head, and Professor Casey, Norman Head, theNationalLiverInstitute (Egypt) President,DonaldDanforthPlantScienceCenter(USA) CEO, TransAmGroup(USA) Director,BibliothecaAlexandrina(Egypt)

Research Scientist, Institute of Internal Medicine, Novosibirsk Medicine, Internal of Institute Scientist, Research rfso o Ciia Imnlg ad ahlg, aut of Faculty Pathology, and Immunology Clinical of Professor ed Aaei ad utrl ﬀis etr Bibliotheca Sector, Aﬀairs Cultural and Academic Head, rfso, rpcl eiie eatet Fcly of Faculty Department, Medicine Tropical Professor,

Lecture Hall Lecture

)

iiin elh Policy Health Division

(Egypt) Delegates Hall Provisional Program Provisional Great Hall BioVisionAlexandria April 2008

11:00-12:30 Environment Stream: Panel B-2: Small Theater “Water Resources: The Global Concern”

As the human population increases dramatically and the demands of industry and agriculture govern many societies, the strain on the available water resources becomes more and more diﬃcult to accommodate. Eﬃcient use of water to meet these demands is a vexed 2008 problem that involves not just appreciation of the physical quantity and quality of water resources but also the interaction with ecological, economic, social and political factors. So the incorporated management of water resources is a key issue for the sustainability of human society in many parts of the world.

Day 3 Chair: Ewald Schnug, Head, Institute for Plant Nutrition and Soil Science (Germany) Rapporteur: Salah Soliman, Professor, Faculty of Agriculture, Alexandria University (Egypt) Daniel Zimmer, Executive Director, World Water Council (France) Water Resources: the Need for Increased Hydrosolidarity Hani El-Nokraschy, CEO, Nokrashi Engineering GmbH (Germany) Solar Power Overcomes Water Deﬁcit in the Middle East – North Africa Dia El Quosy, Professor Emeritus at the National Water Research Center (Egypt) Future Challenges for Water Management in Egypt Abdel Ghani El-Gendy, Professor of Agri-engineering, Faculty of Agriculture, Ain Shams University (Egypt)

11:00-12:30 Food and Agriculture Stream: Panel C-2 : Lecture Hall “Global Convergence in Food Supply 2 (EAGLES)”

Chair: Malcolm Elliot, Executive Director, The Norman Borlaug Institute for Crop Improvement (UK) Day 3 Rapporteur: TBA Zhangliang Chen, Director, National Laboratory of Protein Engineering and Plant Genetic Engineering (China) Marilia Nutti, Director, National Research Center on Food Technology, Embrapa (Brazil)

Clive James, Chairman and Founder, ISAAA (USA) BioVisionAlexandria 11:00-12:30 Track 6: Project on South-to-South Collaboration for Genomics Innovation: “Plenum 1” Delegates Hall

The project has both mapped research and entrepreneurial collaboration between developing countries and carried out case study research in a wide set of developing countries. The case study research examined the factors and conditions that have shaped research and entrepreneurial collaboration and their impact on health biotechnology innovation in developing countries. 17 Chair: TBA Day 3 Rapporteur: TBA Halla Thorsteinsdottir, Professor, Mclaughlin – Rotman Center for Global health, University of Toronto (Canada) Tirso Saenz, Centre for Sustainable Development, University of Brasilia (Brazil) Christina Melon, University of Toronto, (Canada) Monali Ray, University of Toronto (Canada) Wen Ke, Institiute of Policy Management, Chineese Academy of Sciences (China) South to South Collaboration in Biotechnology- Case Study of China 12:30-13:30 Lunch Break 18 BioVisionAlexandria 2008 13:30-15:00 13:30-15:00 Day 3 Day 3 of GraduateStudiesandResearch, AlexandriaUniversity(Egypt) Soumya Swaminathan Development ofaVaccineAgainstTuberculosis:FromPromises toPractice Infection Biology(Germany) Rapporteur: Institutes ofHealth(USA) Chair: Joel Breman, Senior Scientific Advisor, Fogarty International Center, National older people. medicines, to reduce the vulnerability of affected persons, particularly orphan children and for prevention, treatment, care needed and support, as well resources as to provide of enhanced access to affordable presence the ensure to response international concerted a require and world entire serious the challenges to the achievement of development goals. for TB and other emerging diseases risks severe poses diseases infectious other among Tuberculosis “Tuberculosis: ComprehensiveOverviewandChallenges” Health Stream: Panel A-3: A-3: Panel Stream: Health Windeyer InstituteofMedicalSciences Rook, Gerham Tuberculosis: ComprehensiveOverviewandChallenges Chair: world communitythatrequiresconcretecollaborationsbetweenallconcernedgroups. the by faced challenges urgent most and greatest the of one represents change climate that doubt little now is There impacts. environmental and social economic, potential its and change climate global of magnitude and speed the over concern international an is There “Climate Change:ImpactsandResponses” Environment Stream:PanelB-3: of TwoDominicanRepublicBateyes Population Migrant Economic the in Tuberculosis Intrathoracic for Factors Risk for InternationalMedicine(USA) Rodney Finalle , Founder and Director, Children's Hospital of Philadelphia's Alliance Beijing (Norway) Embassy, Norwegian Royal Counsellor, Technology and Science Christie, Werner Countries thatNeedThem of theMontrealProtocol(Egypt Madkour, Samia Governing inaWorldofClimateChange (USA) Berg, J. Robert (Egypt) for Max-Planck-Institute Member, and Director Founding Kaufmann, Stefan Rapporteur Omar El-Arini, Rising SurfaceOzone:ItsImpactonPlantGrowthand Global Warming Damanhour, (Egypt) mlctos o te ein f ueclss acns ht il ok inthe Countries: Work will Developing That Vaccines and Tuberculosis Rich of Design in the for Systems Implications Immune between Differences Mohamed El-Raey, Mohamed

Adel El-Beltagy, :

Raﬁk Nakhla,BibliothecaAlexandrina(Egypt) Salah Soliman, Salah Honorary Chief Oﬃcer, the Multilateral Fund for the Implementation Professor, Centre for Infectious Diseases and International Health, International and Diseases Infectious for Centre Professor, Senior Advisor, World Federation of United Nations Associations Nations United of Federation World Advisor, Senior Professor of Environmental Physics and Former Dean, Institute Dean, Former and Physics Environmental of Professor rfso, aut o Arclue Aeadi University, Alexandria Agriculture, of Faculty Professor, , DeputyDirector,TuberculosisResearchCentre(India)

Chair, GlobalForumonAgriculturalResearch

Professor, Faculty of Agriculture, Alexandria University Alexandria Agriculture, of Faculty Professor,

Great Hall Great )

(UK) SmallTheater Provisional Program Provisional

(Egypt) BioVisionAlexandria April 2008

13:30-15:00 Food and Agriculture: Panel C-3: Lecture Hall “European Research Policy and Global Food Security (EAGLES)”

Chair: Huanming Yang, Co-Vice Chairman EAGLES (China) Rapporteur: Jorge Huete Perez (Nicaragua) 2008 Christian Hoste, Coordinator, French Agricultural Research Centre for International Day 3 Development (CIRAD) (France) Gurdev Khush, Adjunct Professor, University of California (USA) Improving the Nutritional Status of Food Crops Stephen Jarrett, Principal Adviser, UNICEF Supply Division (USA) Making Ready-To-Use Therapeutic Foods Readily Available to Treat Children with Severe Acute Malnutrition

13:30-15:00 Track 6: Project on South-to-South Collaboration for Genomics Innovation: Plenum 2 Delegates Hall Chair: TBA Rapporteur: TBA Magdy Madkour, Professor, Arid Lands Agricultural Research Institute (ALARI), Day 3 Faculty of Agriculture (Egypt) Sachin Chaturvedi, Research and Information System for Developing Countries (India) Victor Konde, Economic Aﬀairs Oﬃcer,UNCTAD’ Enterprise Policies and Capacity Building Section, DITE (Zambia) Characteristics and Drivers of International Health Biotechnology Collaborations in Africa

15:00-15:30 Break (Visit BioFair @BioVisionAlexandria and Posters Area!)

15:30-17:00 Health Stream: Panel A-4: Great Hall “New tools in Medicine: A World of Possibilities”

Several advancements and novel tools in medicine have evolved oﬀering solutions to combat infectious diseases and improve human health in both the developed and developing countries over the last decade. Advances in diagnostic medicine have come through the application of science and technology as a result of a coordinated eﬀort among academia, industry, government, and private institutions. A need for private-sector alliances and BioVisionAlexandria venture capital remains a conditional aspect in developing countries for them to succeed in bringing forth the newest and most powerful science and technology available for the modern-day practice of diagnostic laboratory medicine this era.

Day 3 Chair: Dianna Derhak, Director, Business Development, EPOS (USA); Co-Chair, Oxford University Conferences on Innovation and Technology Transfer for Global Health (USA) Rapporteur: Rafik Nakhla, Bibliotheca Alexandrina (Egypt) 19 Joel Nobel, Founder and Professor Emeritus, Emergency Care Research Institute (ECRI) (USA) The Tools of Medicine Pierre Anhoury, Senior Vice President, Business Leader Europe, MattsonJack (France), Clet Niyikiza, Vice President, GlaxoSmithKline (GSK) (Rwanda) Rafael Rangel-Aldao, Director, Project Digital Molecular Medicine and Professor of Biotechnology, Simon Bolivar University (Venezuela) Development of Digital Molecular Medicine in Venezuela Mohamed Ali Saber, Professor of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute (Egypt) 20 BioVisionAlexandria 2008 15:30-17:00 15:30-17:00 15:30-17:00 Day 3 Day 3 Day 3 Is "Natural"Always"Safe"And"Synthetic""Hazardous"? 2007 andtheprogressofJapan-EgyptYearScience and Technology2008. Technology and Science of Year German-Egyptian the on reports feature will session The Track 7:ScientificEgyptianPartnerships Food andAgricultureStream:PanelC-4: groups have found unjustified any possible risk to the environment posed by the introduction environmental many Therefore them. benefiting technology new this from derived product any seen yet not have countries developing or industrial the either in living people the of most challenges, millennium the meeting in plays now biotechnology role the with agree Although in principle most people with a certain knowledge of the potential of biotechnology “Environmental SafetyandBiotechnology:TrustingBiotechnology” Taizo Yakushiji,Member,theCouncilforScience andTechnologyPolicy(Japan) Ahmed Khairy, Maged El-Sherbiny, German EgyptianYearofScienceandTechnology2007 Christian Huelshoerster Rapporteur: (Egypt) Chair: Tom Arnold, Rebbie Harawa, Huanming Yang, Discussion Leaders: (Ireland) Production Animal for Association European President, Flanagan, Jim Rapporteur: (Ireland) Chair: Hans-Joerg Jacobsen, Saving thePlanetthroughBiotechnology Alexandria University(Egypt) Badr, Effat Japan's PolicyonPromotingBiotechnology and Trade Industry (Japan) Economy, of Ministry Division, Bio-industry Director, Limited Kurata, Kenji Pty Technology Environmental SafetyofBiotechnologicalInnovationsinCrops Arrays Diversity Manager, (Australia) General Huttner, Eric (Egypt) Rapporteur: Chair: of thesebiotechnologicalproducts. Environment Stream:PanelB-4: “EAGLES FoodSymposiumConclusionsandRecommendations”

João PaesdeCarvalho,

Tarek Hussein, President, Academy of Scientiﬁc Research and Technology and Research Scientiﬁc of Academy President, Hussein, Tarek ai McConnell, David

rfso Eeiu, eatet f eeis Fcly f Agriculture, of Faculty Genetics, of Department Emeritus, Professor TBA Salah Soliman, Professor, Faculty of Agriculture, Alexandria University Alexandria Agriculture, of Faculty Professor, Soliman, Salah Chairperson, theEuropeanFoodSecurityGroup(Ireland) Deputy, MinisterofHigher Education(Egypt) Science Coordinator,TheMillenniumVillage(Malawi) Co-Vice ChairmanEAGLES(China) Coordinator,German-Egyptian ScienceYear(Egypt) Institute forPlantGenetics,HannoverUniversity(Germany) , Director,DAADCairo

mrt nttt o Gntc, rnt Clee Dublin College Trinity Genetics, of Institute Smurﬁt

Principal, BiznessBrazil(Brazil)

(Germany)

Delegates Hall Small Theater Lecture Hall Provisional Program Provisional BioVisionAlexandria April 2008

17:30- 19:00 Evening Event 2: CEO Panel: Great Hall “The Outbreak in Drug Discoveries and Vaccine Technologies”

Vaccines have led to some of the greatest achievements in public health and are among the most cost-effective health interventions. Recombinant technologies are now at the forefront of efforts to produce new vaccines for diseases once thought to be out of reach for prevention 2008 efforts. The development and delivery of new and existing vaccines remain a formidable challenge. The vision of change is driven principally by the need to make the delivery system more equitable, safer and more efficient.

Chair: Ismail Serageldin, Director, Bibliotheca Alexandrina (Egypt) Day 3 Rapporteur: Francis Vella, Coordinator, Secretariat, EURODOC (France)

Clet Niyikiza, Vice President, GlaxoSmithKline (GSK) (Rwanda) Yves Champey, Chairman, Drug for Neglected Diseases initiative (DNDi) and CEO, Genopole (France) From Promises to Practice: The Case for Drug and Therapeutic Innovation Research Paul Herrling, Head, Corporate Research, Novartis (Switzerland) Jacques-François Martin, President and CEO, Parteurop (France) Vaccines in Public Health: Challenges and Opportunities for the Next Decade

17:30- 19:00 Track 8: PRRI– Participation of Public Researchers in Cartagena Protocol and the Biodiversity Convention Delegates Hall

In 2004, the Public Research and Regulation Initiative (PRRI) was established with the objective of oﬀering public researchers, involved in modern biotechnology, a forum through which they become informed about and involved in relevant international discussions.

Chair: Marc van Montagu, Elected and Acting President, the European Federation of Technology (Belgium) Day 3 Rapporteur: Salah Soliman, Professor, Faculty of Agriculture, Alexandria University (Egypt) Clive James, Chairman and Founder, ISAAA (USA) The Role of Biotechnology in Sustainable Production of Food, BioVisionAlexandria BioVisionAlexandria Feed and Fiber in Developing Countrie Piet van der Meer, Executive Secretary, Public Research and Regulation Initiative (PRRI) (Belgium) Participation of Public Researchers in the Cartagena Protocol and the Biodiversity Convention

21 22 BioVisionAlexandria 2008 09:00-10:30 09:00-10:30 Day 4 Day 4 “Gene ModificationsandAdvancesinRecombinantTechnologies” A-5: Panel Stream: Health Sergei Varfolomeev, Jane Morris,Director,AfricanCentreforGeneTechnologies(SouthAfrica) Rapporteur: Infection Biology(Germany) Chair: developing countries. A Patient Friendly Framework for Introducing Novel Interventions into Clinical into Interventions Novel Introducing for Framework Friendly Patient A (Spain) Environment Stream:PanelB-5: And StrategiesForTherapeuticalIntervention Immune Escape Of Tumor Cells: Molecular Mechanisms Of Complement Resistance Heidelberg (Germany) of Diversity Functional and Structural as Variation Biomacromolecules. ThePathwaytoIndividualMedicine Genetic Human Sciences (Russia) Chair: for moreNorth-Southpartnerships. “ Kirschfink, Michael Practice Alastair Kent hita Suojanen, Christian Agriculture Private-Government-Academia: TriangleLeadershipinA Bio-Intelligent Companies Association(FELAEB) (Uruguay) Shotkoski, Frank Avesthagen- IndianBiotechSuccess Villoo Patell (Egypt) Rapporteur: Salah Soliman, Professor, Faculty of Agriculture, Alexandria University with a need for more cost effectiveness studies of these technologies in both developed and developed both in technologies these of studies effectiveness cost more for need a with but come, to yet is More hormones. growth human and interferon, insulin, antibiotics, effective more and safer developing for as well as hepatitis further and diabetes, developed cancer, fight being to is biotechnology Pharmaceutical cells. target on impact more potent and effects side fewer include biotechnology health of current advantages distinct our The for challenges. hopes great provides diseases, individual for specificities alter to Using biotechnology in terms of genetic modifications and DNA-recombinant technologies , President, Latin American Federation of National Biotechnology National of Federation American Latin President, Pagliano, Daniel Agriculture biotechnology:ARoadMaptoCommercialization Cornell University(USA) Such models provide many valuable lessons for South-South collaborations and promote and collaborations South-South for lessons valuable many provide models Such sector. private the of efficiencies and expertise the and support, and policies government are success this for components important The biotechnology. and technology information as demonstrated such fields, technology has high emerging innovation in successful be and can country developing biotechnology any that of field the in model leading India's Home GrownBiotechFirms”

Claudio Carlone,Chairman,Hypothesis(Italy) Stefan Kaufmann, Founding Director and Member, Max-Planck-Institute for

, FounderandCMD,AvesthagenLimited(India) Raﬁk Nakhla,BibliothecaAlexandrina(Egypt) Director,GeneticInterestGroup(UK) Director, Agricultural Biotechnology Support Project (ABSP) II, (ABSP) Project Support Biotechnology Agricultural Director, Wednesday, 16April2008 Director, Institute of Biochemical Physics, Russian Academy of rfso o Imnlg, eia Fcly Uiest of University Faculty, Medical Immunology, of Professor ertr Gnrl Erpa Fdrto o Biotechnology of Federation European General, Secretary

Small Theater Provisional Program Provisional Great Hall Great

BioVisionAlexandria April 2008

09:00-10:30 Food and Agriculture Stream: Panel C-5: Lecture Hall “Agricultural Biotechnology: Food for a Better World”

Agricultural Biotechnology has enormously contributed to the production of healthier foods, better animal feeds and more ﬁber, while also preserving the environment through reduction in pesticide applications and soil erosion. Much research has been dedicated to 2008 the growing role of plant biotechnology in the poorest developing countries, as well as the global crop economy. Biotech food could possibly provide various means of increasing food production and alleviating hunger and malnutrition.

Chair: Klaus Amann, Guest Professor, Delft University of Technology (Switzerland) Rapporteur: Eric Huttner, General Manager, Diversity Arrays Technology Pty Limited (Australia) Mpoko Bokanga, Executive Director, African Agricultural Technology Foundation Day 4 (Kenya). Comparative Eﬀect Of Regulations On The Dissemination Of Bioscience-Based Application To African Agriculture Gnissa Konaté , Director , Agricultural and Environmental Institute (INERA) (Burkina Faso) Socio-Economic And Environmental Impacts Of Bt Cotton Varieties Under Burkina Faso Cropping Conditions Natalie Dinicola, Director, International Partnerships, Monsanto (USA) Public-Private Partnerships To Enable Agricultural Technology Access Magdy Abdelzaher, Professor, Faculty of Agriculture, University of Alexandria (Egypt) 09:00-10:30 Track 9: Bio-ethics: Racing up the Road to Research Delegates Hall

The critical bioethical case in point strikes a raw nerve in every conscientious biomedical researcher. Clinical research involving human subjects – testing either medicinal products or other treatments – and biomedical research involving the processing of human biological samples or personal data must meet certain ethical norms on the protection of participants. The guidelines relate mainly to ethical justification and scientific validity of research; ethical review; informed consent; vulnerability of individuals, groups, communities and populations. Therefore, establishing ethical principles and developing worldwide policies BioVisionAlexandria BioVisionAlexandria for scientific research has become an essential step for the advancement of science and technology.

Day 4 Chair: Peter Singer, Sun Life Financial Chair in Bioethics and Director, University of Toronto Joint Centre for Bioethics (Canada) Rapporteur: Quentin Cooper, Broadcaster and Science Journalist (UK) Sandy Thomas,Director, Foresight (UK) Eberhard Schockenhoﬀ, Professor, Albert-Ludwigs-Universität Freiburg (Germany) Aida Al Aqeel, Senior Consultant Pediatric Medical Geneticist and Endocrinologist, 23 Department of Pediatrics , Riyadh Military Hospital (Saudi Arabia) Ethics and Genetics : An Islamic Perspective Cynthia P Schneider, Executive Director, Perspectives in the Future of Science and Technology; Former Ambassador, the United States to the Kingdom of the Netherlands (USA) Ethics Meets the Marketplace: the Virtual Incubator Model for Building Knowledge-Based Economic Development 10:30-11:00 Break (Visit BioFair @BioVisionAlexandria and Posters Area) 24 BioVisionAlexandria 2008 11:00-14:00 Day 4 by sharingtheirviewsandhopesontheglobalapplicationsofLifeSciences International leaders will close the World Life Sciences Forum BioVisionAlexandria 2008 Health Stream: to open and presented discussion forallparticipants. be will streams three the of Recommendations and Conclusions “ Plenary Session7: (FAO) (Italy) Magdi Yacoub, Professor of Cardiothoracic Surgery, Imperial College of London and Food andAgricultureStream: University (Egypt Stream: Environment ae Ghanem, Hafez Head, theMagdiYacoubCardiacResearchCenter(UK) Ismail Serageldin, Reporting andClosingSession” RaﬁkNakhla, ) sitn Drco-eea, od n Arclue Organization Agriculture and Food Director-General, Assistant Director, BibliothecaAlexandrina(Egypt) Salah Soliman, Salah TBA Bibliotheca Alexandrina(Egypt)

Professor, Faculty of Agriculture, Alexandria Agriculture, of Faculty Professor, Great Hall . Provisional Program Provisional

BioVisionAlexandria April 2008 2008

Speaker List BioVisionAlexandria BioVisionAlexandria

26 Speaker List 2008 Nobel Laureates

Ernst, Richard R. Wiesel, Torsten N. Chemistry 1991(Switzerland) Physiology or Medicine 1981 (USA) Session 1 Session 1

Fenn, John Chemistry 2002(USA) Rowland, F. Sherwood Session 1 Chemistry 1995 (USA) Session 2

S p e a k e r s A

Abd El-Aziz, Farha Professor of Clinical Immunology & Pathology, Faculty of Medicine, El-Mansoura University (Egypt) Panel A-2

Abdel-Latif, Ahmed Program Manager, IPR Programs, ICTSD (Switzerland) Track 2 BioVisionAlexandria BioVisionAlexandria

Abd El Wahab, Hala Head, Resource and Development Unit, Bibliotheca Alexandrina (Egypt) Track 3

Abdelzaher, Magdy Faculty of Agriculture, Saba Basha, University of Alexandria (Egypt) 27 Panel C-5

Abou Zeid, Perihan Private Lawyer and Lecturer, the Arab Academy for Science, Technology and Maritime Transport. (Egypt) Track 2

Al Aqeel, Aida Senior Consultant Pediatric Medical Geneticist and Endocrinologist, Department of Pediatrics, Riyadh Military Hospital (Saudi Arabia) Track 4 Plenum 2, Track 9 BioVisionAlexandria April 2008

Amaral, Weber Professor and CEO Brazilian Biofuels Programme (Brazil) Plenary Session 4

Ammann, Klaus 2008 Guest Professor, Delft University of Technology (Switzerland) Panel C- 5

Anhoury, Pierre Senior Vice President, Europe for MattsonJack (France) Session 1, Session 2, Panel A-4

Arab, Morsi IDF Regional Chair Diabetes, EMME Region (Egypt) Track 1

Araki, Kazuhiro Director, Research and Development Division Health Policy Bureau, Ministry of Health, Welfare and Labour (Japan) Panel A-2

Arnold, Tom Chairperson, the European Food Security Group (Ireland) Panel C-4

Ashour, Fayrouz Diabetes Supercourse Project Coordinator, Bibliotheca Alexandrina (Egypt) Track 1

Assaad-Khalil, Samir H. Head, Department of Internal Medicine and Head, Unit of Diabetes and Metabolism, Faculty of BioVisionAlexandria BioVisionAlexandria Medicine, Alexandria University (Egypt) Track 1

Azzazy, Hassan M. E. Chairman and Associate Professor, Department of Chemistry, The American University in Cairo (Egypt) Panel A -1

28 B

Badr, Eﬀat Professor Emeritus. Dept. of Genetics, Faculty of Agriculture, Alexandria University (Egypt) Panel B-4

Badran, Ibrahim Former Minister of Health (Egypt) Track 4 Plenum1 Speaker List

Balzi, Elisabetta Directorate-General for Research, Food, Agriculture and Biotechnology Unit, European Commission (Belgium) Track 3 2008 Baydoun, Elias Professor of Biology, American University of Beirut (Lebanon) Track 4 Plenum1

Bayoumi, Riad Professor and Head of Clinical Biochemistry, the College of Medicine, Sultan Qaboos University (Oman) Track 4 Plenum 2

Beachy, Roger President, Donald Danforth Plant Science Center (USA) Panel C-1

Benediktsson, Indridi Scientiﬁc Oﬃcer, European Commission (Belgium) Track 2

Berg, Robert J. Senior Advisor, World Federation of United Nations Associations (USA) Panel B-3

Bokanga, Mpoko Executive Director, African Agricultural Technology Foundation (Kenya) Panel C-5

Bouis, Howarth

BioVisionAlexandria BioVisionAlexandria Director, HarvestPlus (USA) Plenary Session 2

Breman, Joel Senior Scientiﬁc Advisor, Fogarty International Center, National Institutes of Health (USA) Plenary Session 2, Panel A-3

29 C

Carlone, Claudio Chairman, Hypothesis (Italy) Panel B-5

Casey, Norman Professor, Department of Animal and Wildlife Sciences, Faculty of Natural and Agricultural Sciences, the University of Pretoria. (South Africa) Panel C-1 BioVisionAlexandria April 2008

Catley-Carlson, Margaret Chair, Global Water Partnership (USA) Session 2

Champey, Yves 2008 Chairman, Drug for Neglected Diseases initiative (DNDi) and CEO, Genopole (France) Evening Event 2

Chaturvedi, Sachin Research and Information System for Developing Countries. (India) Track 6 Plenum 2

Chen, Zhangliang Director, National Laboratory of Protein Engineering and Plant Genetic Engineering (China) Panel C-2

Christie, Werner Science and Technology Counselor, Royal Norwegian Embassy, Beijing (Norway) Panel A-3

Chu, Chengcai Principle Investigator and Laboratory Head, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences (CAS) (China) Plenary 5

Clark, Brian Vice President, European Federation of Biotechnology (Denmark) Track 4 Plenum 2

Cooper, Quentin Broadcaster and Science Journalist (UK) BioVisionAlexandria BioVisionAlexandria Track 1, Track 9

Cunningham, Patrick Professor of Animal Genetics, Trinity College, Dublin and Chair, IdentiGEN Ltd (Ireland) Panel C-1

30 D

Daar, Abdallah Professor of Public Health, University of Toronto Network (Canada) Plenary Session 2, Track 4 Plenum 2

Daub, Carsten Team Leader of the Bioinformatics Team, Genome Exploration Research Group, Genomic Science Center, RIKEN Yokohama Institute (Japan) Plenary Session 3 Speaker List

Degett, Jens Executive Director, the European Action in Global Life Sciences (EAGLES) (Spain)

Derhak, Dianna Director of Business Development, EPOS USA, Co-Chair Oxford Univeristy Conferences on Innovation 2008 and Technology Transfer for Global Health (USA) Track 4 Plenum 2, Panel A-4

Desmarescaux, Philippe Chairman, The World Life Sciences Forum, BioVision (France) Opening Session

Diderichsen, Boerge Vice President, Corporate Research Aﬀairs, Novo Nordisk (Denmark) Track 1

Dinicola, Natalie Director, International Partnerships, Monsanto (USA) Panel C-5

Discher, Dennis E. Professor of Chemical and Biomolecular, Mechanical, and Bio- Engineering, University of Pennsylvania (USA) Panel A -1

Doss, Wahid Head, the National Liver Institute (Egypt) Panel A-2

BioVisionAlexandria BioVisionAlexandria E

Echeverria, Rubin Director, the CGIAR Science Council (Italy) Plenary Session 5

El-Arini, Omar 31 Honorary Chief Oﬃcer, the Multilateral Fund for the Implementation of the Montreal Protocol (Egypt) Panel B-3

El-Awadi, Mohamed Professor, Faculty of Pharmacy, Tanta University (Egypt) Track 4 Plenum 1, Plenum 2 and Plenum 3

El-Beltagy, Adel Chair, Global Forum on Agricultural Research (Egypt) Panel B-1, Panel B-3

BioVisionAlexandria April 2008

El-Gendy, Abdel Ghani Professor of Agri-engineering, Faculty of Agriculture, Ain Shams University (Egypt) Panel B-2

Elliott, Malcolm 2008 Executive Director, The Norman Borlaug Institute for Crop Improvement (UK) Panel C-1, Panel C-2

El-Nokraschy, Hani CEO, Nokraschy Engineering GmbH (Germany) Panel B-1, Panel B-2

El- Raey, Mohamed Professor of Environmental Physics and Former Dean, Institute of Graduate Studies and Research, Alexandria University (Egypt) Panel B-3

El-Sherbiny, Maged Coordinator, German-Egyptian Science Year (Egypt) Track 6

El Quosy, Dia Professor Emeritus, the National Water Research Center (Egypt) Panel B-2

El-Zayadi, Abdel-Rahman Professor, Tropical Medicine Department, Ain Shams Faculty of Medicine and Director, Cairo Liver Center (Egypt) Panel A-2

El-Zoheiry, Hamid BioVisionAlexandria BioVisionAlexandria Coordinator, European commission (Egypt) Track 3

Finalle, Rodney Founder and Executive Director, Children's Hospital of Philadelphia's Alliance for International 32 Medicine (USA) Panel A-3

Flanagan, Jim President, European Association for Animal Production (Ireland) Panel C-4

Fraser, John Assistant Vice President for Research and Economic Development, Florida State University (USA). Track 3 Speaker List

Ganguli, Prabuddha CEO, Vision-IPR (India)

2008 Plenary Session1, Track 2

Ghanem, Hafez Assistant Director-General, Food and Agriculture Organization (FAO) (Italy) Closing Session

Gillespie, Iain Head of Biotechnology Division, Directorate for Science, Technology and Industry, OECD (France) Plenary Session 2

Hamed, Mohamed Raouf Professor of Pharmacology and Toxicology, National Organization for Drug Control and Research (Egypt) Track 2

Hamer, Geoﬀrey Honorary Secretary, Biofocus Foundation (UK) Plenary Session 4

Harawa, Rebbie Team Leader and Science Coordinator, The Millennium Village (Malawi) Panel C-4

BioVisionAlexandria BioVisionAlexandria Hassan, Mohamed Executive Director, The Academy of Sciences for the Developing World (TWAS) (Sudan) Opening Session

Hassouna, Salah Professor, High Institute of Graduate Studies and Research, Alexandria University, Alexandria (Egypt) Plenary Session 4

Helal, Hany 33 Minister of Higher Education (Egypt) Opening Session

Herrera-Estrella, Luis Head, National Laboratory of Genomics for Biodiversity, Center for Research and Advanced Studies, the National Polytechnic Institute (Mexico) Plenary 5

Herrling, Paul Head, Corporate Research, Novartis (Switzerland) Evening Event 2 BioVisionAlexandria April 2008

Hillman, John Former Director, Scottish Crop Research Institute (SCRI) (UK) Track 4 Plenum1

Hoste, Christian 2008 Coordinator, French Agricultural Research Centre for International Development (CIRAD) (France) Panel C-3

Huelshoerster, Christian Director, DAAD oﬃce in Cairo (Germany) Track 7

Hussein, Tarek President, Academy of Scientiﬁc Research and Technology (Egypt) Track 7

Huttner, Eric General Manager, Diversity Arrays Technology Pty Limited (Australia) Panel B-1, Panel B-4, Panel C-5 J

Jacobsen, Hans- Joerg Professor, Institute for Plant Genetics, Hannover University (Germany) Panel B-4

James, Clive Chairman and Founder of ISAAA (USA) Panel C-2, Track 8

Jarrett, Stephen BioVisionAlexandria BioVisionAlexandria Principal Adviser, UNICEF Supply Division (USA) Panel C-3

Joergensen, Birte Holst Managing Director, Nordic Energy Research (Denmark) Plenary Session 4

Jutzi, Samuel 34 Director, Animal Production and Health Division, FAO (Italy) Panel C-1

Kaufmann, Stefan Founding Director and Member, Max-Planck-Institute for Infection Biology (Germany) Panel A-3, Panel A-5 Speaker List

Ke, Wen Institute of Policy Management, Chinese Academy of Sciences. (China) Track 6 Plenum 1

Kent, Alastair 2008 Director, Genetic Interest Group (UK) Panel A-5

Khairy, Ahmed Deputy, Minister of Higher Education (Egypt) Track 7

Khush, Gurdev Adjunct Professor, University of California (USA) Panel C-3

Kilama, John President, Global Bioscience Development Institute (USA) Plenary Session1

Kirschﬁnk, Michael Professor of Immunology, Medical Faculty, University of Heidelberg (Germany) Panel A-5

Kitasato, Ichiro President, Japan Bioindustry Association (JBA) (Japan) Plenary Session1

Konaté, Gnissa Director, Agricultural and Environmental Institute (INERA) (Burkina Faso) Panel C-5 BioVisionAlexandria BioVisionAlexandria

Konde, Victor Economic Aﬀairs Oﬃcer,UNCTAD’ Enterprise Policies and Capacity Building Section, DITE (Zambia) Track 6 Plenum 2

Krattiger, Anatole Research Professor, Arizona State (USA) Track 2 35 Kurasaki, Takaaki Director, Division of Advanced Medical and Radiological Science, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Japan) Panel A -1

Kurata, Kenji Director, Bio-Industry Division, Ministry of Economy, Trade and Industry (Japan) Panel B-4 BioVisionAlexandria April 2008

Lang, Roland Institute of Medical Microbiology, Immunology and Hygiene, Technical University of

Munich (Germany) 2008 Plenary Session 3

Laporte, Ronald Professor of Epidemiology, Graduate School of Public Health, University of Pittsburgh (USA) Track 1, Track 5

Linkov, Faina Research Assistant Professor of Medicine, University of Pittsburgh Cancer Institute (USA) Track 5

Madkour, Magdy Professor, Arid Lands Agricultural Research Institute (ALARI), Faculty of Agriculture, Ain Shams University (Egypt) Track 2, Track 6 Plenum 2

Madkour, Samia Professor, Faculty of Agriculture, Alexandria University, Damanhour, (Egypt) Panel B-3

Marei, Mona K. Professor of Prosthodontics and Head, Tissue Engineering Laboratories, Faculty of dentistry, Alexandria University (Egypt) Track 4 Plenum1 BioVisionAlexandria BioVisionAlexandria

Martin, Jacques-François President and CEO, Parteurop (France) Evening Event 2

Marton-Lefèvre, Julia Director General, The World Conservation Union (IUCN)(Switzerland) Session 1 36

Massoud, Ahmed Professor, Faculty of Dentistry, Alexandria University and Director, Egyptian Association for Continuing Education and Training (Egypt) Panel A -1

McConnell, David Co-Vice Chairman, EAGLES and Professor, Department of Genetics, University of Dublin (Ireland) Panel C-4 Speaker List

Melon, Christina C. University of Toronto (Canada) Track 6 Plenum 1

Mooney, Pat 2008 Executive Director, ETC Group (Canada) Panel B-1

Morris, Jane Director, African Centre for Gene Technologies (South Africa) Plenary Session 3, Panel A-5

Moussa, Mariam Research Specialist, Center for Special Studies and Programs, Bibliotheca Alexandrina (Egypt). Rapporteur

Nakhla, Raﬁk Bibliotheca Alexandrina (Egypt) Rapporteur

Nazif, Ahmed Prime Minister (Egypt) Opening Session

Niyikiza, Clet Vice President, GlaxoSmithKline (GSK) (Rwanda) Panel A-4, Evening Event 2 BioVisionAlexandria BioVisionAlexandria Nobel, Joel Founder and Professor Emeritus, Emergency Care Research Institute (ECRI) (USA) Panel A-4

Norrby, Erling Secretary General, the Royal Swedish Academy of Sciences (USA) Session 2 37 Nutti, Marilia Researcher, National Research Center on Food Technology, Embrapa (Brazil) Plenary Session 2, Panel C-2

Oborne, Michael Director, International Futures Programme, OECD - French Delegation (France) Plenary Session 2 BioVisionAlexandria April 2008

Omi, Koji Former Japanese Minister of State for Science and Technology Policy (Japan) Opening Session

P 2008

Paes de Carvalho, João Principal, BiznessBrazil (Brazil) Plenary Session 4, Panel B-4

Pagliano, Daniel President, Latin American Federation of National Biotechnology Companies Association (FELAEB) (Uruguay) Panel B-5

Patell, Villoo Morawala Founder and CMD, Avesthagen Limited (India) Panel B-5

Perez, Jorge Huete (Nicaragua) Panel C-3

Potocnik, Janez European Commissioner for Science and Research, European Commission (Belgium) (video message) Opening Session

R BioVisionAlexandria

Rabbinge, Roelof Professor, Wageningen University and Chair, the Science Council of the CGIAR (Netherlands) Plenary Session1, Plenary Session 4

Rangel-Aldao, Rafael Director, Project Digital Molecular Medicine and Professor of Biotechnology, Simon Bolivar University (Venezuela) 38 Panel A-4

Ray, Monali University of Toronto (Canada) Track 6 Plenum 1

Reva, Oleg National Bioinformatics Network Node Manager, ACGT Bioinformatics and Computational Biology Unit University of Pretoria (South Africa). Plenary Session 3 Speaker List

Rios, Gilbert M. Coordinator, NanoMemPro Network of Excellence (France) Panel A -1

Rook, Graham 2008 Professor, Centre for Infectious Diseases and International Health, Windeyer Institute of Medical Sciences (UK) Panel A-3

Saber, Mohamed Ali Professor of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute (Egypt) Track 4 Plenum 3

Sachez, Elena Science Counselor, Delegation of the European Commission in Egypt (Belgium) Track 3

Sachs, Jeﬀrey D. Director, Earth Institute (USA) (video message) Session 2

Saenz, Tirso Centre for Sustainable Development, University of Brasilia (Brazil) Track 6 Plenum 1

Sauer, Francois CEO, Trans Am Group (USA) Track 5 BioVisionAlexandria BioVisionAlexandria

Schneider, Cynthia Executive Director, Perspectives in the Future of Science and Technology and former Ambassador, the United States to the Kingdom of the Netherlands (USA) Track 7

Schnug, Ewald 39 Head, Institute for Plant Nutrition and Soil Science (Germany) Panel B-1, Panel B-2

Schockenhoﬀ, Eberhard Professor, Albert-Ludwigs-Universität Freiburg (Germany) Track 9

Serageldin, Ismail Director, Bibliotheca Alexandrina (Egypt) Opening Session, Evening Event 1, Plenary session 1, Plenary Session 5, Track 5, Evening Event 2, Closing Session BioVisionAlexandria April 2008

Shotkoski, Frank Director, Agricultural Biotechnology Support Project (ABSP) II, Cornell University (USA) Panel B-5

Shoukry, Mohsen 2008 Professor, Academy of Scientiﬁc Research and Technology (Egypt) Track 4 Plenum 1

Shubnikov, Eugene Research Scientist, Institute of Internal Medicine, Novosibirsk (Russia) Track 5

Singer, Peter Sun Life Financial Chair in Bioethics & Director, University of Toronto Joint Centre for Bioethics (Canada) Plenary Session 1, Track 9

Soliman, Salah Faculty of Agriculture, Alexandria University (Egypt) Rapporteur

Suojanen, Christian Secretary General, European Federation of Biotechnology (Spain) Panel B-5

Swaminathan, Soumya Deputy Director, Tuberculosis Research Centre (India) Panel A-3

T BioVisionAlexandria

TThomas, Sandy Director, Foresight (UK) Track 9

Thomson, Jennifer Professor, Department of Molecular Biology, Cape Town University (South Africa) 40 Panel C-1

Thorsteinsdottir, Halla Mclaughlin – Rotman Center for Global health, University of Toronto (Canada) Track 6, Plenum 1

Trigo , Eduardo J. Director, Grupo CEO Consulters S.A. and Scientiﬁc Adviser, Directorate for International Relations, Ministry for Science, Technology and Innovation (Argentina) Plenary 5 Speaker List

Van der Meer, Piet Executive Secretary, Public Research and Regulation Initiative (PRRI) (Belgium)

2008 Track 8

Van Montagu, Marc Elected and Acting President, the European Federation of Technology (Belgium) Plenary 5, Track 8

Varfolomeev, Sergei Director, Institute of Biochemical Physics, Russian Academy of Sciences (Russia) Panel A-5

Vella, Francis Postdoctoral Researcher, EURODOC (Belgium) Evening Event: CEO Panel Y

Yacoub, Magdi Professor of Cardiothoracic Surgery, Imperial College of London and Head, the Magdi Yacoub Cardiac Research Center (UK) Closing Session

Yakushiji, Taizo Member, the Council for Science and Technology Policy (Japan) Track 7

Yang, Huanming

BioVisionAlexandria BioVisionAlexandria Director, Beijing Genomics Institute, Chinese Academy of Sciences and Director, Huada Genomics Research Center (China) Plenary Session 3, Panel C-3, Panel C-4

Yilma, Tilahun Distinguished Professor, Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California (USA) Plenary 5 41 Z

Zimmer, Daniel Executive Director, World Water Council (France) Panel B-2

Zaky, Yehia Head, Academic and Cultural Aﬀairs Sector, Bibliotheca Alexandrina (Egypt) Plenary 2, Panel A-2 Nobel Laureates 2008 BioVisionAlexandria BioVisionAlexandria

42 BioVisionAlexandria April 2008 2008

Nobel Laureates BioVisionAlexandria BioVisionAlexandria

43 Nobel Laureates

ERNST, Richard R. 1991 Chemistry

Richard Robert Ernst is a Swiss physical chemist and Nobel Laureate. Born in Winterthur, Switzerland, Ernst was awarded the Nobel Prize in Chemistry 2008 in 1991 for his contributions towards the development of Fourier transform nuclear magnetic resonance spectroscopy while at Varian Associates, Palo Alto, and for the subsequent development of multi-dimensional NMR techniques. These underpin applications of NMR both to chemistry (NMR spectroscopy) and to medicine (MRI). He also received Louisa Gross Horwitz Prize in 1991. He studied at and served in the faculty of the Eidgenössische Technische Hochschule (Federal Institute of Technology) in Zürich, Switzerland from which he is now retired.

Abstract

Today’s Providence for Tomorrow’s Survival R.R. Ernst, Chemistry 1991

Today's means in human hands, for constructive or destructive actions are nearly unlimited. We urgently need control mechanisms on various levels. Perhaps the most effective one relies on education towards societal responsibility. Only when we learn to respect the needs of others, also of future generations, instead of maximizing our personal profit, we will contribute to the world's stability and future hospitability. In the context of current globalization, global institutions are indispensable in defining the rules of international trade and cooperation. The BioVisionAlexandria BioVisionAlexandria

44 BioVisionAlexandria April 2008

FENN, John 2002 Chemistry

John Bennett Fenn (born 15 June 1917 in New York City) is a research professor of analytical chemistry who was awarded the Nobel Prize in Chemistry in 2002. Fenn won the award for his work in the field of mass 2008 spectrometry, specifically for the electrospray ionization technique often used to identify and analyze biological macromolecules. He was awarded the Association of Biomolecular Resource Facilities Award for outstanding contributions to Biomolecular Technologies in 2002. Fenn earned his AB degree from Berea College, and PhD from Yale University in 1940. He then spent three years at Princeton University as Director of SQUID Project, funded by the Office of Naval Research. He joined the Yale University faculty in 1962. Fenn joined Virginia Commonwealth University in 1994 as professor of analytical chemistry, after more than 20 years at Yale University. BioVisionAlexandria BioVisionAlexandria

45 Nobel Laureates

ROWLAND, F. Sherwood 1995 Chemistry

Sherwood Rowland, born in 1927, is an American chemist who shared the 1995 Nobel Prize in Chemistry with chemists Mario Molina and Paul 2008 Crutzen for research on the depletion of the Earth's ozone layer. Rowland specializes in the research areas of radiochemistry, photochemistry, and atmospheric chemistry. Rowland, while working with Molina, discovered that man-made chlorofluorocarbon (CFC) propellants accelerate the decomposition of the ozonosphere, which protects the Earth from biologically harmful ultraviolet radiation. Rowland and Molina theorized that CFC gases combine with solar radiation and decompose in the stratosphere, releasing atoms of chlorine and chlorine monoxide that are able to destroy large numbers of ozone molecules. Rowland has also been investigating the effect of methane gas, which has been steadily increasing in concentration, on the atmosphere. Methane absorbs global infrared radiation, increases in its concentration, and thus contributes to the “greenhouse effect”; the gradual warming of the Earth's surface. He is currently the elected Foreign Secretary of the National Academy of Sciences. Awards offered to Rowland include the Tyler World Prize in Ecology and Energy, and the Albert Einstein Prize.

Abstract

The Greenhouse Gases and Global Climate Change F. S. Rowland, Chemistry 1995

The incoming solar energy lies chiefly in the visible wavelengths from violet (400 nanometers) to red (700 nm), and the invisible wavelengths just longer than the red (the near infrared to about 1100 nm), corresponding to the surface temperature of the sun (about 5000 °Kelvin). The calculated surface temperature of the Earth for an equivalent amount of energy to escape from the Earth is 255 degrees °K (-18°C), with the single assumption that all of the terrestrial emission in the far infrared escapes directly to space. However, this assumption cannot be accurate, because the average surface temperature of the Earth is about 287 °K, or +14°C. This difference of 32 ° (K or C) is the natural greenhouse effect. Most of the gases which make up the atmosphere BioVisionAlexandria BioVisionAlexandria are either diatomic or monatomic, and are transparent in the far infrared. Consequently, the only gases which absorb the terrestrial far infrared radiation are trace gases, with three or more atoms per molecule: carbon dioxide (CO2), methane (CH4), nitrous oxide (N2O), water vapor (H2O), etc., which are collectively called the greenhouse gases. Measurements in the atmosphere have established that each of the first three gases, and some others, have been increasing in global concentration over the past half-century largely because of the activities of mankind. The present concern is how much additional warming above the 32 degrees from the natural greenhouse gases will be caused by these additions to the atmosphere. Studies of ancient gases stored in ice 46 cores taken from glaciers, have shown that methane varied in its atmospheric concentrations from 0.3 to 0.7 ppm over the last 450,000 years, until the rise to the present levels began around BioVisionAlexandria April 2008

Wiesel, Torsten N 1981 Physiology or Medicine

Torsten N. Wiesel was awarded the Nobel Prize for Physiology or Medicine in 1981 in recognition of his pioneering work on the neural basis of visual perception, carried out at Harvard Medical School in collaboration with 2008 David Hubel. He served as President of the Rockefeller University from 1992-1998. He was awarded the National Medal of Science (USA) in 2005 in recognition not only of his scientific excellence but also of his outstanding leadership in international scientific supporting collaboration, principally as Secretary General of the Human Frontier Science Program since 2000. He also currently co-chairs the Board of Governors of Okinawa Institute of Science and Technology, chairs the Scientific Council of the Israeli-Palestinian Science Organization and serves on the Board of the Pew Center on Global Climate Change. He is a member of many distinguished societies, including the Royal Society, the National Academy of Sciences, the Philosophical Society, the Royal Swedish Academy of Sciences and Chinese Academy of Sciences BioVisionAlexandria BioVisionAlexandria

47 48 BioVisionAlexandria 2008 Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 s e i h s p t a c r a g r o t i s B b A ’ s & r e k a e p S

49 BioVisionAlexandria 2008 50 BioVisionAlexandria 2008 n itrrpig f hs atraie ot pce poie ucet ucinl eue for refuges could that strains functional resistant potential with mate would sufficient which borers of populations providesusceptible species host alternative these of intercropping and Cropping nubilalis. O. for hosts are tomato and pepper potato, Agamemnon; C. for host a is The study revealed that few vegetable crops could act as alternative hosts for corn borers: cabbage Barnyardand nubilalis. GrassO. and/or Agamemnon creticaC. S. and/or for are hosts specific Reed,BroomCommon Sorghum,Sweet cry1Ac. resistantto strains Sorghum,Sugarcane, Rice alternative hosts can be used as functional refuge for diluting the probable development of insect dynamic of borers’ population on corn and alternative plant host species. The data support that cropping systems. Insect resistance management strategy was investigated through surveying the appeared. infestations failed This study points to thefew potential agronomic anda environmental benefits of Bt100%, corn in Egyptian below was reduction When hybrids. Bt 90.48%- for was 100% reduction infestation of range The seasons. sowing three for the and throughoutseason whole endosperm) white one and endosperm yellow (two hybrids Bt in prevented completely or negligible were nubilalis O. and agamemnon C. cretica, S. of infestations The efficacy the investigation of advocate results that The S. cretica gene. and cry1Ab C. to agamemnon wereresistant more strains deleterious borer to of non-Bt plants. development (iv) insects non-target on effect (iii) components yield and yield (ii) Bles. agamemnon Chilo borer corn purple-lined the Led., cretica Sesamia borers, corn of species three against efficacy biological and 2002 between Egypt (i) on: corn genetically-modified in the of impacts the assessing at aimed experiments investigation The 2007. bacterium field soil open the in from tested gene was It cry1Ab thuringiensis. the Bacillus express to modified corn transgenic a is Bt-corn M. Abdelzaher,FacultyofAgriculture,SabaBasha,UniversityAlexandria,Egypt Agamemnon Bles.andOstriniaNubilalisHbn.inEgypt Effect ofBt-cornHybridsontheInfestationCornBorers:SesamiaCreticaLed,Chilo Abstract arise infields ofBt-corn. Assessment. He has30publishedpapers. Toxicology; Awareness ofpesticidesuse;Biotech crops; Integrated pestmanagement;Risk RESEARCH EXPERIENCES: Biological andmicrobial control andbotanicpesticides; RECENTEMPLOYMENTS &AWARDS: Agriculture, Saba Pasha, AlexandriaUniversity (1990) University (1985)PhD: AgriculturalSciences(Pesticide and Chemistry Toxicology), Faculty of 2. AssociateProf. (1998/2006),Faculty ofAgriculture (Saba Pasha), AlexandriaUniversity 1. Professor (2006tillpresent) inPesticide and Chemistry Toxicology, Faculty of Carolina, USA,(1996/1997). Center, ofPharmacology, Department ofNeurotoxicology, Laboratory Durham, N. Recipient ofascholarshipforPost-Doctoral Research inDuke University Medical Recipient ofTheAlexandria University Award fortheScientific Encouragement, 1998. Agriculture (Saba Pasha), AlexandriaUniversity (Pesticide and Chemistry Toxicology), Faculty ofAgriculture, Helwan Cotton Sciences,Helwan University (1980)MSc.:AgriculturalScience ACADEMIC QUALIFICATION: BSc.:CottonSciences,Faculty of University, Egypt Email:[email protected]. and Chemistry Toxicology, Faculty ofAgriculture Saba Pasha, Alexandria Magdy Abdel-Zaher Massoud Ahmediscurrently Professor ofPesticide Faculty ofAgriculture, Saba Pasha, University of Alexandria,Egypt ABDEL-ZAHER, Magdy Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 countries. ABOU ZEID, different IPRs areas, and in supporting and developing available and new legal tools for the for developed least and developing to technologies of tools transfer the knowledgeand of dissemination legal new and available developing and supporting in and areas, in IPRs interested different is She Question!”. the is That TRAPS? or “TRIPS titled poster a presented she whereSustainable2002 in BibliothecaAlexandrina Developmentthe byConference organised and Biotechnology the them among coferences different in participated She Monshaet2008. Maaref, El Laws”, U.S E.U, Egypt, on Study Comparative A Pharmaceuticals: of Protection by the Univerisity’s Evaluation Regulation. Dr. Perihan is stipulated the author of a grades book titled “The Legal highest the awarded was and Aspirations” and Flexibilities Pharmaceuticals: Protection“Legal of the titled was thesis HerPhDUniveristy Egypt.SwaifBany the – fromof holds a LLM in international business law from the University of Hull – UK, and a PhD degree and Logistics (the Arab Academy for Science, Technology and Maritime Transport – Cairo). She Agricultural Exports and Logistics at the Institute of International Transport 82 for the year 2002. She is also a Lecturer in the Master degree program of of the current Subcommittee for Reviewing the Egyptian IPRs Law Number Intellectual Property Rights in (IPRs) and Internationalspecialized Law.mediator She is and a Member attorney private a is Zeid Abou PerihanDr. and Maritime Transport. Science, Academyfor Arab Privatethe TechnologyLecturerat and Lawyer Perihan

51 BioVisionAlexandria 2008 52 BioVisionAlexandria 2008 to prioritize preventive strategies guidelines provide and world Muslim the in problems genetic of aspects health preventive the they usually lead to morbidity requiring chronic care and to mortality. In this paper, we address since important particularly are They marriages. all of % 60–70 for accounts which marriages, prevalent in the Arabian Peninsula and Saudi Arabia are diseases neurometabolicbecause Inherited Europe. and of StateUnited the in high institutions science degree big of the consanguineous with partnerships budget,with dollars of millions TechnologyUniversity,with and Science a for foundation the put has Saud AL Abdulaziz Bin Abdullaha King TwoHM Mosques, Holy the of Custodian The 2020. by R&D nation’sto the GDP of 1.6% devote to commitment a development plan in 2002.Its priorities are defense, and oil and gas technology, but there is also year. Saudi Arabia is making a slow start, having approved a new national science and technology Al-Thani, has created an endowment that generates millions of dollars in research funding every Khalifa bin Hamad Qatar, Sheikh of HH Emir The Iran.. wealthy less by spent that of third a about and 2.3% of average country developed the of one-tenth product than –less domestic science gross on (GDP) their of 0.2% about spend Kuwait and Qatar Arabia, Saudi (OIC). Islamicconferencethe of Organization the up make that Islamiccountries 57 the in science to commitment more show to change must leaders political of mentality The programs. undertaking research by and background, ethical an with education, science by acquired be only can with the rest of the world. However to ﬂourish, science and technology need a cultural base that Muslimup catch to developingtechnology in and science forward leap big a take must nations of Pediatrics, Hospital RiyadhMilitary PediatricSeniorAqeel,Consultant Al A. MedicalDepartment Endocrinologist, and Geneticist Ethics andGenetics: AnIslamic Perspective Abstract 100 abstractsandgave over 80invitedspeeches,nationallyandinternationally. over presented manuscripts, 60 over published She others. and UK, Cambridge, Foundation, WellcomeMorocco, TrustHealth, of Ministry USA, (NICHD), Health of Institute National Control, USA, University of Oslo and DiseaseMedical Advisory of Board of Centre Biotechnology Oslo, Geneva, Norway,Organization Health WorldUniversity,Egypt, Shams Ain , USA Irvine, YaleUniversity,Medicine,California, of of UniversitySchool University, Sinai Mount lecture to several universities and conferences including Havard Medical School, North Western and teach to invited been Shehas name. my carries Syndrome,Geneticwhich new a described has she StudiesUAEDubai,(CAGS),Genomic Arab of Centre including committees medical higher international and national several in involved being activities, administrative many in involved been have She 2007). July Kingdom,( United Commons, of House the was at She honoredJapan. of Prince Crown the Narohito Prince HRH of presence the In 2006). (Sept Japan Chiba, Metabolism, of Errors Inborn of Congress International 10th the from Award of Human Genetics (May 2005) and obtained the Outstanding Physician Outstanding the obtained and 2005) (May GeneticsHuman of of AwardScience EuropeanMedical2002), SocietyfromResearch(February Federation American the from Award Investigation Outstanding the fellowships in Genetics and Metabolics. She has won Graduated fromseveral Kuwait University with honors, Dr.awards Al Aqeel Endocrinologist, earned three including, and Geneticist Medical ofPaediatrics,Department Hospital RiyadhMilitary Paediatric Consultant S. AL AQEEL, Aida

Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 related itself. tothehostandvirus which factors genetic the to due be may this complication, infection viral develop others while Some individuals can overcome the viral infection and replication which lead to viral eradication, events production. leadingtointerferon signaling early the inhibit to strategies distinct evolved have viruses pathogenic infections, human many viral different of number a of course the influence greatly can responses immune viral on replication in infected effects and neighboring uninfected cells. inhibitory While interferon of production and other multitude a have that genes stimulated IFN as known are what of family a of production the stimulates interferon 1 type turn, In interferon. 1 type of release involving response immune innate immediate an trigger often C hepatitis like infections Viral effects andare curative inonlyafractionofpatients. There is no vaccine available to prevent HCV, and current therapies are costly, have serious side chronic liver disease including of hepatic cause fibrosis, leading the end-stage is cirrhosis, HCV and problem. health hepatocellular public carcinoma. worldwide a is (HCV) virus C Hepatitis recently withtheevolution ofvertebrates. relatively developed however, mechanisms, sophisticated More system. complement the and phagocytosis, defensins, called peptides antimicrobial include mechanisms These pathogens. neutralize and function recognize to that evolved order needs mechanisms in several and challenge, tissues this properly. and worms, To survive cells parasitic healthy own to organism's viruses the from from them agents, distinguish to of variety intensities of wide types and a different detects mount It can responses. that system acomplex is system immune The Professor of Clinical Immunology & Pathology, Faculty Immune Response to of Viral Hepatitis Medicine, Mansoura University (Egypt) Abstract Faculty ofMedicine. Mansoura of student for Family El-Shera of Director and Dakahlia in council women member the of Mansoura, in Center Language French the of Director is Farha Prof.Additionally, Prof. Farha more than50M.Sc.andM.D.Thesisinthefieldof hassupervised Immunology. with Japan. collaboration Universityin Canal Swiss the in held immunology of course training first the at preceded by intensive educational courses of immunology. She has also participated in teaching was congress the where 1994-2004 Mansoura in held Biology Molecular and Immunology of Her scientific activities include organizing the 1st –9th Egyptian - French polymorphism. and HLA Congress and Workshop Prof. El-Chennawi has more than 55 publications in the Biology field of immunology, Molecular molecular biology and Immunology Laboratories attheUrology andNephrology the Center, Mansoura University. of Founder and Head also is She University. Mansoura Medicine, of Faculty Clinical Department, the Pathology at Unit, Immunology Clinical the of Founder and Head is Prof. El-Chennawi is Professor of Clinical Immunology since 1992 till and Graduate Post Studies andResearch atMansoura University, of Egypt. President Vice currently is El-Chennawi Abdel-Aziz Farha Prof. Prof. ofClinicalImmunology and Vice President ofMansoura University ABD EL-AZIZ, Farha

53 BioVisionAlexandria 2008 54 BioVisionAlexandria 2008 Several research fellowships inNorway, United States, andJamaica. Prof. Emeritus end-February 2006. Biosafety, Biodiversity, HistoryofCultivars, Conservation, Vegetation Ecology, Philosophy. NGOs andprivate sector. He speaksﬂuentPortuguese, English, Italian andSpanish. FUNBIO, Programme, Biotrade UNCTAD– PPG7, of Group Advisory International the of than 50 articles in peer reviewed journals, several book chapters and two books. He is a member University of Sao Paulo (UNESP: http://www.fac.unesp.br) 1989-1996. He has published more Professor,Assistant Universityan StatePaulo,Saothe was the Forestryof he at and Agronomy São at assignment of current his University to Prior leave). the (on Brazil(http://www.esalq.usp.br), Paulo at ESALQ, professor associated an also is He the Project. Resources coordinating Forest Global Rome, in based (http://www.ipgri.cgiar.org/), IPGRI Institute, Resources Genetic Plant International the at Scientist Senior formally and (www.polobio.esalq.usp.br), UNIDO facultyonbiosafety. Member Swiss Biosafety Committee Chair Biodiversity Section, Europ. Federation ofBiotechnology. Prof. hon.University ofBern. Director, BotanicGarden, University ofBern. Dr. Phil. University ofBern, Switzerland. Guest Professor, Delft University of Technology AMMANN, Klaus public policy. He is currently the CEO of the Brazilian Biofuels biodiversity, Programme of environmental and use development biosafety,sustainable and sustainable biotechnology of areas the in are interests professional and research His Brazil. (USP), Paulo Sao of University the from degree MA and PhD his obtained degreesfrom Harvard University, HeUSA. Mastera holds Sciences also of national, Brazilian a Amaral, A.N. Weber Professor andCEOBrazilian Biofuels Programme (Brazil) AMARAL, Weber Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 "French House ofOncologyst". BioVision since1999. rapporteur the at management healthcare of hematology.Professor and oncology in drugs expensive and pharma companies delivering drugs for cancer (Roche). Worked on market access for innovative in for consultant RegularNational InstitutCancer). and du Cancer (Mission treatment cancer to dedicated hospitals France. Regular consultant for the national institutions in charge of cancer University the of most of planning strategic oncology.the in Built experience Touche)broad a with Healthcare consulting practice for 18 years (Ernst and Young, Deloitte and Risk Manager) MD and MPH in France. HRM (Healthcarein HRM health), Philadelphia public in and (master MPH Chicago Anhoury,MD, Pierre ANHOURY, Pierre

55 BioVisionAlexandria 2008 56 BioVisionAlexandria 2008 Arab Social andCultural Foundation. and Sciences of Technology.UnionEgyptianMember the of of Writers. Founder The of Morsi in Asia and Mediterranean groups for the study of Diabetes. Member of the Egyptian Academy medicine and poetry. Member of the American, Arab, Pan African, Diabetes of history medicine, internal in books several FederationAuthorof (IDF). RegionInternationalEMME Diabetes of Regional Chairman Association. of Chairman Diabetes Egyptian the of PresidentMedicine. Internal Formerof Department the Alexandria. Emeritus of University Currently Medicine, Egypt. of Alexandria, Professor 1932, born Arab, Morsi Prof. IDF Regional ChairDiabetes, EMMEregion ARAB, Morsi Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 from theCatholicUniversity ofLouvain and Trinity CollegeDublin. Degrees Masters has and Dublin College Universityfrom Economics Agricultural in graduate a is Taxation.He on Government’sCommission Irish the TrustTimesand Irish the both in appointed recently was at Trinityand (IIIS) Dublin,Studies IntegrationCollege International for Institute the Transparencyboth and of Irelandboards International the of member a is he European and Canadian NGOs working together on the reform of international food aid. Also the TransFoodNGO Atlantic PolicyAid Dialogue(TAFAD) American, of alliance unique a – Europeanof FoodVice-Chairand the Group Security(EFSG) of Chairman Group.also Heis Fund’s Advisory Response Emergency(CERF) UN’sCentral the and Council, Advisory 2020 Institute’s(IFPRI) Research Policy Food International the Force,TaskHunger Aid’s Irish of member a currently is He 2005). – (2003 Project’sTaskForceHunger Millennium UN the of member a and 1998) – (1993 AgricultureOECD’s of the Committee of Chairman was He Development and Agriculture Policy issues, including three years in Africa. on Commission European the for workedcareer, he his of stage earlier an and Agriculture Food,ACOT,Seniorin Economistwas and of Farmthe At Service. Advisory Department Irish the to General Secretary Assistant was Worldwide, he Previously, 2001. Concern in of organisation, humanitarian Executive largest Ireland’s Chief appointed was Arnold Tom Chairperson, theEuropean Food Security Group ARNOLD, Tom

57 BioVisionAlexandria 2008 58 BioVisionAlexandria 2008 of twonon-profit hospitalsinAlexandria.Author of140publications. Group. Honorary Member of the Korean Association of Behest’s Disease. Founder and manager International Society of Behest’s Disease (ISBD). Chairman of Collaborative Trials ISBD Study the of Council the of Member Azerbaijan. Journalof Medical the and Diabetes of Association Journal International the Therapy.Georgian the Researchand the of Arthritis of Journal Board Editorial the of Member of and Rheumatology of Journal APLAR the of Assessor-reviewer Metabolism. & Endocrinology,Diabetes of Association Egyptian the of Journal the of Chief Editor-in- 2005. UK World,Arab the in “Diabetes is latest the metabolism; and diabetes to related books of co-author or Author and DESG the of Letters Diabetes Arabic the of Author 2007. and 2005 2003, ManagementNationalDiabetes the for Guidelinesof Co-author 1999. Cyprus Award, International Rotary and 2003 ParisAward, Party TPE Jinns’ EASD-DESG Diabetes the awarded “The film: a produced and Wrote 1999. and 1996 Syndicate Medical ParisResearchAward1989. University,Medal,Lucentina AwardsEgyptianSpain 1990. the of Research Award, Alexandria University 1986. Award of the ALFEDIAM the of Award 1986. University Alexandria Award, Research University1983-4. Member of the Council of the DESG - EASD. Scientific Alexandria MBChB 1971. MD Thesis Medicine. Germany 1975. Doctor of Degree 1982. Faculty Post Doctoral Alexandria Paris Metabolism, and HeadInternalof Department the of Medicine Unitthe of and Diabetesof Metabolism, Faculty ofMedicine, AlexandriaUniversity, Egypt and Diabetes of UnitHead, and Medicine Internal of Department Head, ASSAAD-KHALIL, SamirH.

Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 along witha discussion ofrelated framework. regulatory nanoparticles to develop novel diagnostic assays and smart drug delivery systems of are In introduced use The applications. reviewed. are medical nanoparticles several for of advantages use and properties their presentation, this optimize fully and nanoparticles of toxicity assess to necessary is delivery.work More drug targeted and sustained for assessed been have polymers, them to both absorb and scatter light. Finally, biodegradable nanoparticles, made from different causing radiation, incoming to response in resonate gold the of electrons that fact the utilizing by drugs therapeutic of payload release or heating local by tissues destroy to used be also can They imaging. and targeting tissue for possibilities providing biomolecules, to conjugated be also can and properties resonance-enhancedoptical surface-plasmon exhibit nanoparticles gold multiplex diagnostics. Conjugation of QDs to biomolecules enabling adapts them for target recognition. Colloidal thus emissions, respective their from removed far wavelength single a by excited simultaneously be can sizes different of QDs size. their on rainbow,depending the of colors all in light stable and intense emit can that nanocrystals semiconductor are (QDs) dots Quantum DNA. or drugs of delivery targeted and bioseparations for used been also have and cellular molecules. Super-paramagnetic iron oxide nanoparticles are useful as MRI with contrast interact and cells penetrate to them allows size agents small extremely Their agents. imaging and been already have properties, surface constructed. Nanoparticles nanoparticles, and have unique electrical properties chemical and of make excellent semiconductors composition, assortment shapes, An sizes, frontiers. different of new to applications therapeutic propel and significantly diagnostic to foreseen nanostructures attractive most the among are Nanoparticles The AmericanUniversityInCairo H. M.E.Azzazy,Chairman&AssociateProfessor,DepartmentofChemistry, Nanoparticles: Emerging Diagnostic andTherapeutic Applications. Abstract AZZAZY, articles, abstracts,andbookchapters. articles, peer-reviewed America’s82 Who’sAmong by authored Teachers.Who recognized Dr.Azzazy and Mentor”Student “Best nominated was HeAward. Recognition Chemist Clinical Award, Chair’sGovernors of Board Award,Faculty Graduate Award, Achievement Research Upjohn Award, ProfTop Award, Achievement Bowen including: awards several received Azzazy Dr. Chemistry. Clinical of Board American the by diagnostics molecular & chemistry clinical in of the National Academy of Clinical Biochemistry. He was awarded double board certifications Center at Fort Worth, TX. He is certified as a Specialist in Chemistry by the ASCP and a fellow Biochemistry and in Molecular PhD. Biology his with receivedhonors University.Hefrom Alexandria University from of North Biochemistry in Texasdiploma graduate Health and Science the American Society for Clinical Pathology (ASCP), Chicago, IL. Dr. Azzazy received his BSc. the biotechnology discipline at UMB and chairman of of the Chemistry Examination director Committee, the was He (1997-2002). MD Baltimore, (UMB), Medicine of School Maryland Universityof the at professor assistant an biotechnology.as and served He diagnosis, molecular nanodiagnostics, of fields His the cover interests research College. University Maryland of University School, Biotechnology University In Cairo (AUC) and an adjunct associate professor at Dr. the Azzazy is the Chairman of the Department Chemistry at the American Graduate University In Cairo Chairman & Associate Professor, Department of Chemistry, The American HassanM.E.

59 BioVisionAlexandria 2008 60 BioVisionAlexandria 2008 will andfinancingare needed.In asense,atpresent, mustbeabiologist. everyone the responsibility of having accurate information and wise decisions. Public awareness, political of power growing biotechnology promises, or The threatens, to alter resources. our environmental challenges. of With power uses comes better making as well as bioremediation treatment water biology,waste and conservation pollutants, tool key detecting a sustainability, as environmental upon looked in is Biotechnology problems. environmental global the of aspects some are ecosystems of degradation and pollution environmental deforestation, biodiversity, societies its declining growth, our Population of global. as face well condition as issues regional now the challenging are problems environmental world, to for the way, alter some to in continue subject, humans As is environment. planet this on resource Every increasing pay attention. to ought science which to problem a clearly is environment the of status The E. Badr,ProfessorEmeritus.Dept.ofGenetics,FacultyAgriculture,AlexandriaUniversity Saving thePlanetthroughBiotechnology Abstract Scientific Distinction, AlexandriaUniversity 2006. of present.AwardTechnology, - and 2002 Science the of City Mubarak of Committee, Engineering board editorial the On Biotechnology.Memberof J. Genetic Arab 1978–84 and the Biotechnology and of Genetics of J. Egypt. Center, Research Alexandria of University Unit, of Biotechnology,Laboratory Faculty of Agriculture, 1992–95 Chairman of Molecular Biology Central of DirectorUniversitiesFrench and American with Projects Scientific JointSeveral of PI 1998–present Universities, of Council Supreme Biotechnology, and of Engineering Committee Genetic Sector Education High the of Member 1999–present University, Harvard at Member of the Task Force Committee on Biotechnology, center for International Development and Arts, 1 st Class , Egypt, 1976 Listed in the Encyclopedia of Egyptian National Figures,Sciences of 1989 Medallion 1974 Egypt, Sciences Agricultural in AwardUniversity,Notional 1983 VisitingProfessor, FranceResearchGrenoble(CNRS) NationalScientific and for 1979 Center Board, 1978–present Fulbright Award, Genetic Engineering Research, Harvard University, 1984 Genetics, Supreme Council of Universities, 1995–98 and member of the of member and 1995–98 Universities, of Council Supreme of Genetics, Committee Scientific Permanent the of Chairman 2001–present 84, Alexandria Genetics, 1979– Genetics, of of SocietyUniversity, EgyptianVice-President, 1991–94 Department Chairman, 1977–99 University, Alexandria Genetics, of Professor 1963 University,USA, Columbia PhD University Alexandria Agriculture, of Faculty Genetics, of Dept. Emeritus. Professor BADR, Effat Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 elected aFellow oftheIASin2001. was ProfessorBadran disciplines. social and medical different in surgery,articles in and papers resources.Professorscientific human 120 of Badranhas development and education university of developmentresearch, scientific of future Egypt, in policy health concerning books seven of author is He Egypt. of in Medicine for SpecializedNationalCouncil the Society of Chairman Medicine; Royal of Fellow Organization; Medicine Islamic the of governors of board the of member Consultant, Medical WHO 1995; since Al-Azhar Organization, Research Islamic of member Affairs; Islamic of Council Supreme of member 1996, since National Council of Services Social Chairman 1984, since Sciences Medical of Council Research Specialized the of Technologyand Chairman Research (1980–1984); Scientific of Academy the of President the was He (1976–1978); the Health of Minister of Egyptian the Presidentas served He University, 1966; 1978–1980. since University Cairo Department, Surgery Chairman and of Professor University a been has He Egypt. in Surgery of Father the as known is he and surgeons, eminent and leading the is of Badranone Professor 1951. in University Cairo from MD MCh, his and his MB and ChB degrees from Cairo University,obtained HeFaculty of Medicine in 1947; Egypt. in 1924, in born was Badran Ibrahim Professor Former Minister ofHealth, Egypt BADRAN, Ibrahim

61 BioVisionAlexandria 2008 62 BioVisionAlexandria 2008 Research Interests include:plantcellwallbiosynthesis,membrane fusion, nanotechnology international conferences andbooks. Publications: inrefereed Over 50articles internationaljournalsin addition toproceedings of Sciences and TWAS. American Society forPlant Biologists,USA;Institute of Biology, London;theArabAcademy of Membership inSocieties: CambridgePhilosophical Society; Biochemical Society, London; Award oftheRoyal Society, UK. of theArabFund for Economic andSocial Development, andtheDeveloping World Study Hamid Shoman Prize for Young ArabScientists for Biology, Distinguished ScholarAward Awards include:The Award ofthe Federation ofArabScientific Research Councils, Abdul Yarmouk University, Jordan. by the fact that relevant technologies are getting cheaper. Associated developments must take must developments Associated cheaper. getting are technologies relevant that fact the by aided investments modest with scientists competent of teams small by productivelybe conducted to able entry are nominated areas make three the contrast, arrangements, In expensive. and regulatory difficult areas these complex into protracted, with together breeding, and plant animal and pharmaceutical fermentation, food, the biofuels, Development, in and Research elsewhere stem-cell industry, investments Massive organisms. native of bioprospecting (c) contaminants; and pollutants of elimination and detection the for biotechnology “white” recombinant antibodies and genomics tools, virus vectors, and using diagnostics propagation advanced techniques, systems; analytical new utilizing (b) but observations industrial and remedies traditional on building plants, medicinal (a) are These resources. available given exploitation, Sciences, of for ripe Academyespecially industry. areas and general threearethereacademia involvingthat Itclear is Arab the of meetings special technology foresight exercises in several Western nations, and detailed international discussions including analyses, various on region. the Based to relevance special have that opportunities biotechnological of range enormous the reflecting after possible is reversal a fortunately but manifold, are situation this for reasons The positions. competitive global relative their in decline relative a suffering are nations Arab biotechnology.exceptions, modern few in With talents indigenous its on adequately capitalize to far so failed has world Arab technology,the and engineering, science, of areas many in As E. Baydoun,ProfessorofBiology,AmericanUniversityBeirut Opportunities forBiotechnologyResearchandDevelopmentinthe Abstract and medicinalplants. place, suchasinourbioinformatics and AssistantPresident andDirector ofPlanning andDevelopment at Previous positionsinclude:ChairmanoftheBiology atAUB Department Biology atAUB andSecretary General ofthe Arab Academy ofSciences. of Cambridge(MPhil, 1978andPhD, 1980).At present Professor of American University (AUB) ofBeirut (MSc,1977)andthe University He waseducatedattheUniversity ofJordan, Amman(BSc,1971),the Professor ofBiology, AmericanUniversity ofBeirut BAYDOUN , Elias Arab Region Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 taken towards asolution? questions now are: Do Arab nations realize the magnitude of the problem? Have any steps been harmony.in work to have decision-makers major and The industry academia, ambitions, these Innovations across society must be fostered and an enabling environment created. Yet to achieve encouraged. be should government and industries academia, between transfer knowledge that building and development of excellence in targeted areas need to be promoted. It is also essential capacity occur,research to that For developed. be to has mechanisms new communities, Arab of needs social and development business, with aligned be to research for that anticipated is It Qaboos University Sultan Medicine, of College the Biochemistry, Clinical of Head and Professor Bayoumi, R. Did theArab World Cover theGaps between Research AmbitionsandCurrent Realities? Abstract BAYOUMI, Syndrome, Hereditary Spastic Paraplegia andMultiple Epiphyseal Dysplasia. Arab United Sudan, the in research Emirates andOman. In inmappingofJubert thestudyofgeneticdiseaseshewasinstrumental genetics human to contributions important made has He 1991-97. UniversityEmirates Arab United the at Biochemistry of Professor and 1977-91; positions included: Assistant, Associate and Full Professor of the University of previous Khartoum, His Oman. Sudan, of SultanateMuscat, in UniversityQaboos Sultan at Medicine of College the in Biochemistry Clinical of Head and Professor currently is He 1995. in PathFRC and 1975 in Biochemistry) Clinical ( Degree ( MB BS) in 1967, his PhD ( Biochemistry) in 1973, his MRC Path Riad A.L Bayoumi was educated in Sudan the UK. He obtained his Medical Medicine, of Sultan Qaboos University College the Biochemistry, Clinical of Head and Professor Riad

63 BioVisionAlexandria 2008 64 BioVisionAlexandria 2008 developing achemicalgene-switchingsystemforuseinplants. including rice and sweet potato; characterizing functional activities of transcription factors; and resistance virus transgenic of mechanisms of studies includes: research His infection. virus to resistantare that plants transgenic developing researchin pioneering his for as well as plants in of Plant Biotechnology. He is recognized for his work in molecular virology and gene expression on Agriculture, Food and Renewable Resources and is President. of the International Association Phytopathological Society among many others. Beachy serves as Chair-Elect of the AAAS Section Hoagland Award from the Society of Plant Biologists and Ruth Allen Award from the American Robert D. the Agriculture, Wolfin Prizethe received has he Science, of Advancement the for Sciences and a Fellow of the American Academy of Microbiology, and the American Association Laboratory for Tropical Agricultural Biotechnology. A member of the U.S. National Academy of nttt, a ol, A wee e a c-one o te International. the of co-founder was he where CA, Jolla, La Institute, Research Scripps The and Louis, University,WashingtonSt. at positions the at University positions of AZ post-doctoral and has at Cornell also University he NY. University, StateHe previously Michigan held academic at PhD. his earned MO, Louis, St. institute, research non-proﬁt a Center, Science Plant Danforth Donald the of president Beachy,founding Roger President, Donald Plant Danforth ScienceCenter BEACHY, RogerN. Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 present atBioVision productive 2008,thatavery discussionshouldbepossible be will talent such but answers, deﬁnite have to new too are challenges The consideration. for cases current best present review,to a invited After be time? will governancein audience of the national governments. What are the possibilities of governments and the UN changing patterns all levels of governance, but the focus will naturally be particularly on the United Nations and on environmental fate the of direct its will home, humanity morepresents forever the where largest era governance an Earth’schallenges entering the in and history.change Climate This involves R. J.Berg, Senior Advisor, World Federation ofUnited Nations Associations Governing ina World ofClimateChange Abstract BERG, master’s degrees studentsfrom anumberofuniversities and doctoral involving Association, NationsUnitedDirector,Program,Fellows Graduate also is He boards. NGO and education of number a of member A change. climate of implications governanceand economic the on group expert UN the of member a Heis USAID. for evaluation of Director founding and Committee Assistance United the of Nations. He parts was founding chair of of evaluation for number the OECD Development a to adviser senior been has He Science. Nations & United Art of WorldTrusteea Academythe is of of He (WFUNA). Associations Federation World Adviser, Senior is Berg J. Robert Senior Adviser, World Federation ofUnited Nations Associations Robert J.

65 BioVisionAlexandria 2008 66 BioVisionAlexandria 2008 eoig itr atn ppie fo poen yrlsts sd n od omltos from formulations; 2002 to2003hewasa Visiting Professor food ofFood Science attheAlabamaA&MUniversity in used hydrolysates protein from peptides tasting bitter removing for system a developed and systems enzyme and microbial immobilized on worked he where 1989, in Connecticut Milford,New in based WestrecoCompany Nestléwith Research a Inc., Researcha Associate careerprofessionalas United his the in started Stateswherehe America of were achievements career other His Nigeria. Abuja, in (UNIDO) Organization Development Industrial Nations United (Agro- the of Oﬃcer Centre Development Development Industrial Regional Industrial the was at Industries) he 2004, to 2003 from project; Systems PostharvestImprovement the of Coordinator was and program utilization crops root the heading the at Scientist Research was he a where (1989-2002) as years working12 for Tropical(IITA) Nigeria,of Agriculture Institute International in career years 13 a had has but Congo, of RepublicDemocratic the of national a Heis USA. the Universityin Cornell both from (PhD) BOKANGA, the Massachusetts Institute of Technology (MIT) and a doctorate degree doctorate a and Technology (MIT) of Institute Massachusetts the from (MSc) master’sdegree a with scientist food a is Dr.Bokanga Africa. Sub-Saharan in productivity agricultural increase to farmers smallholder by use for technologies proprietary disseminate and access to is aim whose African Agricultural Technology Foundation (AATF), the new organisation Dr. Mpoko BOKANGA is the ﬁrst Executive Director of the Nairobi-based Executive Director, AfricanAgricultural Technology Foundation Mpoko

Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 Progress inthesethree areas will bediscussedfouryears intotheproject. must be adopted by farmers and consumed by those suffering from micronutrient malnutrition. crops biofortified the Third, consumed. normally as varieties biofortified the consuming when improveto shown be must subjects human of status micronutrient the demonstrated, be must high nutrient density must be combined with high yields and successful, high profitability.be must Second,breeding efficacy the First, successful. be to biofortification for occur must things nutrition, food science, farm extension, communications, and economics. In broad terms, three biology,human molecular breeding, plant in agencies involved countries implementing developed and developing and in institutions scientific of alliance global a through A provitamin (rice, staples and zinc, iron, food in high are of which millet) pearl varieties and beans, sweetpotato, distribute cassava, maize, wheat, and develop to seeks HarvestPlus costs. recurrent low at time across country after country in available become cost varieties low biofortified adapted at as benefits recurrent high generate can location central a areas at investments research Initial agricultural urban infrastructure. in good with centralized areas in in only regions rural best into reach work then and which programs, supplementation and fortification complements biofortification way, this In marketed. are surpluses production as populations which comprise a majority of the undernourished in many countries, and then extend to urban populations, remote more these reach initially design, by that, intervention rural-based a offer through conventional plant breeding or through use of transgenic techniques. Biofortified crops through plant breeding, a process known as biofortification. Biofortification can be accomplished The density of minerals and vitamins in food staples eaten widely by the poor may be increased H. Bouis,Director,HarvestPlus HarvestPlus Biofortification --UsingAgriculturetoImproveHumanNutrition:ProgressUnder Abstract Food Research Institute. University'sStanfordfrom PhD and MA his University;Stanfordand from Economics in BA his received Bouis Howarth Asia. in particularly outcomes, nutrition and demand food affect Institute (Washington, ResearchDC ). His Policy past research Food has concentrated on International understanding how economic the factors and Colombia) (Cali, Agriculture Tropical for As Center International the at appointment fund-raising. joint a holds Dr.Plus,Bouis Harvest and of Director symposiums, workshops, seminars, publications, through community nutrition human the in and (NARES), Systems Extension and Research NationalAgricultural the partner of their including (CGIAR), Research Centers Agricultural International on Group the Consultative within both activities “biofortification” promote to sought has he 1993, Since nutrition. improving in impact their measure to and crops food staple micronutrient-dense disseminate and develop to together working agencies implementing and centers research of alliance interdisciplinary,an global HarvestPlus, of Director the is Bouis Howarth institute Research Policy Food (Washington) International HarvestPlus, Director, BOUIS, Howarth

67 BioVisionAlexandria 2008 #JP7JTJPO"MFYBOESJB Island report sharp decreases in the malaria burden giving hope that sustained control and control sustained that elimination ofthisscourge maybepossible. hope giving burden malaria the in decreases sharp report Island Zanzibar and Ethiopia, Rwanda, countries, African Southern Initiative. President’sMalaria TB, and Malaria, World Health Organization, Bill & Melinda Gates Foundation, and the U.S. control and prevention are the Multilateral Initiative on Malaria, Global Fund for HIV/AIDS, research, malaria in increases major the stimulating Organizations insecticides. alternate and DDT with dwellings of (IRS) spraying residual insecticide in interest renewed pregnanta and women; for (IPT) treatment preventive intermittent protection; personal for (LLINs) nets treated insecticide long-lasting malaria; resistant drug to exposed patients (ACTs)for ments research and public health practice have resulted in use of artemisinin-based combination treat- malaria in advances Recent nature relapsing its to due dangers added yearly,with malaria of episodes clinical million 400 to up causing as P.recognized now is meals. vivax blood its for humans prefers which of female the gambiae, Anopheles of pervasiveness the to sub-Saharandue African in is malaria of burden greatest The impairment. cognitive including sequelae dire and derangements, metabolic malaria, cerebral weight, birth low anemia, in manifesting disease, severe most the causes parasites, malaria human four the of one falciparum, modium Plas- children. young mainly day, per 5,000 malaria—over from yearly die persons million Malaria is endemic in over 100 countries containing half the world’s population. Close to two Senior Scientific Advisor, Fogarty International Center, National Institutes of Health (USA) Conquering theIntolerable Burden ofMalaria: Promises toPractice…to ScaleUp Abstract Tropical Medicine andHygiene (2001,2004,2007). Journalof American the to malaria on supplements 3 of editor lead the PrioritiesProject;and Diseasethe of editor co-managing boardEbolais Controlon supplement JID 1999 a virus; of editorial the on was He countries. developing in strengthening capacity research and diseases Senior Scientific Advisor. Dr. Breman hasand authoredprograms, over 100training publications focusedand on infectious research and diseases infectious several of TrainingInternationaldirector Research, of and Division the of Director Deputy been has He 1995. in Health of Dr.malaria. on work gan FogartyBremanthe Internationaljoined Center, National Institutes Eradication Unit, WHO from 1977-1980. In 1980, Dr. Breman returned to the CDC and be- Smallpox the in was Fever. He Hemorrhagic Ebola of outbreak first the investigated Breman tion in the Control of the Major Endemic Diseases in Burkina Faso. In 1976, in the DRC, Dr. disease surveillance and vaccine research with the Organization for Coordination and Coopera- for responsible was he 1972-1976, From 1967-1969. from Program Control ication-Measles UBMFOUXJMMCFQSFTFOUBU#JP7JTJPOTPUIBUBWFSZQSPEVDUJWFEJTDVTTJPOXJMMCFQPTTJCMF CFTUDVSSFOUDBTFTGPSDPOTJEFSBUJPOɨFDIBMMFOHFTBSFUPPOFXUPIBWFIBSEBOTXFST CVUTVDI DIBOHJOHQBUUFSOTPGHPWFSOBODFJOUJNF "GUFSBSFWJFX UIFBVEJFODFXJMMCFJOWJUFEUPQSFTFOU /BUJPOTBOEPOOBUJPOBMHPWFSONFOUT8IBUBSFUIFQPTTJCJMJUJFTPGHPWFONFOUTBOEUIF6/ ɨJT IJTUPSZ JO DIBMMFOHFT HPWFSOBODF MBSHFTU JOWPMWFTBMMMFWFMTPGHPWFSOBODF CVUUIFGPDVTXJMMOBUVSBMMZSFTUQBSUJDVMBSMZPOUIF6OJUFE UIF QSFTFOUT IPNF JUT PG GBUF FOWJSPONFOUBM $MJNBUFDIBOHFBOEUIFFBSUIhTFOUFSJOHBOFSBXIFSFGPSFWFSNPSFIVNBOJUZXJMMEJSFDUUIF 4FOJPS4DJFOUJmD"EWJTPS 'PHBSUZ*OUFSOBUJPOBM$FOUFS /BUJPOBM*OTUJUVUFTPG)FBMUI 64" $PORVFSJOHUIF*OUPMFSBCMF#VSEFOPG.BMBSJB1SPNJTFTUP1SBDUJDFUP4DBMF6Q "CTUSBDU GSPNBOVNCFSPGVOJWFSTJUJFT 'FMMPXT1SPHSBN JOUIF6OJUFE/BUJPOT"TTPDJBUJPO JOWPMWJOHEPDUPSBMBOENBTUFSTTUVEFOUT DIBOHF"NFNCFSPGBOVNCFSPGFEVDBUJPOBOE/(0CPBSET IFJTBMTP%JSFDUPS (SBEVBUF JTBNFNCFSPGUIF6/FYQFSUHSPVQPOUIFFDPOPNJDBOEHPWFSOBODFJNQMJDBUJPOTPGDMJNBUF in epidemiology. Dr. Breman was advisor to the Guinean Smallpox Erad- SmallpoxGuinean the to epidemiology.advisor in Dr.was and Breman diseases, infectious medicine, internal in trained was He Medicine. Tropicaland Hygiene of School London the and (USC); California ern Medicine,UniversitySouth- of of School Keck (UCLA); Angeles Los nia, Joel G. Breman, M.D., D.T.P.H., was educated at the University of Califor- of Health Senior Scientific Advisor, Fogarty International Center, National Institutes BREMAN, Joel "TTJTUBODF$PNNJUUFFBOE'PVOEJOH%JSFDUPSPGFWBMVBUJPOGPS64"*%)F /BUJPOT)FXBT'PVOEJOH$IBJSPGFWBMVBUJPOGPSUIF0&$%%FWFMPQNFOU "SU PG 4DJFODF)FIBTCFFOTFOJPSBEWJTPSUPBOVNCFSPGQBSUTPGUIF6OJUFE "DBEFNZ 8PSME UIF PG B5SVTUFF JT )F "TTPDJBUJPOT /BUJPOT 30#&35+#&3(JT4FOJPS"EWJTFSBUUIF8PSME'FEFSBUJPOPG6OJUFE PG)FBMUI 64" 4FOJPS4DJFOUJmD"EWJTPS 'PHBSUZ*OUFSOBUJPOBM$FOUFS /BUJPOBM*OTUJUVUFT #3&."/ +PFM 4QFBLFST#JPHSBQIJFT"CTUSBDUT BioVisionAlexandria April 2008 Economic Development) for Association (Italian APE of board the on sits Milano-Ovest, Club Rotary the of president former and member a is He congresses. and conferences seminars, international numerous in participated or chaired has Carlone Technologyand (CAST). Science Milan’sfor Committee recovery plan for the the former for FalckCommission industrial the area of in General Sesto SecretarySan Giovannithe was (Milan) Heand coordinated firms). hi-tech of Exchange’sindex StockItalian (the Italiana Borsa Nuovoof Mercatothe in partner a is and companies listed of boards the on served He sectors. financial he and hi-tech the 1990s, in adviser the strategic a Since as worked development. has in technology new of role the and society and enterprise science, between relationship the on focusing communications, in career a launched Carlone later 1980s, and the In Council. Research (1977) National Italian Sapienza”the at biotechnology “La in research conducted Rome of University the from biology and engineering chemical in degree a received Carlone institutions. and firms of variety wide a to sector hi-tech the in services consulting strategic and public and institutional relations which he founded in 1989 to provide company specialized in communications, special projects, corporate image, Presidentthe Hypothesis–ais of 1952, in Rome in born Carlone, Claudio Chairman, Hypothesis CARLONE, Claudio

69 BioVisionAlexandria 2008 70 BioVisionAlexandria 2008 carefully, theentire worldfacesunimaginable societalimplications. the interactions of these three forces, LR, Food-for-Fuel and Climate Change, are not considered of a change in global climate that could impact negatively on agriculture. If the consequences of material for both human and animal food for ethanol production, and the increasing likelihood increasingthe demand for determinants: liquid fuel other has accelerated two a move with towards contact using highly fermentable into plant head-on come has However,it eased. not has relationship this later, decade a Almost term. long the morality,in not sustainability,if its on and both the resources it depended on and the concentrated waste it generated, raised questions livestock, underpinned by relatively cheap and accessible grain-based diets. Recognition of the LR effect on the magnitude of the shift of animal production towards intensively raised monogastric showed that the improving wellbeing of growing populations in the DECs was having a of livestock profound production. The LR was brought to the foreground in the late-1990s when analyses and Food in DECs. These three papers are fundamental to taking a futuristic look at key drivers Supply in their papers on The Livestock Revolution (LR), Food and Fuel, and Climate Change Foodin Convergence Global of topic the addressing speakers respective the by interpretations factual and philosophical supportive and salient the of analysis an present will rapporteur The Agricultural Sciences,theUniversityofPretoria. N. Casey,Professor,DepartmentofAnimalandWildlifeSciences,FacultyNatural Global ConvergenceinFoodSupply:Rapporteur’sanalysis Abstract Honoris Causacandidates. two promoted and candidates PhD seventeen and MSc forty-five supervised has and reports scientific contracted thirty-eight manuals, reference and books twenty-two presentations, and proceedings conference eighty publications, reviewed peer scientific sixty-nine has He Science. Animal Journalof SA the and ResearchSmallRuminant Science, Livestock the of boards editorial on serves He profession. Science Animal the to services for and excellence academic and International Symposium on Ruminant Physiology (1999). He has received awards for research Goat International Association (2000-2004) the and chaired of the 8th Vice-PresidentInternational Conference was on Production,Goats (2004) Animal and 9th of of Association Congress World of the President is He Professions. Scientific Natural for Council the on appointee President and former President of the Honorary Integrity.is Heand South Ethics Research on African Committee Senate Society the on sits of and Sciences Animal Science, and Agricultural and is Natural a of FacultyMinisterial Committee, Ethics the of chairperson is He 1992-2005. was the Department head, Department of Animal and Wildlife Sciences, Wildlife and Animal of Department head, Department the was the University of Pretoria in animal production physiology. As professor, he at appointment academic an accepted he 1979, In Pretoria. of University (Agriculture) the MSc from (Agriculture) DSc the and and Natal of University the (Agriculture)from degrees BSc the attained Casey Norman and AgriculturalSciences,theUniversity ofPretoria Professor, Department of Animal and Wildlife Sciences, Faculty of Natural CASEY, Norman Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 way forpromises tobecomereality. actual the be may This world. academic the and industry from contribution South,with the in themselves to drug research with the needed capacity for building strong drug research consortia and science funding. It is of also their responsibility terms to provide the in small number resourcesof organizations, committing needed the provide to governments of responsibility the is It patients. poor for progress to access true a give to resources the have not do of TDR efforts since world War II. A small number of public - private partnerships, all together with the noted researchpersists therapeutic and science of fruits the to access no have world the in population patients’ of proportions largest the where situation The diseases. parasitic of series long a and poverty,of leishmaniasis diseases visceral infectious tuberculosis, all malaria, almost research of to costs social higher security and private at insurance systems. This situationpatients continues to excludeof from the scope groups identified precisely of smaller and smaller for responses therapeutic bring probably will and active very is research bio-therapy insights, new giving is effects. side potential to progressWhile screeninginto throughmethods HTS imaging cell and understanding of the activity of new compounds, mechanistic more more imposes knowledge requests because for is contrary.This specificity the on and diseases, more important for attention drugs new of numbers larger into translated not has knowledge recent of acquisition massive of pathophysiology and regulatory requirements have led to the unexpected situation where the understanding of evolution concomitant Stillthe sciences. computer and biotechnologies to as related to the progress in knowledge of molecular biology, genomics and related disciplines therapeutic as innovation research well have made considerable progress in the last twenty years. This is and Innovation Drug Therapeutic Research and Drug for Case FromPractice:the Promisesto Chairman, Drug forNeglected Diseases initiative (DNDi) andCEO,Genopole (France) From PromisestoPractice:TheCaseforDrugandTherapeuticInnovationResearch Abstract and member, Inter-Ministerial Mission onPublic Research andDrug Innovation Research. of Pharmaceutical Physicians; Founder and President of the Rhône-Poulenc Rorer Foundation; Rhône-PoulencPharma R&D of Board member of former Directors; a has been is YvesGeneral Secretary addition, then d’Evry.In President,Genopole Frenchthe the Association at built for fund project national French a Genopole: Evry development of biotechnology activities; and General,CEO of Genopole Premier Jour, Director a private seeding the to Adviser is He researchdrug and development in human pharmaceutical and health biotechnology industries. 1997. Yves is founder of ITEEC and a consultant providing counselling in 1995- Poulenc, Rhone Development, Drug International Vice-President, the in Senior was and Santé, Poulenc experience Rhone and Pfizer Miles, yearswith worked has 40 over with physician pharmaceutical industry. He started as Medical and Scientific Director. He a is Champey Yves CEO, and (DNDi) Genopole (France) initiative Diseases Neglected for Drug Chairman, CHAMPEY, Yves

71 BioVisionAlexandria 2008 72 BioVisionAlexandria 2008 Cooperation. Biology (ISPMB); and member of the Sino-Euro Administration Committee for Biotechnology Biotech Committee of UNESCO; Consultant for the International Society for Plant Molecular ProfessorUniversity.Plant Agricultural of PresidentChina Chair the of as been 2002, has serves Chen Healso Since papers. 200 nearly and books 7 published have colleagues his and He commercialization. and trials ﬁeld GMO approves which Committee, Bio-Safety Agro-GMO NationalChina on member is He issues. biosafety and researchagrobiotechnology in involved etr i Cia o RD f goitcnlg. e a be actively been has He agrobiotechnology. of largest R&D of for one China in Engineering, centers Genetic Plant and Engineering Protein of Laboratory National China of Director as served and University; Peking pioneer Vice-Presidentin was Professorand the is He plants. transgenic in researchers of one lab as Beachy’s 1987, Roger in Prof. Louis, St. University, in Washington from PhD his received Chen Zhangliang Prof. President, ChinaAgriculturalUniversity CHEN, Zhangliang Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 environmental, building,medical,marineandbio-sciencetechnologies. Technologyand Counselor Science for the as Royal Norwegian2004, Embassy,May Beijing,in where appointed, his work was mainly focused Heon energy,enterprises. public and private both advising and Biotechnology, Medical in strategies investment and entrepreneurship on focusing Connections”, Health“World business consulting fulltime own his started he 2001, partnership In organizations. global 40 public–privatethan more included it until initiation its from tuberculosis, against worldwide a (www.stoptb.org), initiative TB” “Stop WHO’s of development the chaired Francisco.He San in function that in years two served and Council, networks. He was, for 5 Biotechyears, of a network special ScanBalt adviser and in Biotechnology of Medical Federation EuropeanBiotechnology including and for start-ups, investors the providers, Norwegian care health Tradefor boards of number a on served has He care. health of Norway and has carried out research and published a textbook in the planning and management in ManagerHospital and oﬃcer health public a as worked farmer.has He part-time a as experience years 13 than more has also He Science. Social in educated also Doctor Medical a Norway.Werneris of Board Advisory former Minister of Health of Norway; and former chair a Werneris children. of Christie two Married, 1949. the April 26 Oslo, Biotechnology in Born (china) Beijing Embassy, Norwegian Royal Counselor, Technology and Science CHRISTIE, Werner

73 BioVisionAlexandria 2008 74 BioVisionAlexandria 2008 2007. Vol 450,pp. 494-496 Persad D, et al. Grand Challenges in Chronic Non-Communicable Diseases. Nature. November PA,Singer AS, Daar work. Partnership its GlobalGrand and Challenges newly-established the research questions that need to be addressed to solve the Grand Challenges. I will also highlight 39 policy,and and science both for Challenges Grand 20 goals, 6 identify to experts of panel on our work published in Nature in November 2007 that used the Delphi method and a global report will I 2015. by deaths million 36 least at avert can we action, concerted Withyears. 10 countries. developing Without concerted action, in some 388 million people particularly will die of neglected, one or more been CNCDs in the have next they yet prevented, be largely can CNCDs These toll. economic huge a exact They foods. unhealthy of consumption and increasing activity physical decreasing use, tobacco include factors risk The combined. deficiencies nutritional and conditions, perinatal and maternal diseases malaria), HIV,and infectious (including tuberculosis from that double is low deaths in of number occur The deaths countries. these middle-income of and 80% worldwide. deaths) premature of 44% (and deaths all 60% of for account They countries. many in proportions epidemic throughout reaching rapidly are and increasing world are the diabetes) 2 type and diseases some respiratory stroke, chronic disease, cancers, heart include which (CNCDs, Diseases Non-communicable Chronic A. Daar, Professor ofPublic Health, University of Toronto Network Developing Countries for Priorities Diseases- Non-Communicable Chronic in Challenges Grand Abstract cadaveric donorkidneytransplant. the of Committee HumanEthics Genome Organization. He holds the official world record for the performing youngest the of member a is Toronto.He of University College, Massey of Canadian Academy of Health Sciences, the New York Academy of Sciences and a Senior Fellow Royalthe Thirdthe SocietyCanada, of for Developing Sciences World of Academy the World, of Fellow a Biotechnology.is ModernHe on Panel Level HighUnion African the of member a is and UNESCO, and WHO UN, the with capacities consulting in works He publications. Universitythe movingto of Torontooverhas 300 and books fiveco-authoredHe has 2001. in helped he before decade a East, for Oman in Surgery Middle of foundation the chaired the and schools medical Intwo start Oxford. of University the at transplantation in fellowship a s el s dcoae n rnpat muooyimngntc, and immunology/immunogenetics, transplant in doctorate a as well as medicine, internal in and surgery in training clinical postgraduate his out Health Network. Following Medical School in London, UniversityEngland, Health, he Global carried and Sciences Life on Program Center Rotman McLaughlin- the at Scientist Senior also Toronto.of Universityis Hethe Dr.Abdallah ProfessorDaaris Publicof HealthSurgery at of and Sciences Professor ofPublic Health, University of Toronto Network (Canada) DAAR, Abdallah Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 DEGETT, World Federation ofScienceJournalists (WFSJ). Danish for consultant as working been communication projects in the developing world. has He was also one of the founding members of he and (IBIS) NGO development Danish a of member board as experience years five Novohas Nordisk.company He biotech Danish the in media and stakeholders with communication for responsible was he days, broadcast his Before from experience. broadcast Denmarktelevision and radio of years in hours/6 400 than more has 2000” he 1994-2000, ”Studie programme (ESF) radio Foundation weekly most the to of Science listened host and Producer European 2005. - the 2000 from (France) at Strasbourg units Information and Sciences (EAGLES) in Madrid, Spain. He was Head of the Communication Sciences Jens Degett is the Executive Director of Life the European Action in Global Life Global in Action European (EAGLES) the Director, Executive Jens

75 BioVisionAlexandria 2008 76 BioVisionAlexandria 2008 DC, USA;andKyiv, Ukraine. and evaluation management, operations monitoring and field policy level dialogues. DNA International implementation, Consultancy is based in Washington, launch, and design project all facets of international development work including strategic planning, strategic including work development international of facets all in experienced is Derhak Dianna management. business and law health, and MBA, with 15 years of international development experience in public on Conferences Universityattorney an Technologyis and InnovationShe Health. OxfordTransfer Global in the of Co-Chair and Consultancy, DiannaFounderDerhakthe is ExecutiveChief and InternationalDNA of Founder andChiefExecutive, DNAInternational Consultancy DERHAK, Dianna Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 Philippe Desmarescaux isalso: BioVision since1998. Desmarescaux chairstheScientificFoundation ofLyon andthe World LifeSciencesForum, Chairman oftheBoard oftheEcole Normale Supérieure deLyon (1994-2000),Philippe Rhône-Poulenc Group in1992. Group's Rhône-Poulenc Americansubsidiary Inc. (1986-1997),thenhewasPresident ofthe Company (1980-1996).ChairmanofChemicalsSector (1991-1997),Chairmanofthe Committee. He hasbeenPresident andlaterChairmanoftheAgrochemical Sector ofthe In 1980,Philippe Desmarescaux becameMember oftheRhône–Poulenc Group’s Executive Division in1979. Agrochemical the of President before (1977), Exports ad Marketing of Director was he Then became Research Director in the Agrocheminal Division of Rhône-Poulenc. 1963 as an engineer in the Research Department of PROGRIL. In 1974, he Research in 1961 (CNRS, France). He joined the Rhône-Poulenc Group in His career started as a Research Attaché at the National Centre for Scientific National ofParis; SchoolofChemistry withaDoctorate inPhysics. JulyHigher16 the fromDesmarescauxon Philippe graduated Born 1938, Chairman, The World LifeSciences Forum, BioVision DESMARESCAUX, Philippe Eurotab andmore). - Chairman/Board memberofvarious companies(SEBGroup, Auriga, Innate Pharma, - ChairmanoftheSociété Française deChimie(French ChemicalSociety). - Chevalier delaLégiond'Honneur (LegionofHonor medal).

77 BioVisionAlexandria 2008 78 BioVisionAlexandria 2008 Life SciencesSteering Committee,2003. on Biotechnology in China), Co-Chairman 2002-2005. EAGLES – European Action on Global Vice-Chairman October BioRegion,2002. High-Level Supervisory Committee ScanBalt of EFBIC (European 2002-. Focus FP,October 6th the Health, for Biotechnology and Genomics, Biotechnology, President, 2002-2005. European Commission Advisory Group for Life Sciences, the of directors Nano- of and Microelectronics Institute, Chairman, October 2001-2004. BoardEuropean Federation of 2001-2005. Chairman, Industries, Pharmaceutical of Association University,Aalborg Senateat 1997, Research2001-2004. Policy Steering GroupDanish the Sciences, Technicalof of Academy 1997-2001. Copenhagen, of University Sciences, Health of eio Vle Aaey 19-07 Fcly oni o te Faculty the of of Board Council Faculty 1996-2000. 1997-2007. Academy, Valley Association, Medicon Management Research Industrial Vice- European 1981-. the of Board GoverningUniversity, 1993-. Aarhus at Professor Industry, Adjunct 1996-. Novo Nordisk, Novo Affairs, Research Corporate scientist, of President Research 1980. University, Copenhagen from Microbiology in PhD Professor, Diderichsen, Boerge Vice President, CorporateResearch Affairs,Novo Nordisk DIDERICHSEN, Boerge Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 sizes andshapes. various of particles CD47-decorated of studies ongoing motivating thus system, immune the motors' that are used to eat objects. Some viruses might be exploiting such mechanisms to evade 'nano- macrophage's the of blockade specific a through off, turned is macrophage the present, is CD47 of version “self” a If CD47. called protein membrane particular form a identification, second of a for checks also it target, its engulfs macrophage a before So cells. body’sown the to attaching sometimes sloppy, are antibodies the But interlopers. to bind usually which the first step, macrophages ensnare Inand begin swallowing objects studded with antibody molecules, attacks. misdirected avoid helps intruders recognizing for procedure two-step A cells? "self" from cells and objects "foreign" distinguish macrophages, called system, immune the of develop applications. Such studies have motivated the question: how do perhaps the main policing cells and interactions study to order in viruses as shapes similar into water in assemble to made being are polymers natural, than rather Synthetic, importance. general of cells question a immune is especially cells, various with interact and body the such in how transported and are particles shapes, filamentous and to quasi-spherical agents both have active to their found are deliver Viruses and cells. target, protect, which viruses, are 'nanocarriers' Nature's University ofPennsylvania Engineering, Bio- and Mechanical, Biomolecular, and Chemical of Professor Discher, E. D. Cells with Interactions Their DiverseEngineeredParticlesand Natural'NanoBio'Shapeof or - Abstract Friedrich Wilhelm Bessel Award from theHumboldt Foundation. PastNationalPNAS. US Foundationand a Science awardsinclude Presidential Award the and and hasappeared inawiderangeofjournals,includingScience,Nature Nanotechnology, Cell, biology, cell and molecular as well as mechanics biophysics. and chemistry physical cell emphasizes work stem The and molecule single to filomicelles and polymersomes of development chapters ranging from topics in polymer-based nano-delivery of drugs with book and papers 150 of Berkeley.author at is the HeCalifornia University of from Ph.D. his received He Physics. and Biology Molecular in & Groups Cell Graduate the and Science Applied & Engineering of School the Pennsylvania,in of University the at Professor a is Discher E. Dennis University ofPennsylvania Professor of Chemical & Biomolecular, Mechanical, and Bio- Engineering, DISCHER, DennisE.

79 BioVisionAlexandria 2008 80 BioVisionAlexandria 2008 Businessmen inGermany. Egyptian of 1999:Association Since applications. energy renewable and protection climate to devoted scientist of network a Co-operation, Trans-MediterraneanTREC, Energy Renewable in organisations: Since 2003:e5 European Business Council for Sustainable Energy. Since 2002: electricity and demand potential around Energy the TRANS-CSP,Renewable and Mediterranean MED-CSP and teams electricity study transmission the to of Europe.Member Membership 2004-2005: Conference” Energy Renewable North-Africa “Middle-East series conference the Solar Power” 2006:Creator and administrator of the web site “www.menarec.org”Concentrating which with gathers Desalination “Seawater team. study AQUA-CSP of 2006-2007:Member Team for renewable energies in the frame of the German Egyptian year of science and technology MENAREC 4 in Damascus, 21-24 June 2007 2007:Consulting member to the German Expert for Committee Executive the of 2007:MemberStudy/Work teams: Germany.in Membership introduction must start immediately in order to achieve the necessary freshwater production freshwater necessary the achieve to order in immediately start must introduction market but problem, the solve help can CSP desalination. seawater scale large for fuels fossil to becoming expensive and scarce. Concentrating solar power (CSP) offers a sustainable alternative neither sustainable nor economically feasible in a long-term perspective, as fuels are increasingly supply.reasonablewater a levelof maintain is fuels fossil on based seawater of desalination The to order in unavoidable therefore is seawater desalted of use Increased resources. groundwater over-exploiting by covered poorly are which deficits, considerable leave would practice best to change the However,even possible. as soon as established be to are management water better and use of efficiency enhanced distribution, water for infrastructure Modern MENA. of parts natural resources of potable water in MENA are leading to serious deficits of freshwater in many of Growth here. presented limited rather the and are economy,industrialization, and and population urbanization increasing project this of results main The plans. expansion national in for base approach this of data inclusion the reliable facilitate to and a sector water the provide in makers to policy and decision order in dissemination scale large a by implied impacts, quantifies the potential of this technology in MENA and the socio-economic and environmental the German by Federal sponsored Ministry project AQUA-CSP for The the approach. Environment, obvious Nature rather Conservation a and is NuclearMENA in Safety problem (BMU), scarcity water the solve to steam, process with generation combined in or electricity by either desalination seawater power to plants (CSP) power thermal solar energy.concentrating Using solar for potential outstanding an have countries (MENA) Africa North and East Middle All H.El Nokraschy,CEO,NokraschyEngineeringGmbH Solar PowerOvercomesWaterDeficitintheMiddleEast–NorthAfrica Abstract rates intime. CEO of NOKRASCHY ENGINEERING GmbH in Holm (Hamburg), Holm in GmbH ENGINEERING NOKRASCHY of CEO and 2003:Owner Since www.solarec-egypt.com Site: Web 2005: (SOLAREC). Since Thesis Managing director and owner PhD partner of “Egyptian Solar Research Center” Darmstadt/Germany, University Technical 1968 Darmstadt/Germany. UniversityTechnical 1963 University/Egypt, Cairo Engineering of Faculty 1958 Egypt, Cairo, in 1935 June 28 Born CEO, Nokraschy Engineering GmbH EL NOKRASCHY, Hani Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 n rprs Sprie nmru Ms ad hD tdns n aiiis f niern and Engineering of facilities Agriculture. in students Ph.D and M.sc numerous Supervised reports; and BanhaUniversities;and Zagazigpapers Shams,Alexandria, Einpublished Cairo, About 100 at Agricultural for Organization Development, International Center for Agriculture Research in Arid Regions; Arab Visiting Lecturer Program, Development Nations United Organization, Scientific of Agriculture and Technology.and WorldFoodResearchfor Bank, Academy Consultant activities: Other Committee, Irrigation and Institute; Resources Water Research of Management Chairman Water 1995-date of Director then and Director Deputy 1991-1996 Irrigation; 1998-2001 Vice president of International Commission on Irrigation and Drainage; Dredging Egyptian 2001 Chairman of Horizontal Expansion 1998- and Projects Center; of Sectors, Ministry Researchof WaterWaterNational Resources of and Chairman Chairman Deputy 1996-2001 Egypt; 2001-2002 Company, Egypt; Irrigation, and 1979 UK, Birmingham in Practical University experience: 2001-date Advisor to the Ministry of Aston Water Resources Engineering, Civil D Ph B ScCivilEngineering from AssioutUniversity, Egypt, 1963; Academic qualifications: Dia El Din AhmedEl (18/6/1941). Quosy wasborninKhartoum Professor Emeritus attheNational Water Research Center public-private partnership inwaterissues. public-private partnership of use make to and projects water in invest to sector private the encourage to levels, low its at such huge changes, to attract stakeholders’ participation in managing the water system especially less and produce more. It would be challenging to reform the Egyptian institutions to cope with consume to has agriculture Therefore, agriculture. of share the from deducted be certainly will requirementstouristic industrial, domestic, Everythe allocation. increasein on policy water its reach 10-11 million Fadden, leaving no more supply for increment. By 2017, Egypt has to base will time that by area cultivated that fact the is reason The realized. be will land agricultural in expansion more no 2017 However,by agriculture. to default by allocated and was requirements,remaining the industrial by followed uses domestic to given was priority first i.e. based, development were policy 1997-2017 the to up Egypt in policies water Successive needs. other as such hydropoweruses generation, inland navigation consumptiveand environmental water needs non are released to satisfy and inflow total the of 80% than more consumes agriculture bcm/year,5-7 between exploits industry budget, water national the of bcm/year 9 almost takes in Egypt is an important input to all development and activities. service Domestic water supply this population exceeded 75 million, creating progressive fall in per capita share of water. Water Egyptian The 2%. about at population was only less than maintained 30 million at the time of the 1959 agreement, hardly at the present time is Egypt in growth Population Sudan. with at fixed is country the 55.5 billion cubic meters per year since the of year 1959, according to an international agreement share water Nile River the by represented Egypt in Supply Water D. El Quosy Professor Emeritus attheNational Water Research Center Future Challengesfor Water Management inEgypt Abstract EL QUOSY, Dia

81 BioVisionAlexandria 2008 82 BioVisionAlexandria 2008 l’Institut d’Egypte. He hasauthored/co-authored more than140scientificpublications. been awarded Al-Istiklal Medal by His Majesty King Abdullah II bin Hussein of Jordan;Azerbaijan Agricultural Academy; Member,of Fellow of Council ThirdScientific the World Academyof ofProfessor Sciences (TWAS), Honorable andAcademy; has Agrarian Kyrgyz of Academician Academician(Foreign Member) the of TajikHonorableand Sciences; AcademyAgricultural of Egypt (1986-1991). Foreign Member of the Russian Academy Reclamation, of Land SAHEL Agricultural Sciences, for Moscow; and State of SAHARA Under-Secretary FirstOBSERVATORY International (1993-2002); (SSO) the of Council Technical Scientific the for Chairman (1993); Walesof University the of Fellow (1991-1995). Egypt Center, Research Agricultural of Director/BoardChairman Center (1995-2006). (ICARDA) Areas Dry in Research InternationalAgricultural for the of Director-General University; Shams Agriculture/Ain of Faculty eeomn Cmiso (DC (03peet; rfso a the at Professor (2003-present); Dryland (IDDC) International Bibliotheca Commission the the Development of of Chairman member (2006-present); Board Alexandrina (ARDC); Council Research Agricultural Development the of Chairman and Research Minister for Agriculture the of to Adviser (2006-present); (GFAR) Research Agricultural on Forum Global the of Chair the currently is El-Beltagy Adel Dr.Prof. Chair, Global Forum onAgriculturalResearch (Egypt) EL-BELTAGY, Adel Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 the sustainableenhancementofglobalagriculturalproduction. applying cutting edge plant science by techniques world in developing crop the improvement in programs wealth which of will creation enable and security food of delivery the facilitating as role Institute's Borlaug Norman The envisages Elliottfor Professor Centre (2006). NationalSciences Agricultural Bulgarian the of Causa) (Honoris DSc the and (1994) Medal Purkyne EvangelistaJan the (1993), MeritExceptional of Research Sciences Biological for Medal Gold to approaches cereal biological improvement. He was awarded the Charles molecular University Medal (1992), the Gregor on Mendel emphasis with publications research of hundred author several the is Founding Executive Elliott Professor then to-date). (1994 Institute (1989–93) Borlaug Norman University The DeMontfort of Director at of Deans College The of Head of The School of Life Sciences at De Montfort University, Leicester (1971–94); Chairman in LecturerPlant Biochemistry at The (1967–69); University of Leicester (1969–71); University Professor and Yale at Fellow Research and Scholar Fulbright a was He (1966). Wales of University The from Biochemistry Sciences from The University of WalesPlant (1963)in andHonors, receivedClass hisFirst PhDwith ingraduated, Plant He Improvement. Crop for Malcolm Elliott is the Executive Director of The Norman Borlaug Institute Executive Director, The Norman Borlaug Institute for Crop Improvement ELLIOTT, Malcolm

83 BioVisionAlexandria 2008 84 BioVisionAlexandria 2008 international societies. many of member A Center,1991. Liver Cairo Founded worldwide. researchers eminent research with joint for channels opened conferences, international 100 than more in Participated theses. technology in the field of therapeutic endoscopy (1983-1998). Supervised 31 MS and 25 MD 25 and MS 31 Supervised (1983-1998). endoscopy therapeutic of new field the in technology Introduced 1975. in efforts personal by University Shams Ain at Unit Endoscopy GIT of establishment the in Boardof WorldEditorialMember of 2000. in AMAGE Shared JournalGastroenterology. of Founded (1997-2001). Gastroenterology of Association Arab Pan in President of First International Symposium on Viral Hepatitis, Cairo 1996. Chief of Herpetology(1986–1994). President of the African Association for the Study of Liver Disease (1992– Gastroenterology994). of CongressWorld the in committee Educational the of Member 1982. in Disease Liver of Study the for Association African the of establishment the to contribute He books. text werepapers important these 3 wrotein he chapters and 3 internationally published 1975. He published 122 articles in the field of hepto-gastroenterology and endoscopy –most of GIT Endoscopy in Erlangen University, 1974 and Bad Canstatt Hospital, Stuttgart, Germany, He received international training in Tropical Institute, Hamburg, 1973, Hamburg, Tropicalin Institute, training international received He Emeritus professor of Tropical Medicine, Ain Sham University from 1998. University Shams Ain Professor1972. of Tropical from UniversitySham-1998). Medicine, Ain (1982 MD his awarded University was Cairo El-Zayadi from Dr 1964. graduated and 1938 on born was El-Zayadi Dr and Director, Cairo Liver Center Professor, TropicalFacultyShamsMedicine Ain of Medicine Department, EL-ZAYADI, Abdel-Rahman Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 Mycobacterium tuberculosis infection. in bateyes of the Dominican Republic may be attributable to Mycobacterium bovis rather than tuberculosis of prevalence high the that possibility the raise data Our “possible”tuberculosis. with diagnosed children about assumptions varying under and age and contacts tuberculosis size, household vaccination, Calmette-GuérinBacille for adjusting after even 1.4-7.4) interval: independent risk factor for intrathoracic tuberculosis (adjusted odds ratio, 3.2; 95% confidence diagnosed in 83 (20.8%) of was 400 children. tuberculosis Unpasteurized possible milk consumption was or identified as Definite an Republic. Dominican the of bateyes the in migrant populations in living children among tuberculosis intrathoracic for factors risk identify cross-sectional to a study conducted We disease. of if incidence high particularly a with tuberculosis, countries in for originate they populations high-risk are migrants economic and Refugees International Medicine Director,ExecutiveChildren’s and FounderPhiladelphia’s of Finalle,for Hospital R. Alliance Dominican Republic Bateyes Twoof Population Migrant Economic the TuberculosisIntrathoracic in for Factors Risk Abstract living inextreme poverty intheDominican Republic. residents and medical students to improve children’spractitioners, health in a nurse population of migrant Haitians and nurses, physicians, utilizing approach interdisciplinary successfully an has developed program AIM The country. scarce resource a in system health health academic a with tertiary center US-based a partners which model a championed has he Medicine, has Finalle Dr. Republic. Dominican the and worked collaboratively with less Haiti, developed countries, and through the in Alliance for International work extensive included has work international His Medicine. of School Pennsylvania of University the at School Medical and Children’sthe at training SouthHepediatric America. his completed Hospital Philadelphia,of and guided he whereprovided health care Ministry to children in Healthunder-developed nations such as Global the Caribbean, Central and of Director Clinical former the is Finalle Dr. Academy of Pediatrics (FAAP), he in serves the AAP Section of the International Child Health. American the Fellowof a As Medicine. of PennsylvaniaSchool Universityof the Pediatrics,at of Professor, Department Associate Clinical a is Hefacility. comprehensive care primary a Creek, Cobbs at Center Care Primary Philadelphia of Finalle is a pediatrician, and the Medical Director Dr.of the (CHOP-AIM). Children’sMedicine International Hospital for Philadelphia’sAlliance of Dr. Finalle is the Founder and Executive Director of the Children’s Hospital Philadelphia’s of Alliance forInternational Medicine. Hospital Children’s Director, Executive and Founder FINALLE, Rodney

85 BioVisionAlexandria 2008 86 BioVisionAlexandria 2008 for AnimalProduction. Society British the of member Committee; EURAGRI the of member Research; Agricultural of the World Breeding Federation for Sport Horses; member of the EU Standing Committee on Vice-Presidenta Production; Animal for Association EuropeanWalsh the Fellow;Presidentof for TeagascMenbershipplanning. strategic on Distinctions:and Fulbright and Scholar Teagasc FoodAuthority.Development part-time worksnow and position this retiredHerecentlyfrom development aid projects in Africa. In 2002, he became Director of Teagasc, the Agriculture and of number a oversaw and planned and aid development agriculture-food on ForeignAffairs of Services and Chief Adviser to the Minister in these areas. He also acted as adviser Agriculture-Foodto ProfessionalTechnical the the and Ministry of Head as culminating Ireland in Food and College Dublin. He spent most of his career in the of Ministry Agriculture Science. He has Computer a and Master's Biometrics degree Genetics, Populationin in Public US Service the Management in from University Trinity years studying and working at Michigan State University and West Virginia six spent he which following Science Agricultural in degrees Master's and Bachelor's with Dublin College University from graduated Flanagan Jim President, European AssociationforAnimalProduction FLANAGAN, Jim Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 technologies. sharing arrangements. The presentation will explore options taking examples of various fields of and benefit balanced workable process, innovation national a on based be should This IPR. of and steady capacity building in technology, with the creation and institutionalized management enforcement,its for developmentalframework national a needs, with law competition statutes, divide. technology the IPR the of gelling bridge the facilitate pragmatically and effectively synergistically Policiesshould IPR National could partners cooperating the involving process mediated IPR an that Itbelieved benefit. is societal further build to technology-haves the from technologies the acquiring of means and ways explore in or process development indulge technology the either should they which at phase the on quandary a in technology-seekers other developers on one hand aggressively protect their technologies using diverse tools of IPR leaving development. sustainable on impact significant Technologyhave that practices and statutes the in elements encompasses that issue multidimensional a is divide widening this across transfer Technology significant. contextually become (IPR) Rights Property Intellectual that this context in is It unbridgeable. seem apparently that contrasts to leading sharpened has have-nots technology- and technology-haves the between divide technology the advance, technologies As P. Ganguli, CEO, Vision-IPR IPR Mediated Bridging ofthe Technology Divide…Exploring Options Abstract GANGULI, the Indian Subsidiary ofUnilever. research, followed by in 2 diversedecades of industry managerial roles in Hindustan Lever Ltd, academic of period long a spans Fellow,experience FoundationHumboldt his von Alexander from PhD and Tata (Kanpur) TechnologyInstituteFundamental of Research, Mumbai, researchan postdoctoral Germanyas and in of Institute Indian the from Chemistry in MSc With and over 60 publications in Intellectual Property Rights and has authored 4 books in that field. subjects technical in publications 50 than more has He Information“. Patent“World Journal IPR the of BoardFashion Editorial of International Technology,the of member a is He India. International Institute the of Intellectual of Property the Studies,of Board Board Mumbai Advisory and the Advisory a of Senate member the Memberalso of is Washington.Hethe of Institute, NationalProperty Intellectual Institute member a and India of Government Adviser, Scientific Principal the of Office the to matters IPR and Innovation for Consultant Scientific Property Law, Indian Institute of Technology, Kharagpur, India, Honorary Intellectual of Institute the Professorat Adjunct and Sciences of Academy programmes in developing countries, an elected Fellow of the Maharashtra Knowledge and Security management building capacity IPR for to WIPO Consultant IPR Management.a He Informationis in Rights, services Property offering Intellectual “VISION-IPR”, of of CEO the is He CEO, Vision-IPR Prabuddha

87 BioVisionAlexandria 2008 88 BioVisionAlexandria 2008 Heriot’s SchoolinEdinburgh. He ismarriedwithoneson. Canterbury,Kentat and OpenUniversitythe well as Georgeas at that to London prior and UK, the in Edinburgh, of Universities the at educated was He MBA. an and Politics European and Relations International in MA an Microbiology.holds in also HePhD a with training by Industry Competitiveness Task Force (PICTF), reporting to the Prime Minister. Iain is a Pharmaceutical successful highly nowLordthe May).JustIain(the scientist ran OECD, joining before Adviser Scientific UK’sChief the of support in unit policy a ran he where Office Cabinet the Environment,Healththe of of of and Departments UK the in Tradein wellas as Industry and Genetics Co Ltd, Cambridge) before joining Government service in 1991. He held policy posts Iain worked in academia (UK and Middle East) and in the biotechnology industry (Agricultural and other infrastructure issues, and on supply/demand side policy integration in biotechnology. other innovation in the bioindustries, human genetics and genomics, IPRs, biosecurity, metrics delivery of a more resilient biobased economy. The focus of OECD work is on health-related and biotechnology as a driver for sustainable growth and development and the and development growthand sustainable for driver a as biotechnology member countries to develop international consensus on the application of OECD 30 the with works Division Biotechnology The 2001. June since held Cooperation has he post Economic a Division, for Biotechnology Development’s(OECD) and Organization the of Head is Gillespie Iain Industry, OECD Science, Technologyfor DirectorateDivision, Biotechnology of Head and GILLESPIE, Iain Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 ne-mhszd mat o boul rdcin n lbl ad s, atclry associated particularly gaseous emissions,andpossibleameliorationofsome potentialpr use, land global on production biofuel of impacts under-emphasized on ethical and on environmental impact grounds. This contribution will examine some hitherto applauded; the production of transport fuels from cereals and oil seeds must be questioned both generally were gas or oil from projects production food and feed Whereas production. biofuel agricultural commodities between their traditional uses and recently found uses as feedstocks for the production of biofuels from cereals and oil seeds, thereby initiating possible competition for on emphasis huge placing are world the of later, parts years many 35 Some prices. commodity agricultural and costs energy n-alkanes, global between link direct a waxy demonstrated but supplies, protein towards global to contribution directed significant a make to failed was SCP time that At attention methanol. and methane particular feedstocks, possible Amongst nutrition. animal to inaccessible themselves were which feedstocks, from (SCP) Protein Cell incorporation in compound animal feeds. This resulted in industrialfor proteins production alternative routesfor search fora stimulated Single and 1950s the a in malnutrition as of source major identified was deficiency Protein crops. seed oil and cereal on involves based latter feeds the compounded of Production increasing. also is origin animal of protein for demand the that quality,such dietary on and requirements quantity food both on impact standards living period a during when the price of fuels crude oil continues to escalate transportation and production remains for constrained. Increased and create, feed to animal food, continue for will demand and accelerating created, ever have changes Such come. to decades for predicted are Global population explosion has been a feature of the past century and further massive increases G. Hamer,HonorarySecretary,BiofocusFoundation Agriculture andEngineeredAquaticEnvironments Methanotrophy: FromSingleCellProteinProductiontoGaseousEmissionsfromWetland Abstract publications, scientific and in2006wasawarded theDonald160 Medel oftheInstitution ofChemicalEngineers. some of author the is He Foundation. Biofocus the of been Secretary has 2002 since and Dublin; College University at and Engineering Professor Chemical was of he Chairman 2001, to 1992 From Biotechnology. Environmental in specialized he where Zurich, Technologyin of Institute Federal Swiss the at TechnicalBiology appointed of Professor was 1980 in and Scientist, Principal a as Kuwait in KISR joined he 1978, In gas. (Fermentation) Bioprocess Research at Shell Research of Ltd. in England, working Head primarily on SCP production from was natural 1968/1978 and Stockholm, in From 1962 to 1968 he was a Research Associate at the Karolinska Institute sectors. NGO governmentaland industrial, academic, the in teaching and developmentresearch, Bioprocess in engaged been has he years 45 last the For 1962. in Birmingham of University the from PhD his obtained and Engineering, Bioprocess and Chemical in graduate a is Hamer Geoffrey Honorary Secretary, Biofocus Foundation, United Kingdom HAMER, Geoffrey oblems.

89 BioVisionAlexandria 2008 90 BioVisionAlexandria 2008 Key words: cropping season;foodsecurity;householdandmarketing. of theapproach totherest ofthecountry. a “green revolution” achieved within two years and efforts are now being made on more the scalability are that legumes of example as a an as sets experience MVP The soil. the for such better and nutritious moreprofitable, crops alternative for space up opened literally have maize in good price that economically benefited the farmers. The impressive productivity improvements a at board marketing grain community.Government a ADMARC, to the sold was in maize of MT schools 333 Another four supporting is that program feeding school a towards maize of MT 700 about contributed they and surpluses maize reported households the of majority seasons, The these practices. traditional under Inthose times five to three seasons. yields maize obtained households cropping the 2006/07 and 2005/06 hectare in 0.45 households cover to 11,000 enough to seed land maize of hybrid of kg 10 and fertilizer chemical of kg 100 foods. In order to address this goal, the project provided an agricultural input package containing eliminate hunger and to malnutrition by is increasing which production, access of and utilization one of nutritious communities, rural in Goals Development Millennium is the project implement to the of objective overall The insecurity. food chronic country’s the to response a as Green A Achieving to Approach Team LeaderandScienceCoordinator, Integrated The Millennium Village Project, Malawi. An Malawi: Revolution: in Villages Millennium Abstract agricultural watersheds;spatialnutrientdistributioninwatersheds. forest soils; carbon and nitrogen fluxes in agroforestry systems; management and utilization of utilization and management systems; agroforestry in fluxes nitrogen and carbon soils; forest and agricultural in cycling nutrient soil on emphasis with productivity crop and fertility soil are interests research Her districts. five in communities rural and commissioners district with Food Program (WFP) as a Food Aid Monitor, designing Food-for-work Worldfor projects worked in also She Malawi.collaboration southern of areas prone drought and depleted nitrogen in agroforestry of performance on trials on-farm implemented she where Agroforesty(ICRAF) in years experience in Malawi. This includes the 3-year job with International Centre for Research 7 over has Harawa Rebbie project. overall the for providing oversight management entails and coordination work scientific Her Millennium level. the community achieving local at at (MDGs) aiming Goals is Development which building) - capacity and Education/Gender (Agriculture/Environment,Health,Energy/Transport,project multi-sectoral Water/Sanitation, The The Millennium Villages in activities its implementing 2005 in Malawi Project started (MVP) Science Coordinator for the UN-Millennium Villages Project in Malawi, a NewYork, Currently,a 2005. Teamas workingin is USA, she and Leader of University Malawi. Agriculture, She of obtained a PhD College in Soil Bunda Science from from Cornell University, Agronomy in Ithaca, degree Rebbie Harawa received a Bachelor's degree in Crop Science, and a Master's Malawi Project, Village Millennium The Coordinator, Science and TeamLeader HARAWA, Rebbie Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 f h Pksa Aaey f cecs Hs eerh ra icue hoeia pam physics, plasma theoretical Hephysics ofwinderosion andsandtransport. ismarried,andhastwodaughtersason. include areas research His Sciences. of Academy Pakistan the of corresponding member of the Belgian Royal Overseas Academy of Sciences, and Foreign Fellow NaturalSciences, and Physical Exact, of Academy Colombian the of member honorary as well Scientific Merit of Brazil. He is a fellow of TWAS, AAS, and the Islamic Academy of Sciences as of the School of Mathematical Sciences at the University of Khartoum, he received the Order of PhD in Plasma Physics from the University of Oxford, UK (1974). Former Professor and Dean a holds and 1947, in Sudan the in born was He worldwide. organizations other in committees of number a on serves and (TWNSO) Organizations Sciences (AAS); Secretary General of the Third World Networkof ofAcademy Scientific African the of PresidentWorld; Developing the for Sciences of Academy the TWAS,of Director Executive is Hassan H.A. Mohamed (TWAS) World Developing the for Sciences of Academy The Director, Executive HASSAN, Mohamed

91 BioVisionAlexandria 2008 92 BioVisionAlexandria 2008 (DNDi). Neglectedfor Drugs DiseasesInitiativethe of Committee Advisory Scientific the and Alliance, London, Board of Trustees Foundation Maison de la Chimie, the Board of Directors of the TB of TrusteesBoardNovartis Foundationin the the notably of most boards, several on serves he activities, editing scientific to addition In (UCLA). Angeles Los California, of University the at Institute Neuropsychiatric the at fellow post-doctorate a was and Zurich of University the from 1975 in Doctorate his obtained He Research. Corporate of Head 1994, in and Pharma; Sandoz Pharma in Basel. In 1992, he was named Head of Preclinical Research Basel for Sandoz at Department Research CNS Preclinical of Head and Bern Institute Research Sandoz the of Head became he 1985, In Bern. Wanderand in Basel in Sandoz both at research in positions various held and 1975 in Pharma Sandoz joined Herrling Dr. (PEC). Committee Executive Pharma the of member a and Pharma Novartis at Research Global of Head was he position, serves on boards of several other research institutions. Prior to his current his to Prior institutions. research other several of boards on serves and California, Jolla, La in FoundationResearchNovartis Genomics the of Institute the and Basel in Institute Miescher Friedrich the oversees he addition, In Singapore. Tropicalfor in Institute NovartisDiseases created he assumed position in November a Novartis,2002. He at is Research also Chairman Corporate of the of Board Head of the is newly- Herrling Paul Head, CorporateResearch, Novartis HERRLING, Paul Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 that relevant technologies are getting cheaper. Associated developments must take place, such as fact the by aided investments modest with scientists competent of teams small byproductively these areas difficult and expensive. In contrast, the three areas into nominated entry make are arrangements, regulatory able complex and protracted, to with together breeding,be plant animal conducted and pharmaceutical fermentation, food, the biofuels, Development, in and Research elsewhere stem-cell industry, investments Massive organisms. native of bioprospecting (c) contaminants; and pollutants of elimination and detection the for biotechnology “white” recombinant antibodies and genomics tools, virus vectors, and using diagnostics propagation advanced techniques, systems; analytical new utilizing (b) but observations industrial and remedies traditional on building plants, medicinal (a) are These resources. available given exploitation, Sciences, of for ripe Academyespecially industry. areas and general threearethereacademia involvingthat Itclear is Arab the of meetings special technology foresight exercises in several Western nations, and detailed international discussions including analyses, various on region. the the Based to reflecting relevance special possible have is that opportunities reversal biotechnological a of range fortunately enormous but manifold, are situation this for reasons The positions. competitive global relative their in decline relative a suffering are nations Arab biotechnology.exceptions, modern few in With talents indigenous its on adequately capitalize to far so failed has world Arab technology,the and engineering, science, of areas many in As J.R. Hillman, Former Director, ScottishCrop Research Institute (SCRI) forBiotechnologyOpportunities Research andDevelopment intheArabRegion. Abstract PhD, DSc,FIBiol, FIHort, FRAgS,FLS,FRSE Biotechnology Group. International Potato Industry Award, Scottish Horticultural Medal. BSc, Industrialof Chairman BoardDirectorsand of BioIndustryAssociation of of of Chairman Member Programme. University. ForesightTechnology UK of Glasgow Panels Sector Department, two Botany of Head and Professorthat, Before (1986-2005). Scotland Statistics & Biomathematics Research Institute Group, including Mylnefield Research Services Ltd. and Crop Scottish the of Executive FormerChief Sciences. Life in Consultant Former Director, ScottishCrop Research Institute (SCRI) in ourbioinformatics. HILLMAN, John

93 BioVisionAlexandria 2008 94 BioVisionAlexandria 2008 for scientistsandPhD candidates,andthefundingofmobility andresearch projects. and between the Egyptian Ministry, in cooperation with DAAD, including various scholarships The initiated. been have term, long extraordinary success is a supported through several on follow-up projects cooperation between the two scientific ministries the deepen to supposed are which projects, research new and expanded been have networks strengthened, were operations co- existing projects, and events these of help the community.With scientific broader the to open also were which events and events cross-section events, highlight several been have there Germany. and Egypt additionally and topics, specialist 6 the within in workshops holding werescientists Considerable place took conferences and projects 150 Around term. long the on working them keep to but Science, Yearof the for only not scientists, German and Egyptian between networks expand and build to was aim The countries. two the between exchange for need the as well as Egypt, in potential scientific the out pointed and research, and science of priority the Water.emphasized and It Sciences Social Energies, Renewable Sciences, Material scientific exchange. The Year of Science 2007 focused on 6 main topics: Biotechnology,between Egypt and Germany, Medicine, and to provide a wide range of specialists with the opportunity for cooperation scientific the strengthen the to of was objective Science The project. of the Year of Hany Helal. The DAAD (German Academic Exchange Service) took over the coordinating role Higher Prof.Dr.HE of and Dr.Schavan HE Annette by represented Research, Ministry Scientific and Education Egyptian the and Research and Education of Ministry Federal German the of initiative bilateral a was 2007 and Technology Science of German-Egyptian Year The C. Huelshoerster,Director,DAADofficeinCairo,Egypt German EgyptianYearofScienceandTechnology2007 Abstract (1995/1996); various internshipsandtrainingswithnationalinternationalinstitutions University, Bangkok, Thailand (1998-2001); Guest Lecturer, University of Wales Lampeter, UK DAAD Information Centre, Bangkok, Thailand (1998–2001); Visiting Professor, Chulalongkorn “University Marketing”, DAAD Bonn, Germany (2001–2005); Head of Head (2001–2005); Germany Bonn, DAAD Marketing”, “University Section of Head Positions: Previous (2005-2008). Egypt Office, Branch Cairo Service) Exchange Academic (German Director,DAAD Currently: Literature, German phil), (Dr. PhD 1995-1997: Münster of University 1989- Münster 1995: State of Examination for Teachers University (German, Theology, Social Sciences) Education: J. Christian Hülshörster, Dr. Director, DAADofficeinCairo, Egypt HUELSHOERSTER, Christian Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 genetic diversity andgeneflows. monitor and tomorrow of varieties improved safe the invent breeders plant help can methods profiling Technology,Arrays genome Diversity high-resolution agriculture. high-throughput a sustainable productive a to contribute will crops improve to diversity genetic wider and better factors, and to delay or forego risk many environmental environmental important, benefits more possibly biotechnology other, may missing of offer. risk Harnessingthe for “dangerous” runs innovationsenvironment the of source a as biotechnology on focus narrow A regulated. and assessed be should innovations biotechnological of safety environmental the which in context will impact on the environment through the production system they are deployed in. This is the varieties, obtained through biology-assisted plant breeding or through genetic engineering. They specific of biotechnology. Biotechnological innovations in agriculture are rarelymostly improved are crop raised issues safety environmental The issues. technical and scientific to issues than rather socio-economic and political, to related and context-dependent, complex, is unsustainable practices identifying and sustainability Defining difficulties. with fraught is area decisions this making sustainability,in improves deploy we innovation any that critical is it While practices. agricultural current some of sustainability the about doubts are There massive. been has environment the on agriculture of impact The engineering. genetic and methods breeding facing. Modern biology has been contributing to crop improvement for decades, through better Crop improvement will play a major role in solving this challenge, one of many we are currently feed and fibre, while preserving the biosphere’s capacity to do the same for the next generations. affordablequality producegood to food, ability Ourcurrentour on standarddepends living of E.Huttner, GeneralManager,DiversityArraysTechnologyPtyLimited Environmental SafetyofBiotechnologicalInnovationsinCrops Abstract Australian Biotechnology Council(2005-2008). Advisory the of Member (France,1998-2001). program Génoplante the in projects several of Manager Director (2001-present) of Gene Shears Pty Limited. Chief Scientific Officer of Biogemma and Cooperative and the (1991-1998) adviser Scientific 1991-1998). (Canberra, of Science Plant for Centre Research member Founding resistance. virus and sterility male artificial for genes improvement, crop for tools Molecular Australia. in Limagrain Groupe of laboratory research the (1990-1998), Pacific Limagrain Groupe Director, (1988-1990); FranceVersailles, INRA Agronomique scientist, Staff (1987/1988); China Shanghai, Science, of NationalAcademy Chinese Biochemistry, of Institute Shanghai Yu, Guang Institut Zhou Prof. of laboratory scientist, Postdoctoral from 1986); (Paris, Engineer-Doctor highlights: Career breeding. plant for technologies marker molecular of deployment effective the interests: Current barley. and deliveringwheat for company services genotyping a Triticarte, of Manager genotyping. low-cost and Pty Limited, a company delivering a novel technology for high throughput Eric Huttner, currently is General Manager of Diversity Arrays Technology General Manager, Diversity Arrays Technology Pty Limited HUTTNER, Eric

95 BioVisionAlexandria 2008 96 BioVisionAlexandria 2008 actual risksinorder topave thewayforamore realistic debate. as fertilizer is under the radar of public perception. The presentation will highlight some of these farming. Also the higher risk for microbial contaminations organic in food in stuff produced extracts using manure "natural" of use the to countries developing in pesticides old-fashioned of occur, use they the as from risks actual ignores debate This hazards. virtual on scenarios flawed Current debates on biosafety focus solely on GMOs, sometimes using exaggerated or scientifically- H.J. Jacobsen, Professor, Institute forPlant Genetics, Hannover University Is "Natural" Always"Safe" And"Synthetic" Always"Hazardous"? Abstract etc. 2005:Elected Spokesman fortheGerman Biology Faculties (KBF). Physiology,PlantEuphytica,Journal of for Editor Associate or BoardEditorial the Memberof international an of (Colsciencias) member Colombia in (Biotechnology) Excellence 2006 of Centers Evaluating 2004, for GroupPeer (vdbiol) Biologists of Association German the of (2001-2004) President (1998-2000), Vice-PresidentGermany BMVEL, Ressources”, Genetic “Plant for Minister the to Board Advisory the of Member 2003: since Saxony Lower of state “Agrobiotechnology1999-2004”; program research the of Coordinator 1995-2003 crops”; of and related techniques for the conservation and use of Micropropagationplant genetic resources and the improvement “Biotechnology: on DSE.course the for coordinator Scientific 2001) Biotechnology”Professor,(since “Plant Visiting teaching (3). UniversityNortheasternBoston, 2002-2005,2004-2007 1999-2004, 1996-1999, CIAT,GTZ/BMZ, and by ICARDA funded with projects biotech in leader Project (2). Syria and BangladeshAlexander from Humboldt-Fellowsof v. Host 1999, since assigned, tasks detailed Biotechnology Plant Department, of French reading (C3) positionheldanddescriptionofdutiesProfessor andHead Professor 1987, (C2) English; in fluent Professormother-tongue; Hannover.German of 1991,University 1978, Genetics in PhD Biology (1974), in Diploma 1969-1974 Bonn) of University (Biology, Student EDUCATION Jacobsen, Hans-Jörg, born29April 1949,Germany. Professor, Institute forPlant Genetics, Hannover University, Germany JACOBSEN, Hans-Joerg Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 biotech crops inalleviatingpoverty andhunger. of contribution potential and development, researchand agricultural international Experience: Founder andChairofISAAA. Deputy Director General, CIMMYT, Mexico. Senior Adviser, CIDA,Canada. FAO Staff, Rome, Italy. Researcher, Federal ofAgriculture, Department Canada. Canada. University.Cambridge PhD, obtainaed to UK Emigrated the in Educated Chairman andFounder, ISAAA JAMES, Clive

97 BioVisionAlexandria 2008 98 BioVisionAlexandria 2008 required inorder toproperly address thesituationofsevere acutemalnutrition. is countries developed least of number significant a in basis commercial a on production local of building effective the support to investment and transfer technology in effort concerted A enhances local capacities with a potentially positive effect in terms of longer-term sustainability. number a of countries in Africa, in Middle East and Southunderway Asia. Productionare in developing productioncountries local in initiatives several and Ethiopia; and MalawiNiger, in successful proven has RUTF of production local The need. estimated the of 5% or children, million one only treating MT,for 16,000 enough around currently is Totalcapacity available have to be substantially increased for any significant scale-up of community-based management. Foods Therapeutic Ready-to-Use (RUTF), which have using been developed in the last decade. The production capacity of RUTF will communities their numbers in treated large medical be severe can that of freecomplications, are suggests and appetite evidence have who New children, annually.malnourished acutely severely deaths of million one over to leading malnutrition, acute severe from suffer to estimated are five under children million 20 Nearly S. Jarrett,PrincipalAdviser,UNICEFSupplyDivision Acute Malnutrition Making Ready-To-UseTherapeuticFoodsReadilyAvailabletoTreatChildrenwithSevere Abstract services strengthening. services health and immunization with concerned issues on articles numerous published has He USA. University,York,Columbia New from degree MPH an and UK; Southampton, of University the from degree BSc a holds JarrettMr. countries. low-income other and Africa sub-Saharan in systems supply drug on focus a with strengthening, systems health on UNICEF to adviser senior a as worked 1980s, also has the He immunization. in child China universal of in achievement the officer supporting health senior as and 1970s; the in Americas the of several countries in management program in assignments field diverse included have various These in capacities. worked UNICEF,having with service of manufacturing. years local 36 completed including recently Jarrett malnutrition, Mr. child combating for foods ready-to-use on is development, focus specific current and His Goals. survival Development Millennium the child meet to to countries by related needed technologies new of scale-up and introduction the on UNICEF advises Currently,he worldwide. companies vaccine and pharmaceutical in muiain aeil, anann cnat ih eir management senior with contact maintaining materials, and immunization pharmaceuticals vaccines, of management the overseen and has procurement He global annually. countries value procurement 160 billion in $1 over programs children’swith concerning supporting problem-solving function and supply issues the strategic in engaged been has As part of UNICEF Supply Division Management for 12 years, Mr. Jarrett Principal Adviser, UNICEFSupply Division JARRETT, Stephen Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 though notinthefieldofrawmaterials/feedstock. countries, policies seem to converge in R&D in 2nd and 3rd generation bioenergy technologies, Sweden has been a pioneer with respect to biofuels. Whereas support measures differ among the whereasNordic countries, all for priority political general a is heating for Bioenergy countries. extent. However, the national measures to support bio-energy differ between supported the different have Nordic countries Nordicelectricity and heat generation from renewable energy sources during the to 21st some Century the All policies. EU with complying from apart countries Nordic the among conditions framework political and measures policy actual of use common no is Currently,there countries. Nordic the between differ for sector conditions bio-energy the framework supporting political The markets. bioenergy expanding of opportunities and will present preliminary results from a study on how the Nordic countries address the challenges task how to make wise market pull difficult and technology push policies for the bioenergy sector.the The paper facing are decision-makers interests, and agendas conflicting with situation a In resources. water and biodiversity,soil use, land on pressure puts biomass of use increased for demand increasing the biomass resources in Europe and on the world market, prices are likely to increase. with Further, the advantages, many has bioenergy Although how. know and providing a cost efficient alternative to fossil fuels, offering business opportunities in technologies Sweden. It has the potential to contribute to securing energy supply, reducing GHG emissions, Bioenergy plays an important role in the four Nordic countries – Denmark, Finland, Norway and B.H Joergensen,ManagingDirector,NordicEnergyResearch Nordic PerspectivesonBioenergy Abstract risoe.dk). (www.Denmark in NationalLaboratory Risø at Department Analysis Systems the at Scientist Norway of Senior a was she Research,Nordic Energy Council at affiliation (www.forskningsradet.no).her Priorto Research the under established RENERGI, programme research the of TechnologyHydrogenfor Platform Fuel (www.hfpeurope.org);and Cells boardmember a and European the of GroupMirror the of Vice-Chair the is She institutions. funding research and an acknowledged is expert and reviewer at Jørgensenthe EU Commission, and several Holst Nordic research councils Ms. Copenhagen. of Political University in the from PhD Science Business a and in School; Business MSc Copenhagen an from Economics holds She (www.nordicenergy.net). Ministers of funding innovation institution, and which has researchbeen operating Nordicfor 20 years a under the Research, Nordic Council Energy Nordic of Director Managing the is Jorgensen Holst Birte 2005, September Since Managing Director, Nordic Energy Research JORGENSEN, BirteHolst

99 BioVisionAlexandria 2008 100 BioVisionAlexandria 2008 to provide theinfrastructure forclinicaltrialsindeveloping countries. tiered-price system and guaranteed purchase of the vaccine. Finally, capacity-building is needed reductions, tax through e.g. attracted, be to needs industry Thus, field. the to bench the from academic research laboratories. Public-private partnerships are needed to transfer these vaccines and non-governmental organizations. Most vaccines against governmental tuberculosis foundations, have been from developed support in as well as partnerships public-private include These exploited. be to need strategies support novel countries, developing in live of cases majority tuberculosis vast the As stage. early an at failure needed or urgently success vaccine are of biomarkers prediction allow Hence, which populations. study large require and years, 10 to 5 their efficacy can only be revealed in clinical trials. These are long-term endeavors ranging from ultimately preclinicalmodels, in candidates these of success some of Invaccine.spite subunit a Obviously,recombinantwith prime as combined be can with strategies booster both and BCG BCG. substituting at aimed efficacy improved with BCG recombinant and BCG current and in, or have passed, clinical phase I trials. Current vaccines are subunit, booster vaccines primary are vaccines pre-exposure Currently,several needed. are vaccines post-exposure and exposure pre- both disease, developing of risk increasedtherefore at and tuberculosis M. with infected is tuberculosis critically depends of on Control design disease. of this of novel form vaccine. prevalent most Since the one adults, third of tuberculosis of pulmonary the against world population not but tuberculosis childhood against protects only it available, is vaccine BCG the Although Tuberculosis remains a major health threat with 9 million new cases and 2 million deaths annually. S. Kaufmann,FoundingDirectorandMember,Max-Planck-InstituteforInfectionBiology Development ofAVaccineAgainstTuberculosis:FromPromisestoPractice Abstract Gutenberg University, Mainz, in1977. Johannes from PhD his received He laboratories. European/US seven and sites African seven comprising Africa” in HIV/AIDS of context the “Tuberculosisin 6 Challenge Grand the of PIFoundation. is MelindaHeGates & Bill the EuropeanUnionFoundation,and the Science German the by others, amongst funded, programs research international and national several of coordinator been has He Societies. Immunological of Union International the of future president and Societies, Immunological of Federation European the of president Immunology, for Society German the of president former is and awards numerous received has He Ulm. of to 1998, Kaufmann was Professor and Chair of the department of immunology at the University increasingly and capacity-building interestedin Africa. From partnerships in north/south 1991 metabolome, proteome and transcriptome analysis in infection. Aside from this, he has become n Tcl ppltos n muiy gis itaellr atra and bacteria, intracellular against immunity in populations T-cell and presentation antigen cytokines, of role the strategies, vaccination novel of development tuberculosis, against vaccine a of design rational the include Immunology.of Department Directorits of researchinterests His primary as Director,well Acting as Institute's the is He 1993. Infectionin Berlin in Biology for Institute Planck Max the founded Kaufmann H.E. Stefan Infection for Max-Planck-Institute Biology Member, and Director Founding KAUFMANN, Stefan Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 management, and perfecting theprocess ofscience policymaking. management, andperfecting operation of efficiency the Improve (4) collaboration, south to south support to fund special Offer embassies.(3) in counselors technology and science of responsibility the clear clarify and framework collaboration the Sign (2) countries developing other to paying attention more to and more countries developed with (1) cooperating on interviewees. focusing the only from to attitude the according Change countries developing in governments the to suggestions Weseveral 5. conclude collaboration. the of outputs main the are plant and of kind new markets, a finding target the entering medicine, new producing papers, writing fieldwork, our of cases the In collaboration. the of Outputs 4. collaboration. the hindering barriers main the are have not played the expected role in improving south to south collaboration. These three aspects counselors technology and Science (3) collaborations, south to south the disturb will countries developing some of environment political unstable The (2) bio-products; those of export the hinders which time, much too takes office custom by approving and examining of procedure well as from international organizations. 3. Barriers to the collaboration. We found that (1) The as countries, developing and countries developed both of governments the most from supports the the is network Personal collaboration. encouraging factor to important improve the collaboration. 2. Factors encouraging collaboration. We reasons found of kinds five found We collaboration. for Reasons 1. dimensions: several by guided are which research, our in findings the emphasize to turn will I Then, etc. method, connection and list interviewees the as well as members, team the introduce will First,research.I this out carry to way main Fieldworkthe is W. Ke,InstitiuteofPolicyManagement,ChineeseAcademySciences South toCollaborationinBiotechnology-CaseStudyofChina Abstract State inNorthbridge fortwomonth California of University the visited she 2005, In institute. this in working been has Sinceshe then, China. of Technologyand Science of University of School Business from engineering and management science in degree PhD a Dr.Wengot 2004, In China. of Biotechnology in Intellectual Property Rights, and the other is South to South Collaboration leading two projects, one is evaluating the Performance of Chinas Strategy of of latecomer countries and scientists strategies and in science policy-making. following She policy,is Policycurrently innovation of of research evaluation main include Institute Her interests sciences. the of academy at Chinese the professor and Management associate the is Wenke Dr. Institiute ofPolicy Management, ChineeseAcademy ofSciences. KE, Wen

101 BioVisionAlexandria 2008 102 BioVisionAlexandria 2008 maximize the opportunity for sustainable service development, andhealthgain. forsustainableservice maximize theopportunity diseases and reflect patient and family needs, These applications are culturally relevant and they limiting life chronic in intervene that opportunities novel of applications clinical the planning and political public, sap will and for framework a describe will I Insession, biomedicine this and genetics in investorconfidence gain, health for hope the reduce not will knowledge new rapidly,growing is this environment, of and prematureapplication lifestyle and genes between diseases. Whilst it that is scientific true understanding of the links between genes, and the links for claims of number breakthroughs in the prediction, diagnosis vastand treatment of an ever growinga number of genetic reveal will WebWideWorld the or media the of search brief A A.Kent, Director,GeneticInterestGroup A PatientFriendlyFrameworkforIntroducingNovelInterventionsintoClinicalPractice Abstract issues concerningpolicy, development anddisabledpeople. service on organizations voluntary of number a for worked Alastair GIG, joining to Prior conditions. mrvd evcs n spot o te ramn o crety incurable currently of treatment the for support and services improved into knowledge recent this of transfer speedy the see to and disease, and scientific of health in play factors development genetic that role the the and genetics promoteof understanding to is mission GIG's disorders. the genetic by affected people for (GIG), groups support and charities Groupof alliance UK Interest Genetic the of Director the is Kent Alastair Director, Genetic Interest Group KENT, Alastair Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 with a higher level of iron, zinc and vitamin A through plant breeding and biotechnological approaches. Considerableprogress hasbeenmadewhichwillbereviewed. and breeding plant through A vitamin and zinc iron, of level higher a with crops food develop to aims CGIAR of program Plus Harvest poor. the of crops staple the of content micronutrient the raise to is poor the of status nutritional the improve to approaches development of human potential and nation’s social and economic development. One the hinders of Malnutrition the people. billion best 3 affect hungry.deficiencies Micronutrientbed to go every human being on this planet. Yet, 800 million people, mostly in developing countries, daily Improving the Nutritional Status of Food Crops Access to healthy diet is fundamental rights of G. Khush,Adjunct Professor, University ofCalifornia Improving theNutritional Status ofFood Crops Abstract Academy ofSciences,USNational Academy ofSciencesandtheRoyal Society. world's most prestigious academies, such as Indian National Science Academy, The Third World 1987, World Food Prize in 1996, and Wolf Prize in 2000. Dr Khush was elected to some of the a 30-year period. For his contributions to world food security, Dr Khush received Japan Prize in progenies are now grown on 60% of world Riceland; and world rice production has doubled in years. High yielding, disease and insect resistant varieties developed under his leadership and their Department, in 1972. He Breedingled the Institute's Rice Breeding program for 35 Plant of Head as Philippines, promoted was the and 1967, in Institute, Breeder Plant Research as Rice International joined he years seven for UCD of faculty the on serving After 1960. in Genetics, in PhD his received and (UCD) Davis California of University the at studied he India.in Followingborn Drwas Khush India,in receivingeducation early Adjunct Professor, University ofCalifornia KHUSH, Gurdev

103 BioVisionAlexandria 2008 104 BioVisionAlexandria 2008 the keystepsthatdeveloping countriescantaketoacquire technologiesand utilize it. take to advantage of steps the New necessary Economy features the which are taking achievable. In by my presentation, Economy I Newwill outline the into leap a making of chance better much a have countries Economy.However,Industrialdeveloping the during economies uplift their to failed countries developing many Unfortunately, Economy. Industrial than decade effectively past the in transformation more produced has technologies computer and communications by can driven Economy, New The countries divide. technology the developing close to E-commerce drivers,the use and develop these of interdependence the By market. understanding free global for platform implementation the become has Internet markets. all in competitors new many create de-regulation and globalization standpoint, competitive a From the around barriers choice. consumer more of and more created has This trade. freeincreasinglyallowing thus world, lot a removed effectively has globalization beliefs, many to Contrary J. Kilama,President,GlobalBioscienceDevelopmentInstitute The DevelopingWorld’s"TechnologyDivide”:IsthereHopetoClosetheGap? Abstract Transfer, Biotechnology; Biotechnology and Law. technology of Aspects Global including: topics of range wide a on countries middle-income to Intellectual Property and Healthcare Strategy. He has conducted several training courses in low- States. Dr. Unitedof areas in decision-makers for symposia and the courses training of organizer an and been has Kilama Kingdom United Rica, Costa Thailand, Tanzania,Switzerland, Africa, South Nigeria, India, China, Brazil, Botswana, Bangladesh, in publications leading in appeared have articles His science. and Agriculture on Representatives’Committees of House in articles review peer scientific several internationally recognized journals. Dr. published Kilama has presented testimony expert twice to the US and sciences life the in chemicals of class new a of applications innovative cover that patents several awarded was Kilama Dr.DuPont, At 1989. in Company DuPont joined Kilama Dr.inhibitor. nucleoside transcriptase reverse of Minnesota where he provided key to support the synthetic development of Cabovir, an HIV ee, etcy i 17, S i Pamc fo te nvriy of University of Arizona in1988.Dr. the Kilamawasapostdoctoralfellow attheUniversity from Pharmacy in Kentucky in 1979, BS. and a PhD in Medicinal Chemistry from the University 1976, in Kentucky, Berea, broad a College, has Berea from Chemistry in BS his received Dr.Uganda,Kilama GBDI, in of President Born agro-chemistry. and biotechnology pharmaceuticals, and in background Founder PhD, Kilama, John President, Global Bioscience Development Institute KILAMA, John Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 complement tocancercells inantibody-basedimmunotherapy. to interfere with these evasion mechanisms and for effectively targeting the cytotoxic activity of strategies of development the for essential is complement to resistance cell tumor induced and oligonucleotides, siRNA). Understanding the complex molecular mechanisms involved in basal (antisense silencing either gene by or cells, antibodies regulator anti-tumor-anti-complement tumor bispecific by on regulation complement surface of neutralization targeted a including mechanisms, resistance these counteract to made being now are Attempts molecules. forming pore- other and complement of doses sublytic with even or drugs hormones, cytokines, with stimulation upon augmented or induced also be cancers. Tumorcan protection certain cell in complement resistance to cancer cells and has been correlated with increased metastatic activity functional activity of certain complement components. Increased sialic acid that expression degrade complement proteins or also ecto-protein kinases which impair confers by phosphorylation the ecto-proteases surface their on express and inhibitors complement soluble several secrete cells tumor microenvironment, protective a generate Tocells. malignant on CD59, and Protein) regulatory complement membrane-associated (DAF,CD55 as such of proteins, Factor),Decay-Accelerating(MCP, CD46 Membrane (over)expressionCofactor the include resistance of and represent mechanisms a protective major several barrier byfor successful hampered antibody-based is cancer lysis immunotherapy. cell Basal tumour mechanisms Complement-mediated M. Kirschfink,Professor ofImmunology, Medical Faculty, University ofHeidelberg Strategies forTherapeutical Intervention and Resistance Complement of Mechanisms Molecular TumorCells: of Escape Immune Abstract studies). clinical and (preclinical institutions pharmaceutical and clinics international and laboratories) national for diagnostic (accredited analysis complement Comprehensive destruction. tissue complement-mediated with interfere to improve strategies therapeutic and of development to rejection); diseases graft renal aiming (e.g. inflammation mechanisms in evasion Complement (b) immunotherapy. tumor cancer with antibody interfere to developed are Strategies mechanisms employed molecular by tumors of as Analysis well (a) as profile: Baden-Württembergby Research Statepathogenic the microorganisms to of escape Teachingaward complement. Guest Germany professorships, Sao Paulo, Heidelberg, Brasil; Riga, Latvia; of Ljubljana, Slovenia, University Tongji, Immunology, Wuhan, of China 2003; Institute Immunochemistry, of Immunology consultant (German Society of Immunology). Since 1987, Head of the Laboratory Immunology,Germany.Faculty,Immunology.Heidelberg,Medicalof Professor of in University Specialization fellowship). (Fogarty USA of MD, Frederick, Immunobiology, of University Laboratory Immunology,NIH, Institute, Cancer National of 2) grant). (DFG Germany Institute Heidelberg, 1) 1983-1987: fellowships Career Postdoctoral Academic Cancer Germany German Heidelberg, Facility, Pathology, Research Experimental PhD, 1983; year) Approbation), (one (DVM, Medicine Veterinary of Chemistry Doctor 1980; Medicine; in Veterinary and education University Education: University Professor ofImmunology, Medical Faculty, University ofHeidelberg KIRSCHFINK, Michael

105 BioVisionAlexandria 2008 106 BioVisionAlexandria 2008 technology agreements andincollaborationsinternationalhealthbiotechnologyseemsweak. , science international opportunities between linkage The trade. market international and investment by in trends and influenced largely are alliances industrial However,Development and collaboration. Research of driver major a be to appears support donor turn, In support. institutional arrangements in building research and development capacity, and mobilizing donor bilateral than effective more be to perceived are networks regional specialized that We observe trade. international and (FDI) foreigndirectinvestment as such factors other with interactions sectors in Kenya, South Africa and Zambia to determine their characteristics, drivers, trends and industrial alliances and Research and Development collaborations in health biotechnology sub- addresses paper This processes. and products new of marketing and production development, and institutions, often designed to reduce the costs, risks and the uncertainty associated with the International strategic alliances and partnerships are complex linkages among and between firms V. Konde, ChairandCoordiantor in Collaborations Biotechnology Health Africa International of Drivers and Characteristics Abstract xeine H i a elw f h ol Aaey f r ad cec ad od a h in PhD a holds and Science and Art fromBiochemistry Brunel University, of UK. Academy World the of Fellow a is He experience. teaching and industrial of years several has He Development. International for Center the of Associate an and Affairs International and Science for Center University’sBelfer Harvard of of the ATDF Journal. He is a former researcher and Post-DoctoralFellowand researcher former a ATDFis HeJournal.the of editor managing the and Biology Molecular and Biochemistry for Society ATDF Entrepreneurship Hub Limited (Lusaka, Zambia) the and the Zambian Geneva/Lusaka), (ATDF, Forum Development Technology African the of founder the is He DITE. section, Building Capacity and Policies Enterprise UNCTAD’s in Officer Affairs Economic an is Konde Victor Chair andCoordiantor KONDE, Victor Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 products. agricultural and nutritional including countries developing in products other of introduction process. Appropriately modified, the proposed framework can be applied the to the to development leads and strategy identification the of theory,six Components innovationof Innovation of which cover application all aspects of the the vaccine on innovation Relying systems. court IP transparentand offices patent efficient include that systems IP national functioning creationof the capabilities; management IP institutional building affordability; and access global ensure that practices licensing creative of application strategies; management IP effective and policies IP institutional of of formulation enactment policies; and laws include: appropriate—national comprehensive—and context broader a in practices Best access. global achieve to tool a as world’s poor and how these efforts tie in with best practices in intellectual property management toacceleratevaccinefrom development efforts anddistributiontomeetthehealthneedsof given be will Examples goals. their reach to at entities public-sector of aimed ability the is strengthening It health. on in based partnerships presented product-development public-private is from Strategy experiences Access Global comprehensive a managing for framework A A. Krattiger, Research Professor, Arizona State University Public-Private Partnerships in toEnable Global Access Element Essential an as Strategies Management Property Intellectual Abstract Agricultural Innovation: AHandbook ofBest Practices. Editor-in-Chief to the global resource entitled Intellectual Propertyas Management in Healthserved and Today,Strategyand Innovation of Editor-in-Chief Association, Biotechnology Sea Black the of Member Board Center,founding Law PierceFranklin the of Board Advisory the of member a is He Rice. Golden for Board Humanitarian the to Executive as and ISAAA, of from breeding/genetics plant in degree University,ExecutiveCambridge Directoras Mexico; served in CIMMYT at worked agronomy, England; PhD studied and also master’s he a where obtained Switzerland in farmer a became He at Arizona State University and Cornell University, and consults worldwide. teaches and worksphilanthropy. He and businesses, science, government, development, of crossroads the at health global and ag-biotechnology to Anatole Krattiger works on strategic and intellectual property aspects related Research Professor, Arizona State University, USA KRATTIGER, Anatole

107 BioVisionAlexandria 2008 108 BioVisionAlexandria 2008 promotion andregulation ofvarious policiesandactivitiesinsciencetechnologyfield. Agency (STA) in 1986, which was integrated into MEXT in 2001, he has experienced planning, (1986) in Engineering from the University of Tokyo. After joining to the Science and Technology will beshowen. advancedresearchof medical care,outcome medical researchthe actual apply to to aims which In the presentation, Japan’s research and development policy in life science, including translational Promotion Bureau,MinistryofEducation,Culture,Sports,ScienceandTechnology(MEXT) T. Kurasaki,Director,DivisionofAdvancedMedicalandRadiologicalScience,Research Japan’s ResearchandDevelopmentPolicyinLifeScience Abstract KURASAKI, Japan in 1962, and received Bachelor Degree (1984) and Master Degree Master and (1984) Degree Bachelor received and 1962, in Japan and Technology (MEXT) in and Japanese Government. He was born in Tokyo, Medical Advanced Science Sports, Culture, Education, of Ministry of the Science, Radiological Division Director, is KURASAKI Takaaki Technology (MEXT) and Science Sports, Culture, Education, of Ministry Bureau, Promotion Director, Division of Advanced Medical and Radiological Science, Research Takaaki Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 the difficultiestheyare facingwillbediscussedaswell aspromoting thesetechnologies. against the utilization of new obstacles biotechnologies. technological In and social the are therepresentation, time Japan’ssame the At growth. economic policies to for contribute overcoming to expected and field, medical and industry,industry,agriculture food chemical as such fields, Japan's policy on promoting Bio-Industry New Biotechnologies has been introduced in various K. Kurata,Director,Bio-IndustryDivision,MinistryofEconomy,TradeandIndustry Japan's PolicyonPromotingBiotechnology Abstract Professor at Tokyo Institute of Technology. related matters at Public Policy School, Hokkaido University. He is now also and policy serving technology as teaching for professor a a as Visiting served he 2007, to chemistry. 2005 Through biotechnology,of field the in and especially projectsenergy development researchand national of charge in directly was he positions, these industry of some In of required. are implementation policies technology and and planning which in positions, of kinds various experienced has he (METI), MITI the Within METI). now Ministry (MITI, Industry the Tradeand International joined of he 1984, in Keio in course Master’s of completion Keio from University.FollowingKyoto chemistry from science applied energy in in PhD University,and MD and BD his received he 1958, in Trade and Industry (METI), Japanese Government. Born in Tokyo, Japan, Kenji KURATA is Director of Bio-Industry Division; Ministry of Economy, Japan Director, Bio-Industry Division, Ministry of Economy, Trade and Industry, KURATA, Kenji

109 BioVisionAlexandria 2008 110 BioVisionAlexandria 2008 of gene expression profiling with genetically defined mouse models, has proven particularly particularly proven useful forthedefinitionofpathway-specificsignatures. has models, mouse defined genetically with profiling expression gene of responses to infectious danger at the level of individual cells as well as tissues. The combination transcriptional of spectrum full the investigate likegenome- to us enabled has methods analysis genomics transcriptome wide of functional advent The direction. desired the in balance the tip to the manipulated be can answer responses immune innate may of pathways specific release how of question mediator and expression gene cytokine transduction, the signal at regulators of negative level of effects the dissecting responses, immune innate of termination the to contribute all they Consequently,while points. control distinct yet overlapping on act that mechanisms and factors regulatory negative endogenous of multitude a of development the is problem this Nature’sto research. solution in interest of center the to moved therefore has deleterious becoming from hindered be may responses immune valuable how of question burden of disease is due to septic shock, bowelinflammatory disease and multiple sclerosis. The mechanisms causes acute shock, chronic immunopathology and tissue destruction. A substantial effector host of activation prolonged or overshooting recognized, increasingly is damage tissue and infection to responses host of Yangand Yin the hand, other the On protection. host for genetic ablation of TLRs and associated signaling underpin the pivotal of role effects of deleterious innate the recognition humans, and mice In responses. adaptive of development the directs and responsemicrobialinvasion.Innatedefence activationto provides of immune line first the robust and rapid a mount to needs system immune our diseases, infectious Toagainst protect Hygiene, Technical University ofMunich R. Lang, Director, Microarray Core Unit, Institute of Medical Microbiology, Immunology and Understanding Innate Immune Regulation withHelp from Functional Genomics Abstract better understandingandmanipulationofthehost-pathogeninteraction. large scale and functional genomics and bioinformatic analysis, to obtain immune novel insights needed for a innate terminate and inhibit inflammatory that responses. He tries to mechanisms employ a combination and of genetically defined mouse factors models, on focuses group Jude(St.Children’s Munichthe TU at groupMemphis, researchHospital,HisResearch TN). Peterof laboratory the fellowshipin Murraypostdoctoral his during interaction host-pathogen residency in Medical Microbiology,a he to started work on the regulation of After work. thesis MD his performed also he where Munich TU from Medicine in graduated Munich.He the TU of Hygiene and Immunology and Activation” directs the Micorarray Core Unit Macrophage at the Institute of Medical Microbiology, “Balancing group the heads Lang Roland Microbiology, Medical of Institute Immunology andHygiene, Technical Unit, University ofMunich Core Microarray Director, LANG, Roland Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 best lectures from allofScience.From thePromise ofresearch toPractice through education. taught over 1,000,000 students last year. Now at the BA, Wewe have countries. plan 174 from a lectures bold 3583 adventure,collected and capturing members, the 45,000 Welectures.have Supercourse, which is like the Carngegie but freeinstead of books, welibrary share PowerPoint the built Weresearch.have to access having not countries developing many and teaching, for used be to years 4 taking findings lastest with separated becoming are (Mandela) education and world. Science the change to use can you which weapon powerful most the is Education Pittsburgh R. Laporte,ProfessorofEpidemiology,GraduateSchoolPublicHealth,University Scientific Supercourse,WhiskingSciencetoClassroom Abstract Diabetes Association international and national Kelly· NASA projectsand fromNIH, West Diabetes Epidemiology funded Award American fromthe Numerous · Network, Health Global Developer, 1994 · and Monitoring the WHO multinational Project for Childhood Diabetes, involving 155 Disease centers in 70 countries Director, life · outstanding Telecommunications, education for WHO Collaborating Center, Dept in APHA of Epidemiology · Developer Award,and achievement PI of Lillienfeld time · 1989. Pittsburgh of FirstDistinguished Teacher,Publicof Health,UniversityGraduateSchool · Internet and Health, Epidemiology,Global in publications 505 · 1981 Epidemiology,in degree Masters 1977, Psychologyin Cognitive in Ph.D. of Pittsburgh University Health, Public of School Epidemiology,Graduate of Professor LAPORTE, Ronald

111 BioVisionAlexandria 2008 112 BioVisionAlexandria 2008 textbooks. er eiwd cetfi pbiain, n cnrbtd ih hpes n ee international seven in chapters with contributed and publications, scientific reviewed peer 140 authored name; his in issued were insecticides biological novel for patents two 2001, in He received two AOAD awards for scientific excellence, the FAO WorldIPGRI. Food Day recognitionand ICARDA Trusteesof of Board the on and (1996-2000), CGIAR of Committee the Technicalon served HeCenter, Research(2001-2004). Advisory Agricultural Egypt the of appointed Vice-President,Researchand EngineeringInstitute(AGERI,Egypt), President then Genetic Agricultural the established he 1990, In (1989/1990). Davis California, Universityof Prof. Visiting (1982-1989); University,Pathology,Egypt Alexandria Plant of Prof. appointed from the University of Wales, UK in Physiological Plant Pathology; was Pathology; Plant Physiological in UK Wales, of University the from PhD International his obtained for Madkour Prof. Bibliotheca General (2004-2006). ICARDA Director the Cooperation, Assistant to the Adviser was Senior He Alexandrina. and Egypt University, Inst., Research Shams Agric. Lands Ain Arid the at Professor is Madkour, Magdy Agriculture, AinShams University (Egypt) of Faculty (ALARI), Institute Research Agricultural Lands Professor,Arid MADKOUR, Magdy Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 MAREI, outcomes andabove allglobalizationforthedeveloping world. health industrial, academic, of development help can planning strategy national of frame the an in spectrum attempt to improveentire quality of life the for millions of people. unites Expansion of of these which technologies within field nature, the interdisciplinary of its facet is key medicine A regenerative regenerate. to capacities intrinsic its stimulate to body living the to but malfunctioning provide elements required is for in-vivo repair to what devise replacements that seamlessly replaceinteract with to just not is goal Itsbody. human fight the to repair ability disease; our improve dramatically to potential the has and disciplines several of skills and knowledge the combines that field emerging an is medicine Regenerative structure. social and commerce international and growth economic govern and health individual improve to faced by developing countries, yet they are important components of the comprehensive strategy priorities. challenges health health complex the technology,resolve and cannot themselves,science by Although basic from away resources significant drawing is care costly and prolonged to whose diseases non-communicable of rates epidemic manage to increasinglystruggling arealso attributable primarily disability and mortality preventable Ininfectious diseases, malnutrition and complications of childbirth. addition, they avoidable of share burden countries Developing disproportionate regions. a However, across years. distributed fifty past unequally the been over health have of improvements area the in made been has progress Dramatic of dentistry, AlexandriaUniversity M. K. Marei, Professor of Prosthodontics and Head, Tissue Engineering Laboratories, Faculty Development Visions for Regenerative Medicine: Addressing the Challenges of Health Burden for Future Abstract science inDentistry,Boston University,USA 1981 (Last 10 years) one patent in tissue engineering and 23 publications. Education: MScD, PhD of Patent: and Publications 2005-present); Society( Research Material African MRS,The African ; membership(2003-present) Alexandrina Bibliotheca , time) present - (2002 FoundationIOF Osteoporosis International time); (1996-present TERMIS Memberships: 1075-8278 ISSN, associate 2005-International editor in 3; and regenerative medicine engineering journal international tissue journals in Europeanthe field of ,(2007) tissue engineering projects joint Egypt US/ the in reviewerNational and issue, JournalHealthMediterranean Eastern the in reviewer knowledge building for 2004-Peer; Engineering “Tissue and Regenerative countries Medicine International Society emerging (TERMIS); for 2005-Member-at-Large Institution Mandela Advisory/ International time: 2005-Present African Scientific; Committees committee-African Institute of Science and International, Technology-Nelson and –National sector relations cultural and Technology,and Scientific, Research and Scientific new of Academy of materials, advanced (2006-present) committee national the in member Board 2006-present: Technologyand Science Genetic/Education for Egypt Engineering Office in Presidential Board Tissue Committee-Governmental National of and the in Head (1999-present) member PhD Egypt MScD, University, BDS, Laboratories,Alexandria Marei, K. Mona Faculty ofDentistry, AlexandriaUniversity Laboratories, Engineering TissueHead, and Prosthodontics, of Professor MonaK.

113 BioVisionAlexandria 2008 114 BioVisionAlexandria 2008 for optimalimmunizationprocedures. address the issue of weak infrastructures, particularly the insufficient human resources necessary the past for the cheapest ones. Moreover, the international community will have to successfully in did it as vaccines expensive new the for prices tiered offer will industry not or whether seen be to remains it and vaccines, paediatric traditional with do to nothing has which magnitude a of require resources will products new the of price The vaccines. future and existing to access potential same the world the in everybody to secure to remains challenge main reality.However,the a than more hope a remain vaccines, cancer including vaccines, Therapeutic malaria. or tuberculosis HIV/AIDS, as such diseases, major against vaccines for hope much allow not does failure scientific however remain, challenges Major market. vaccine the of attractiveness renewedthis to resourcescontributed financial all haveadditional with initiatives international new progress, scientific people, of groups new therapy,for to including opposed as prevention potential can be compared with the “blockbusters” of the pharma industry. Increasing focus on new demand: the Their papilloma). of human rotavirus, (pneumo, recently launched growth been have products expensive future the of perception changing a this with for do reasons to The have companies. evolution pharmaceutical big the for one strategic a has become market, recently niche non-profitable a considered been has long for which market, vaccine The J. F. Martin, President andCEO,Parteurop Vaccines inPublic Health: fortheNext ChallengesandOpportunities Decade Abstract officer intheFrench Order ofMerit. Technologiesof an AcademyFrench and the of member a is France; Paris, HEC, from MBA Immunization).He Boardthe of member is severalof Martincompanies. sciences an life holds Incapacity,this BoardGAVIthe of of member a also was he for (GlobalAlliance Vaccinesand to low-incometo countries. provide programsupport immunization other vaccinesand lifesaving efforts Fund’s the led He Fund. The Vaccine of CEO and President First the was Martin member of the Board of the International AIDS Vaccine Initiative (IAVI). From 2000 to 2005, a was he 2003, to 1997 From(SAGE). WHO of Experts of Group Advisory Scientific the of member a Hewas ManufacturersAssociations. FederationPharmaceuticalInternational of the of Health). From 1994 to 1997, Martin served as the Chairman of the Biologicals Committee of From 1996 to 1999, he was a member of the Board of France.INSERM (the FrenchLyon, Nationalin Institute based company consulting biotech a S.A.S., Parteurop up set Martin 1991, the Government of Canada the acquisition of Connaught Laboratories. InLaboratories. Connaught of Governmentacquisition the Canada of was named the Company’s CEO in 1988, and successfully negotiated with Marketing, where he largely contributed to its international expansion. He In 1976,Martin joinedtheInstitut Mérieux as Vice-President ofSales and spent a lifetime in the pharmaceutical, biological and life sciences industries. Jacques-Francois Martin, Chairman and CEO of Parteurop. J.F. Martin has President andCEO,Parteurop, France MARTIN, Jacques-François Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 the AAASAward forInternational CooperationinScience. is a Fellow of the Royal Geographical Society of the United Kingdom; and in 1999, she received Development and (IIED), and Environmenta founding member of the for China Council for EnvironmentInstitute and Development. SheInternational the of Directors of board the on currently is a and WorldInstitute, as Resourcesthe Volunteer. of PeaceCorps Vice-ChairThailand was She in teacher university a also was She program. UNESCO-UNEP joint a under Science for Council International (ICSU) based the in Paris; of and Director previous Executiveto that a the Programme also Specialist in was Environmental Education She development. leaders mid-career andtrain sustainable of issues the around skills together leadership their improving in world the of parts all bring from to Foundation Rockefeller The by established program a International,Development) and Environment for (Leadership LEAD of Director Executive was Marton-Lefèvre Formerly,Ms and conflict. peace to related issues on research and training education, provides severalin parts of campuses the world. has The which University,Rica, mandated byCosta the in UnitedPeace Nations, of University the of the Rector was Marton-Lefèvre Ms Director-General, IUCN becoming Before Director General, The World Conservation Union (IUCN)(Switzerland) MARTON-LEFÈVRE, Julia

115 BioVisionAlexandria 2008 116 BioVisionAlexandria 2008 Global LifeSciences(EAGLES). on Action European of Chairman CoVice and Biotechnology of Federation European The of Board Executive the of member a is Irish Times He The Trust. of Chairman currently is and Science Technologyfor Council Irish the Innovationof of Trinityand member a was Provosthe College, Vice Formerly Biotechnology. and Engineering Genetic for Centre International the of location the on reported which Committee Selected the of Chairman many was and projects, on UNIDO advised He Project. Genome Yeast genetics. the of in teaching participant founding and a research was for He centre leading a Genetics, of Institute Smurfit the of development the led and planned HeNovoNordisk projects. and biotechnology variousBP in EC biotechnology programmes, and collaborating with ICI, Guinness, Schering several in Plough, participating Ireland, Biocon, in engineering genetic and genetics molecular of development Research Fellowship at Harvard University in 1976-77. He pioneered the pioneered He 1976-77. in UniversityHarvard at FellowshipResearch Instituteof California TechnologyEleanorRooseveltan held and 1971, in Biology Molecular European the of RoyalAcademy.Irishthe the from and PhD Organisation his receivedHe member a is He Dublin. College David McConnell, a molecular geneticist, is Professor of Genetics at Trinity Genetics, of Department University ofDublin Professor, and EAGLES Chairman, Vice Co McConnell, David Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 group) in 2001. ETC Group is a small international CSO addressing the impact of new new of aroundworks theworld. closelywithCSOpartners impact the addressing CSO international small technologies on rural communities. ETC a has offices in Canada, United is States, and Mexico; and Group ETC 2001. in group) "etcetera" (pronounced group ETC to changed was name whose International), Foundation working on the "seeds" issue in 1977. In 1984, the three co-founded began RAFI (RuralMooney PatAdvancement Shand, Hope and Fowler Cary Togetherissues. with technology new and biodiversity agricultural on authority an as regarded widely is but training, university no has also received the American Giraffe Award given to people who stick their necks out. Pat Mooney 1985. In 1998, Mooney received the Pearson Peace Prize from Canada¹s Governor General. He Livelihood Award (the Alternative Nobel Prize) in the Swedish Parliament in biodiversity,and biotechnology of politics Pat Mooney Right receivedThe the on books several of co-author and author The prairies. Canadian the issues development and related to trade agriculture and biodiversity. Mooney has lived most of his international life on on Society (CSOs) Civil with Organizations worked has Mooney Pat years, thirty than more For Executive Director, ETC Group, Canada MOONEY, Pat

117 BioVisionAlexandria 2008 118 BioVisionAlexandria 2008 Bibliotheca Alexandrina/The Doyle Foundation Nakhla, R; Soliman, S; Erbisch, C; F.Schneider, Forum (2004) Reform An Education overview Alexandrina. of Bibliotheca BiovisionAlexandria, Alexandria: 2004. Development.Alexandria: Vocationaland Education Continuous in IssuesReform (2005) Nakhla,R. M, A, Abdo, A, Refai, Eid, M, Mofty, El Tayeb,M, El Alexandrina. Bibliotheca Secondary Alexandria: in Egypt. in Curriculum Schools Biology (2003) R. Nakhla, Alexandrina. Bibliotheca Alexandria: ControversialTechnology. a Biotechnology (2004); for R. Nakhla,AwardPublications: NationalSome Excellence the of Examiners of Board 2005 the of member a is HeEducation Forum the Reform and Forum Reform Arab the of workshop pre-conference the in participated He Biovisionalexandria2004. and 2003 century 21st the in science Teachingand 2002; math of the North and the ResourcesSouth, in 2002; Ethical Humanand social responsibility of science and and Trainingtechnology, the as Consultant. (BA) He contributed to Alexandrina several international conferences at Bibliotheca the BA; Biotechnology the voices joined he 2002, became a lecturer in Sales and Marketing with the AUC, and a visiting a lecturer and with the AAGSB; AUC,he is also a the Management Consultant. In with October Marketing and Sales in lecturer a became he industry, pharmaceutical the in experience sales and training of years Wolverhampton,Followingfive Universityof UK. the from Management Rafik Nakhla, a graduate pharmacist, he holds a Master’s degree in Quality Alexandrina. BiovisionAlexandria 2008Organizing Committee,Bibliotheca NAKHLA, Rafik Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 This presentation provides case histories, lessons learned and cautions on the limitations of onthelimitations human judgment andcautions learned lessons histories, case provides presentation This by hospitals, ministries and departments of health, planners and health professionals worldwide. extensive databases on both routinely used and emerging healthcare technologies. maintain They arewe used this Todisappears. attain or doubt a beyond proven is it until often given technology a revisit must we evanescent, and fragile often is evidence perceived because which, in effort interdisciplinary dynamic a is It Institute. ECRI non-profit the of function primary a is it and assessment technology healthcare is impact their predicting and technologies healthcare been used to prevent, diagnose or treat disease. The process of collectingtechnologies alternative or informationexisting had been have would they onthan worse are outcomes patient emerging however,Sometimes, care. patient of safety and quality the improve often and diffuse emerge, human course, hopes to prevent disease, minimize pain of and disability. and In spite of all this complexity new tools religion and law ethics, of abstractions and constraints the are factors trials, clinical sciences, applied and regulatory basic requirements, of clinical that acceptance and context, financial another priorities. Overlaying yet all within these developed technical are and hospital administrative systems and financial resources. New tools, or emerging technologies, healthcare priorities, individual patient need, the skills and procedures, and limitations doctrine of clinical healthcare of context professionals and the within applied biotechnologies are They systems. drugs,devices, information include technologies, healthcare of medicine, tools The J. Nobel, Founder andProfessor Emeritus, ECRIInstitute (ECRI) The Tools of Medicine Abstract preferred research ratherthanaclinicalcareer, andestablishedECRI. military service as a medical officer in the US Navy. He served on a nuclear submarine, and then by interrupted was residency neurosurgical His College. Medical University Jefferson Thomas his MA degree in international relations from the University of Pennsylvania; and College; his MD from Haverford from honors, high with degree, BA his received NobelDr. hospitals. and health of ministries agencies, international governmentand many to consultant a as served has legislation, ranging from national telecommunications policy to medical device regulation; and proposed on Congress US the before testified Dr.Nobel continents. five on projects directed in Malaysia the Asia-Pacificto serve region, and in Dubai the Middleto serve East. He has also Europe; serve Unitedto the Kingdom in offices Heestablished Centre. Collaborating (WHO) services. Organization WorldHealth and related its and programs publications ECRI’sinternational developed also ECRI He other many and System Comparison Product Healthcare the Alerts, Devices Health Devices, Health for plans operating and concepts the created He services. assistance technical and including its technology assessment, product evaluation, risk management, researchHeorganization. developedECRI’s overall programs,and policies Joel Nobel founded (ECRI), a 38-year old US-based nonprofit health services Founder andProfessor Emeritus, Emergency Care Research Institute NOBEL, Joel

119 BioVisionAlexandria 2008 120 BioVisionAlexandria 2008 the first to structure a biofortification network of public institutions for the introduction of the was Maranhao of state the partnerships, Concerning 2008. in released be will and Mid-North Embrapa by identified was iron of levels higher with variety, cowpea a Also, breeders. the challenge for a still is productivity the however, respectively; cultivars, conventional of ones the genotypes beans evaluated by common Embrapa Rice and Some Beans, contained iron. iron and and zinc levels zinc 50% and beta-carotene, 43% higher of than levels higher with maize of development the expected is it varieties, QPM these from tryptophan; and lysine more 50% has which (QPM), maize protein quality the implemented Sorghum and Maize Embrapa of Researchers country. the of region semi-arid the in performance their monitoring is years, two last the in and, beta-carotene of levels higher with cassava of varieties two released already has Fruits Tropical and Cassava Embrapa wheat. and cowpea maize, beans, common rice, potato, and on postharvest processing. The main food staples under research in Brazil are: cassava, sweet the two programs is that the AgroSalud Program has a focus on Latin America and the Caribbean number of research centers that are part of the biofortification network. The difference between coordinated with the Brazilian Agricultural Research Corporation (Embrapa), which includes a are Program AgroSalud the of and Biofortification on Program activities challenge the HarvestPlus the Brazil, of In malnutrition. combating of way low-cost sustainable, a provide and interventions nutrition existing bredfor complement could – content –varieties vitamin and mineral crops increased of biofortified introduction nutrients The these processing. with foods postharvest fortifying through on and poor the to supplements mineral and vitamin providing on focus world developing the in deficiency micronutrient combat to efforts Most M. Nutti,Researcher,NationalResearchCenteronFoodTechnology,Embrapa Institutionalizing theBiofortificationStrategyinaSustainableWay:TheCaseofBrazil Abstract fields ofbiofortified cropvarieties urto atvte. eerhr t mrp, rzla Arclua Rsac Croain in food safety, nutrition,biosafetyandlabeling ofgenetically-modifiedfoods. Corporation, Research Agricultural Brazilian Embrapa, at Researcher activities. nutrition and health, responsible for the interface between breeding, biotechnology, food technology and nutrition human improve to order in crops of Biofortification on focus Plus, Harvest the for Plant Origin”; of FAO/WHO expert in Biosafety. Coordinator of the Latin American activities Member of FAO/WHO Expert Consultation “Safety Aspects of Genetically-Modified Foods of representing theMinister ofAgriculture andSupply. Foods,Genetically-Modified of Labeling the for GroupInterministerial the of Member 2000. since (Japan) Biotechnology from the Derived Foods 1997, on TaskForceAd-hoc since Alimentarius Labeling Codex Food in Committee Alimentarius Codex the at delegate Brazilian Uses.Dietary Director ofEmbrapa Food Technology (1996-2003). e Nutricionais, leading a group of 40 researchers, mainly oriented at R&D of Foods for Special Dieteticos S.A-Produtos Nutricia Technicalof committees. Director examination and courses ul ie eerhr n lcue a te eatet f urto and Nutrition of for responsible Campinas(1983-1987), Department of UniversityPlanning,State Food the at lecturer and researcher time Full the at the Studies Consumer at University in ofGuelph,Canada(1985). and Planning (1980); Belgium Nutritional Gent, of University in Course Post-Graduate Brazil(1986); FoodEngineer,State Universitythe Food Campinas, at in of Science MSc Director, National Research CenteronFood Technology, Embrapa NUTTI, Marilia Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 thinking policy and regulatory approaches. thinking policyandregulatory forward requiring challenges present will futures potential These development. infrastructure and delivered. The future outcomes depend on policy choices, private investment decisions, and produced are productshow in changes major improvementsincrementalto of number limited a from futures: multiple face future biotechnologies industrial emerging and the Conversely,health environment. of independently relatively uptake and development rapid continue to are more readily apparent. Contrary to popular belief, agricultural biotechnologies appear poised from this perspective, the potential socio-economic challenges arising from these developments to 2030 project has taken an output, or application-based approach. In viewing biotechnologies biotechnology that focuses on inputs (e.g. R&D spending, venture capital, etc.). The property Bioeconomy regimes, and regulatory models have also intellectual models, business been Emerging 2030. examined. to up sectors Unlikethree these of each much for scenarios of as the research on wellas 2015 until on industry agriculture,and to health, biotechnologies of applications potential reports trend produced has project two-year The 2030”. to Bioeconomy “The on project Programme’s Futures International OECD the of findings main the covers presentation The M.Oborne, Director,InternationalFuturesProgramme,OECD-FrenchDelegation Key findingsoftheOECD’sBioeconomyto2030project Abstract work onbiosecurity. on the promotion of responsible oversight in the biosciences, and is currently developing meeting further Frascati 2004 the chaired Internal and organized Biotechnology. OECD He on Group the Coordinating chairs Oborne Mr. bio-economy. emerging the and risks systemic new that projects on working is IFP economy,security commercializationthe on new focus the space, of managing and monitoring the Currently, China. of economy political the and policy technology information frameworks, policy policy,innovation biotechnology,science of areas career,his People'sAlong the the China. in Mr.in of Republicextensively worked has Oborne issues investmentforeigndirect and technology on articles and books published and countries, Britain, France Greatand States,Italy. United the In the in 1980s, he universities worked on at the political taught economies of the has PacificHe Paris.Basin in the Supérieure Normale and University,Ecole Cambridge PhD), and MA, (BA, Berkeley California, at of educated University was the Oborne Mr. International Forum. Science OECD's Global OECD’s the the and of Programme Futures Director is he Currently, Industry. and TechnologyScience, for Director Deputy and OECD; of Division Policy the to Assistant Senior Executive Deputy Secretary General of OECD; Head of the Science and Technology as Basin); Pacific posts and held (China has Fellow He Research 1980. since (OECD) Development and Michael Oborne has been at the Organization for Economic Co-operation Director, InternationalFuturesProgramme,OECD-FrenchDelegation OBORNE, Michael

121 BioVisionAlexandria 2008 122 BioVisionAlexandria 2008 worldwide network among scientists, policy makers and business people, and discussing the “lights andshadows” ofS&Tforthesakemankind. discussing and people, business and makers policy scientists, among network worldwide a building of aim the with forum (STS) Technologyand Society Science in the founding and and Science Technology,of Institute university,graduate interdisciplinary and international an central role he the played in enacting the including Fundamental Law of achievement S&T in 1995, creatinghis the Japan,Okinawa in S&T of field the in figure political key a considered is Omi Koji (1997/1998). Planning Economic for State of Minister and (2001/2002), Affairs TerritoriesNorthern and Okinawa for MinisterPolicy, and S&T as of Minister (2006/2007), serving Finance of previously Representatives, of House the of Member as serves LDP. He currently Secretary-General, Acting and Finance; on Committee Standing the of Chairman Vice-Minister Parliamentaryfor Finance; of Director-General posts of the Commercethe & Industry occupied Policy has Bureau, he LDP; 1983, in Representatives of FirstHouse Agency.the to Enterprise elected Medium & Small Department, Guidance the of Director-General sa Esen uoe iiin Tae oiy ueu Drco o the and and Technology of Agency; Science the (S&T) Division, Administrative Director Bureau; Policy Trade Division, Europe Eastern South & the Asia of Director York; New in General Consulate Japanese the at Consul as International of served Tradeand 1956 in (MITI) Industry and Ministry the joined Omi Koji University, Hitotsubashi from Graduated Policy Technology and Science (Japan) for State of Minister Japanese Former OMI, Koji Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 to mitigate the deficiency of energy in developing regions and the basic requirements to make to requirements basic the and regions developing in energy of deficiency the mitigate to biotechnology has an important contribution. We present that concept as one possible solution answering this BioVisionAlexandria and the WEC objectives. In several of these “productions”, while feed, cost low and effluents production cleaner energies, friendlier environmentally for quest the addresses that proteins and electricity) and biogas based (biofuels, energies biomass of efficient production the for concept loop closed business-oriented a developed We help? biotechnology can How bioenergy? in practice to promises from go we do How this? achieve we do how distribution and production Fragmented sources energy of Diversification classes Sustainability in terms of environment and return of investment Prices affordable by the poorer reliability of service; Acceptability in terms of social and environmental goals. The requirements: to modern, affordable energy for all; Availability in terms of continuity of supply and quality and WorldAccessibilityAs: 3 the coined objectives,three sustainability established Council Energy the Statement, Millennium its In report. World2005 the of State its in WorldwatchInstitute the by evil” of poverty,"axis true the as among declared are degradation environmental and interplay disease, infectious Festering is everywhere. ignorance evidence daily hunger, poverty, have Weis global; all. to business world bad The ignorance! and hunger sanitation illness, poor deforestation, services, market, industry, consumer no no productivity, production, low to value employment, of no aggregation means no energy No Age! Dark the in living literally are They known. as energy to access have not do who people billion 2 about are There J. P.deCarvalho,PrincipalBusinessBrazil Bioenergy toIlluminatetheDarkAge Abstract fourdevelopment projects running inthebiofuelsarea.R&D interface, Industry-University the in consultant a as works Presently others. and BioVison Conferences, BIO several in participated and seminars Biotech12 Congresses,major 3 organizing meetings, and bodies government in it representing years, 5 for Association Industry Biotech Brazilian the ran Then clients. attracting and capital venture attracting finances, for plant extract high-throughput screening a EXTRACTA,R&D outfit, with where was Initially biotechnology.responsible in working been has years, 10 last the In industry. and consulting banking, in experience Working de Janeiro; MBA from Amos Tuck School of Business, Dartmouth College. Born in Rio de Janeiro, Brazil, in 1947. BA from Federal University of Rio Principal, Business Brazil PAES DECARVALHO,João

123 BioVisionAlexandria 2008 124 BioVisionAlexandria 2008 contribute toamore prosperous future. paramount to and design to possible is the it that sense the communities, local providingthe of to importance has it issues, sustainable and economic with related only not is This process. to or clusters develop existing new integrated competitive bio-intelligent ones, is consolidate a specific result of these to convergence vision The communities. their of progress the improve to proven already has knowledge the of area this in domain the that agreement the following region, the in flourishing are partnerships Private-Government-Academia The Development. of strategies new support to tool important an as defined is it and era new this in knowledge of incorporation the to contributes biotechnology The innovation. and intelligence of sector” “generating a to sector”“receiving a being from itself reconverts sector agriculture the model, new this In sustainable. environmentally and inclusive socially being of characteristic the and practices, agriculture good with involved more is which one, new a to production agriculture arising from the increased demand of agriculture products, are making an in evolution many Latin American in countries. Thethe new emergingregional technologies and economic opportunities development economic and social in revolution dynamic a agronomy,leading and are biology knowledge biochemistry, frominformatics, new science-related as of platforms application The Companies Biotechnology National of Association (FELAEB) Federation American Latin Director, Pagliano, D. Private-Government-Academia: Triangle LeadershipinABio-Intelligent Agriculture Abstract from theEisenhower Fellowships (www.eef.org). and the Inter American Development Bank. He is a member of Rotary International and Fellow Agriculture on Cooperation for EuropeanInstituteUnion,Inter-American the the for projects of the Biotechnology Unit in the National Institute of Agricultural Research, where he developed microbial inoculants. produce He was (www.calister.com.uy) which an Assistant Professor Calister of Microbiology and in the Agronomy area, School and founder embryos bovine in the is which (www.quiniman.com), Quiniman as companies founded He (www.zonamerica.com). ZonamericaBusinessin & platform Hebiotech Biotecorg). a Plaza,founded TechnologyPark first President of the REDBIO Foundation, an NGO sponsored the by was HeFAO (FELAEB). Associations (www.fundacionredbio.Companies Biotechnology of Federation American Latin FruitVegetablesUnionand of the Uruguay. of of Board Exporters the Producersand on is He the National Chamber of Commerce and Services (www.cncs.com.uy) and he is Director of the of Board the on is Pagliano consulting. in specialized is which company (www.scutia.com),a a company related to plant biotechnology and agribusiness, and of Scutia of and agribusiness, and biotechnology plant to related company a Belgium (1989). He is a Director-Founder of Nidetec (www.nidetec.com), (1985) and a Master of Sciences from the Free University of Brussels Uruguay (VIB), Republic, the of University the from Engineering Agronomy in degree Uruguay.Montevideo,a in has Paglianoborn was PaglianoDaniel Association (FELAEB) President, Latin American Federation of National Biotechnology Companies PAGLIANO, Daniel Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 environment-adjusted crops. :The projects new AVESTAGENOME discovery, drug Project, and initiative, cell stem Cancer four launched recently has Avesthagencountry. the from in support investors other significant and acquire capitalists venture to able been have we enterprise biotech home-grown a As the area of agriculture. Similarly, Avesthagen and Cipla (India) continue to be business partners. in (France)projects with Limagrain with and diseases example, infectious of area the ForBioMerieux(France)in locally. and globally both clients with partnering and processes /research technologies new creating for allows model business to IP unique innovation.Our science and level. We have over 160 patents in the areas of biopharmaceuticals, bioagriculture, bionutrition to linked plants medicinal of disease conditions, and MetaGrid- an algorithm that links metabolites to efficacy at the cellular database comprehensive a AdePt, of creation is example One market. the into launched are that products or technologies as commercialized and patented is researchcutting-edge where model Avesthagenbusiness diagnostics. unique and a pharma uses and food of convergence the of integration pillars and the science India’son frontier-based biodiversity,of founded is that entity global India-based an create to was objective our 2001, in operations business formal its began that company private a As finance. of levels those including various at challenges faced partnership public-private a of concept This products. into channelled be could that patented was that research original on based industry and academia on an innovation driven R&D platform. I started the organization in 1998 as a bridge between systems India’sleading biology company is and is Ltd, a Avesthagenshining example of development. a successful and Indian Organizations biotech research company based Researchin involved Contract those comprising and (CROs) lot, diverse a are India in companies Biotech V. M.Patell, Founder andCMD,Avesthagen Limited Avesthagen- Indian Biotech Success Abstract Award ofthe Year include 2006. awards recent Her Biospectrum. Outstanding Women and Entrepreneur The fromand 2005/06 FICCI; BioSpectrum Entrepreneur Biotechnology Nature as such publications, the USA, before moving to her current location in 2000. Dr. Patell has been profiled in leading of laboratories the of out Nation,operating the for platform innovationsustainable a promote to company public-private a as 1998, April Avesthagenin founded SheBangalore. in Sciences Agricultural Universityof the at subsequently and Sciences Biological for Center National the India, she established herself as an independent scientist and principal investigator working from to return her Upondeveloped. first was plants of engineering genetic of technology the Pasteur,where Louis University Belgium, Gent, the of University the at at program biology post-doctoral a by molecular followed France; Strasbourg, plant in program PhD a on embarked Dr.Semi-Arid 1989, TropicsPatellthe In for 1978. Institute Researchin Hyderabad Crops at International the at career professional and her emphasis started PatellDr. science innovation. specific and genetics bioagriculture with bionutritionals, population healthcare biopharmaceuticals, on personalized and on preventive pharmaceuticals focused to food, leading company of biology convergence systems the (Avesthagen), leading India’s Ltd. as Pvt. Technologies recognized Gengraine Avestha of Director Managing and Vice-ChairpersonFounder, is Morawala-Patell Villoo Dr. Founder andCMD,Avesthagen Limited PATELL, VillooMorawala

125 BioVisionAlexandria 2008 126 BioVisionAlexandria 2008 Life Sciences.He ontheboards serves ofvarious internationalagribusinessﬁrms. Greena Nationalthe of RevolutionChairman and FoundationAfrica Science in and Earth for Security andAgriculturalProductivity inAfrica.He ismemberoftheBoard oftheAlliancefor Food on Panel InterAcademy the of Co-Chair and Trustees(1995–2000), of Board Institute the of centers six GroupTrustees of of of International Agricultural Research;Board was Chairman of the the International Rice on Research served He journals. several of editor as served Institute and Royalcountries developing in programs the agricultural and the Tropics.missions of various of led He Chairman and Parliament, Netherlands the of Senate the of member eeomn ad od euiy t aeign nvriy former University, Wageningen at Security Food on Group and Consultative Development the Sustainable of for Professor University Council Research, Agricultural Science International the of Chairman is Roelof Rabbinge (the Netherlands) (member as of 2003), Roelof Rabbinge CGIAR (Netherlands) the of Council Science the Chair, and UniversityProfessor,Wageningen RABBINGE, Roelof

Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 studies withhumansubjects. current in therapeutics and intervention early plan and risk determine to physicians enabling protocols clinical and tools molecular the develop to means electronic and workshops courses, meetings, by interact modules network The engineering. bioinformatics, and for physics computer CompuNet mathematics, (c) proteomics; and genomics for BioNet (b) scientists; physicians and groups that CliniNet (a) clusters: or modules connected three of consist network The region-wide. morbidity of causes major these in practice clinical to biology systems from technologies and information knowledge share cutting-edge translate and countries, to advanced most the of counterparts capable their with physicians and scientists of teams own our achieve this goal we are currently developing a gap.project Tothe fill of to help Digital could field. science Molecular transdisciplinary and the care Medicine medical in integrating network by A experts grouping scientists local with physicians its of integration of lack the second, and region, the within technologies high transfer to experience and understanding of lack a first, gap; this for responsible are causes Twocare. major medical of such system better translate a and into advances appropriate to prepared inadequately is region American Latin the time, mean the In disease. and inflammation to downstream response stress reticulum endoplasmic the from is, That ailments. such preceding information biological of flow the of crossroads the obesity,at predicted preventedpotentially and be can intervention bydiabetes early 2 type and morbidity worldwide is emerging from systems biology. The risk to cardiovascular disease, cancer, A new type of predictive, preventative, personalized and participative medicine to major causes of Biotechnology, of Simon Bolivar University Professor and Medicine Molecular Digital Project Director, Aldao, R. R. Development ofDigital Molecular Medicine in Venezuela Abstract as well asconsultantforseveral Governments ofLatinAmericaandUNagencies. frequent speaker at universities and companies a is in He the prizes. USA, several with European him Union,rewarded has and that Latin profession journalism, America, a scientific of a writer as well as Biotecnología, de Colombiana Revista and Biotechnology, of Journal Electronic Biotechnology,Patentson Recent of board editorial the of member a is He Chile. of Catholic and Paulo, Sao Lovain,Yale, at scientist visiting societies, scientific several of member prizes, and awards numerous received has Rangel-Aldao Caracas, in Born industries. biomedical and food the both to applied biotechnology in patents triadic of author is Rangel-Aldao medicine. in a wide range of fields from biochemistry, molecular biology, chemistry, plant physiology, and contributions with extensively published has he America, Latin of third the Venezuelaand of conglomerate beverage and food largest the (1987-2005), PolarEmpresas of Innovation and Research of Director former University,as Bolívar and New Medicine, Simón at of Biotechnology of Professor as of College served years thirty York.over For Einstein Central Albert Universidad from from PhD and MD. Venezuela, his received Rangel-Aldao Rafael Simon Bolivar University (Venezuela) Director, Project Digital Molecular Medicine and Professor RANGEL-ALDAO, Rafael of Biotechnology,

127 BioVisionAlexandria 2008 128 BioVisionAlexandria 2008 probes fordiagnosticchips. and oligos unique patterns of of infrequent oligos allows development of a tool to search the most appropriate DiscoveryDNA reads. metagenomic short of identification for important is oligos signature of redundancy Apparent developed. was genomes sequenced all for calculated bp, 14 to 8 from signatures oligonucleotide of database a parallel In from. derived were they microorganisms of phylogeny the with accordance in clustered were sequences The sequences. analyzedof number the on analysis of time total the of dependence linear almost with min) 40 per reads (3500 performance high rather showed program The reads). 10,000 to (up datasets genomic a as used was signature to cluster sequences and identify the DNA environmental fragments. The program the is scalable for of analysis of large bias compositional oligonucleotide The species. bacterial differentfrom originating reads, DNA multiple of clustering hierarchical generated by modern high-throughput sequencers. We developed an algorithm of self-organizing addressto algorithms problemsenvironmentalthe of identification and clustering of sequences computer-based of development on Weinterest. focused of species so monitor and reads identify to as DNA short multiple of analysis simultaneous large-scale a for approaches powerful The progress in development of new technologies challenges bioinformaticians to provide more microflora. environmental of monitoring and study the revolutionize to going are they soon, Newfield. in pathogens of monitoring ‘laboratory-on-a-chip’ (LOC) aretechnologies expected automatization of level and diagnostic for routine a as technologies these use Highallowreductionto price significant a and sequenced. be to pathogens bacterial of genomes all expect to realistic it make Solexa and 454 Roche as such technologies sequencing high-throughputNew and Bioinformatics ACGT Manager, Node Network Computational Biology Unit University ofPretoria Bioinformatics National Reva, O. and Metagenomics Chips Genetic Diagnostic for MicroorganismsPathogenic of Signatures Oligonucleotide Abstract metagenomics. eeomn o nw isaitcl loihs n cmue porm fr eois and genomics for programs computer and algorithms biostatistical new of development include interests research Reva's Dr node. Network Bioinformatics National Pretoria communications the intra-node for and inter- in involved is He Manager. Node as Africa South of (Germany). In 2006 Dr. Reva joined the National Bioinformatics Network Hanover of School Medical High the in Bioinformatics in post-doc a did he 2004 to 2002 From Ukraine. Kiev, in Virology and Microbiology of Institute the from 1995 in Microbiology in Ukraine PhD a obtained of He 1990. in University State Kiev Shevchenko from graduated Reva Dr and ComputationalBiology Unit University ofPretoria (South Africa). Bioinformatics ACGT Manager,Node Network Bioinformatics National REVA , Oleg Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 interfaces, hasthepotentialtofavor thiskindofglobalandholisticapproach.interfaces, regulate to and Area Research Membrane European the structure to chosen has Europe that instrument the is which Technologies,NanoMemPro,Membrane on Excellence of Network European the how show to endeavors Finally,also presentationeducation. the through shared and diffused be to have will which expertise and skills technical of requirelot will technologies new these populations, the by accepted totally be to and reality is a become required.to orderIn which acceptance technological and education engineering, membrane nanotechnologies, and sciences material of integration large the on questioning a proposes also but purification, fluid biological or organs artificial with achievements of examples technical typical few a only provides not presentation This well-being. and health improvedcitizen as well as development model, these breakthrough biomimetic approaches offer a ultimate an as privileged membranes cell With area. direction health the in towardspurification fluids biological or artificial sustainable organs include assembly) auto materials matrices, mixed new (nanotubes, level of nanoscale development the at the designed by offered today opportunities promising Very Japan, China). USA, (notably countries are many in technologies technologies” “dominant membrane or economy,strategic tomorrow’s as considered on impact awaited greater their to Due G. Rios,Coordinator, NanoMemPro Network ofExcellence Nanoscale-Designed Membrane Materials forHealth Applications Abstract Technologies” (NanoMemPro –FP6NMP). European“Nanoscale-basedNetworkthe Excellenceon membrane coordinatorof of the Heis (EFCE). Engineering Chemical of FederationEuropean the of MembranesWorking on Party Engineers (London), as well as a Member of International the European Membrane Society (EMS) and of the in Chemical of Institution the Fellowof a is He Board. presentationsCongress of member expertise, scientific poster patents, reports, tasks: other or various in involved also verbal is He Conferences. 100 than more and of more than 120 papers in International Journals or Congress Proceedings, He is a well-recognized expert in Membrane Technologies. He is the author Montpellier.de Chemical Chimie de SupèrieureNationale Ecole the of at Engineering Department the of Head and Professor is Rios M. Gilbert Coordinator, NanoMemPro Network ofExcellence (France) RIOS, GilbertM.

129 BioVisionAlexandria 2008 130 BioVisionAlexandria 2008 be more precisely targeted tothepopulations andcountriesthatneed it. of countries wherecitizens a vaccine is needed. In this session we the will suggest ways in which our effort can to resemblance immunological no bear that animals pathogen-free specific in helminths. Vaccinewith infected often mycobacteria,and screenedare contrast, by candidates, results from high dose challenge in people who are already partially immunized by environmental effect would an not Suchbe weeks.detected or few relevant a in byhuman studies. death Finally,delays only tuberculosis BCG in mice developing countries in but tuberculosis, to exposure but it also fails in mouse models. A vaccine for man must stop development needed, of disease followingis it where man in fail Standard” “Gold this does only Not candidates. vaccine select to used tuberculosis of Standard”“Goldmodels a animal as in BCG of use unavoidable the by aggravated is situation The countries. poor for vaccines tuberculosis creating of problem the to knowledge obtained is being exploited in exciting clinical trials for the rich, but is rarely applied new The autoimmunity,countries. disorders(allergies, rich the in boweldisease) inflammatory inflammatory chronic in increases explain to seeks hypothesis”and “hygiene the by motivated in rich countries differ from the immune systems of people living in developing ones, but this is living people of systems immune the how understanding exerted is effort Paradoxicallyof lot a reasons. same the for and BCG, as places same the in fail candidates new these if tragic be will protect to fails usually but against countries, adult tuberculosis in developing countries. New Northerncandidate vaccines are entering trials. It rich in effective is tuberculosis, for vaccine the design of for tuberculosis implications vaccines that countries: are suitable developing in and the countries rich that need in BCG, the systems only licensed immune between Differences of Medical Sciences G. Rook, Professor, Centre for Infectious Diseases and International Health, Windeyer Institute the Design of Tuberculosis Vaccines Thatwill Work intheCountriesthat Need Them Differences between Immune Systems in Rich and Developing Countries: Implications for Abstract with a major emphasis on the interactions of IL-4 and IL-4 and IL-4 of interactions the on emphasis major a with tuberculosis, of immunopathology the initially was research his of theme The chapters. book of tuberculosis, and in the efficacy of BCG vaccination. He co-founded a biotech company biotech a (Silence Therapeuticsplc.),andisco-inventor ofmore than20patents. co-founded He vaccination. BCG of efficacy the in and tuberculosis, of disorders. This work is feeding back into the question of regional variations allergic in of the field manifestations the in publications and trials clinical led has This cells. antigen-presenting and to exposure changing environmental microorganismsthat is playing role are in the accompanying the dysfunction of regulatory particularly T cells interest, that research major a diseases are disease), bowel The neuroscience. and increasing in incidence in microbiologydeveloped countries (allergies, autoimmune disease and inflammatory immunology, endocrinology, on publications to leading physiology integrative on emphasis interdisciplinary,with is approach His tuberculosis. of immunoendocrinology and endocrinology the include to broadened This than 290 peer-reviewed publications, and more than 80 other reviews and reviews other 80 than more and publications, peer-reviewed 290 than more to led has research His London. UniversityCollege at Microbiology of London. Since 1994, the Prof. Rook at has held the sciences post of Professor natural of Medical basic University studied of Cambridge, UK, before qualifying clinically at the University MD, BChir MB BA Rook, Prof. Institute ofMedical Sciences,United Kingdom Professor, Centre for Infectious Diseases and International Health, Windeyer ROOK, Graham 2 with mycobacterial infections. mycobacterial with δ2 Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 Indian Government, in2007. by Time Magazine. He was awarded the Padma Bhushan, a high civilian honor bestowed by the world the in leaders influential most 100 the among named was Inhe change. 2005, and 2004 climate human-induced of mitigation the promote to efforts large-scale leads Institute Earth the for of Director voices as leading and sustainability, the environmental with of development economic one combining also is He wellbeing. from and benefit opportunities to economic world the expanding of parts and all alleviation, help to poverty policies development, promoting economic globalization, of enlightened challenges the of forefront the in been has Sachs Professor years, 20 than more For generation. his of adviser economic international nonprofit organization aimed at ending extreme global poverty.a He is widely considered to be the leading Alliance, Promise Millennium of Co-Founder and year President the also by is Sachs hunger 2015. and disease, poverty, extreme reduce to goals agreed internationally the Goals, Development Millennium the on Nations Annan United Kofi to Secretary-General Adviser Special and Project Millennium UN Director the was of he 2006, to Nations 2002 United From Ki-moon. to Ban Adviser Secretary-General Special also is He University. Columbia at Sustainable Development, and Professor of Health Policy and Management Jeffrey D. Sachs is the Director of The Earth Institute, Quetelet Professor of Director, EarthInstitute SACHS, JeffreyD.

131 BioVisionAlexandria 2008 132 BioVisionAlexandria 2008 sciences and business totheconviviality ofeconomicprofits andsocialbenefits. Community. The Supercourse helps the Community to evolve from the coexistence of academic marketplace that accelerates the flow of innovation in Healthcare for the “common good” of the worldwide just-in-time a Create to: is Supercourse the of proposition value The them? for pay to deliver these “technologically available” healthcare services to communities who are unable to two questions: 1. How to reduce the gap between the “promise” and the “practice” and 2. How addressing Healthcare, in NCD in further created. Today,step one moving is Supercourse the is mechanism regulating self contract,”“socialresponsibilitya this of sharing the With profits. economic community’sand the social and corporate both increasing while market, to services and products new bringing for speed the and innovation of pace the accelerate can businesses the rate of useful scientific discoveries while realizing greater economic rewards. accelerate can At Scientists AcademicThe community.the context, conviviality same this Inthe time, contract:” “socialresponsibility of good” “common the to value add together purposefully and to Sciences Business of commitment the obtain And Business. and Sciences Academic of languages of the community we propose a conviviality option to: Build a bridge between the cultures and health community.and the prosperity To for the benefits increase of generation the optimizes sub- Business and Sciences Academic for benefits the of maximization independent the that is and the needs of businesses are not frequently understood by academic Frequently,scientists. Thethe knowledge consequence generated by academic scientists is not directly actionable for business, F. Sauer,CEOTransAmGroup and Health“FromCoexistencetoConviviality” Solidarity andSubsidiaritybetweenAcademicSciencesBusinesstoImproveProsperity Abstract MedicineLancet, Military andNature Medicine Published more inpeer-reviewed than20articles journals,includingBritish Medical Journal, Founding memberofNational Letters,Sciencesand Athenaeum ofArts, Technology, Mexico Founding memberofGlobal HealthNet /Supercourse Pittsburgh, PA Member ofSystem DynamicsSociety (MITCambridge,MA) Former board memberofAmericanRed Cross ofKansasCity Faculty Glasser Institute” memberofthe“William Honors: 1970-1975: Adviser totheMedical Director ofIMSS,Mexico 1975-1985: VP National Bank ofMexico 1985-1988: VP andSenior Consultant,Federal Group, Inc. Acton, MA 1997-1999: CEO,CernerInternational, KansasCity 1999-2000: Consultant,KCADC andKC LifeSciencesInstitute Inc., KansasCityMO 2000-2001: VP ofBusiness Development forLatinAmericamarch First, Chicago,IL for KCCatalyst 2001-2004: CEO,BCECandaftermerge VP ofBusiness Development 2004-present CEO: Trans AmGroup Spanish-American University (UIA),Mexico Master inSystem Analysis Surgery Harvard Business Schoolprogram @“IPADE” Mexico MBA. University ofMexico (UNAM)MDwithhonorsGeneral Medicine and CEO, Trans AmGroup SAUER, Francois Positions: with honors

Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 partnerships wouldbeessentialinachievingtheseobjectives. partnerships incentives to retain an educated workforce in Africa, and to stem the brain drain. Public-private provide help could opportunities these term long the On knowledge. their from revenuesto earn them enabling engineers, and scientists for jobs skilled provide would technologies the of enabling them to move from subsistence to revenue producing farming. The commercialization potentially farmers, scale small benefit could products value-added grow or yield increase, that technologies agricultural new develop to mechanisms and means the Establishing research. of and needed products for farmers, if translation mechanisms are economic in development, place jobs (financially to and intellectually foster rewarding commercialization positions for top to lead scientists), could which asset an is world developing and developed in scientists of knowledge The former Ambassador, theUnited States totheKingdomofNetherlands P.C. and TechnologyScience Schneider,Director,of FutureExecutive and the Perspectives in Economic Development Ethics Meets the Marketplace: the Virtual Incubator Model for Building Knowledge-Based Abstract the USandMuslim world.Education: Harvard BAandPhD inFine Arts biotechnology inthedeveloping world;culturaldiplomacy, agricultural culture intherelationship between and Biotechnology Expertise: 2003-06. project, funded Foundation Marketplace", Rockefeller the Meets "Ethics Investigator, Principle University; Georgetown Residence, in Fellow Distinguished Humanities Medical Pfizer Former 1998-2001; Netherlands, the to Ambassador US FormerInstitution.Policy Brookings East Middle for Center Saban Fellow, Resident Non Senior University; Current: Distinguished Profesor in the Practice of Diplomacy, Georgetown (USA) NetherlandsAmbassador,the former of UnitedKingdom the the States to Executive Director, Perspectives in the Future of Science and TechnologySCHNEIDER, CynthiaP and

133 BioVisionAlexandria 2008 134 BioVisionAlexandria 2008 organic compoundsandsoilconservation. like nutrient efficiency and nutrient losses, balanced fertilization, transfer of toxic inorganic and issues specific on exemplarily focuses contribution the agriculture, in development sustainable about discussion general a crops”.Besides luxury and export high-profit primarily growing by and land, the off farmers of millions of tens forcing by increases farming, of cost actually the raising by agriculture hunger Industrial food. to access people deny which landlessness, and KimbrellA. as but hunger; “Worldwrites: creatednot is hunger by bybut food of lack poverty world of alleviation claiming by justified often are agriculture in Technologicaldevelopments sustainable. being from away far are development future prospected today’sits and agriculture named this Berry “We currently live in the economy and culture of the “one-night stand”. Also it requires investments for future generations, which are usually not profitable in the present. W. of future generations to meet their own needs”. The trouble with sustainable development is that development is development that meets the needs of the present without sustainability.compromising the According to ability the definition of “The Brundtland Commission” (1997) “Sustainable “profit”only presentoften the when in performance the than further for indicator an as seen is much go implications Its understood. inadequately cases many in but used widely term a fact in is Sustainability development. sustainable of practise the Janeiro de Rio after years Fifteen Janeiro in June 1992, a de Rio future in conference their in development assured Nations United The remainsgenerations. future to commitment inadequate our of of management humanity sustainable and towards resources natural sustainability.of user largest the far by is Agriculture E. Schnug,Head,InstituteforPlantNutritionandSoilScience Agricultures Contribution to Natural Resource Management - The Promise of Sustainability Abstract in ISI Web of Science; www.isiknowledge.com). Since 1996, 39 successfully supervised and completed PhDs. supervised successfully 39 1996, Since www.isiknowledge.com). Science; of Web ISI in (www.pb.fal.de/;listed journals 152 related and agricultural in contributions and publications Pedosphere, Egypt. Res., J. FAL-Agric. Desert Res., Agric., Arab J. J. Biotech. Elec.Since Polish1980 up Brassica, to AgroPrecise,January 2008, Agriculture, 807 Precisionscientific Science, Nutr.,Plant CropJ. (BALTIC21), Agron.Region Sci., J. SoilEncyc. member: board Editorial Sea Baltic the for 21 Agenda the of Agriculture”“TaskSustainable Force Chair Convention). Fertlization for SoilProtection.and HELCOM“WorkingChair boards Group Agriculture”on (BalticSeaProtection advisory ministerial Member (CIEC). Fertilisers of Centre Scientific ehia Uiest o Bancwi; euy Peiet International President Deputy. Braunschweig; of University Technical the sciences, at lectures Germany; Braunschweig, agricultural in Plants Cultivated and for Center natural Reseach Federal in the at Science Soil and Crop DSc of Institute the of Director and PhD chemistry, of and area agriculture in studied Forest egyptophile, and Western anglo- Roit, the of Count Germany: Hachenburg, 1954, Born Schnug: Ewald Head, Institute forPlant Nutrition andSoil Science SCHNUG, Ewald Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 SERAGELDIN, Ismail PhD from Harvard University, doctorates. andhasreceived 18honorary University,Cairoa Master’sfrom and and Engineeringdegree in degree Science of Bachelor a society.holds Heto science of value the sustainability,and development, biotechnology, rural including topics varietyof a overon and papers monographs over200 and published books 50 Socially Sustainable Development (1992-1998), and for Special Programs (1998-2000). He has a number of capacities at the World Bank, including as Vice-President for Environmentally and Assist thePoorest (CGAP),amicrofinance program (1995-2000).Serageldinin hasalsoserved former to Group Consultative and the (GWP,and WaterPartnership Global 1996-2000) Founder the Chairman, 1994-2000), (CGIAR, Research Agricultural International on Group ofAgricultural Academy National Sciences and the the Indian European Academy of Sciences and Arts. He is Sciences), former Chairman, Consultative of Academy World (Third TWAS efforts which includes the Institut d'Egypte (Egyptian Academy of Science), academic, research, scientific and international institutions and civil society for committees advisory of number a of Member and Chair as serves He and is Distinguished Professor at Wageningen University, the Netherlands. museums; and institutes research affiliated BA's the of each for Directors Ismail Serageldin, Director, Library of Alexandria; also chairs the Boards of Director, Bibliotheca Alexandrina

135 BioVisionAlexandria 2008 136 BioVisionAlexandria 2008 develop anddeliver genetically-engineered crops fordeveloping countries. to adopted have we strategy the discuss and projects our of several of examples present will action, I into translated being is strategy this how Toillustrate channels. distribution broader partnerships to public-private help leverage public createsfunds to facilitate absorbing ABSPII development costs and providepossible, When developed. be not would otherwise that crops genetically-engineered of commercialization and development the for programs effective cost biotechnology. Where demand exists, ABSPII works with local institutions to establish safe and agricultural about decisions informed make to countries developing in public general the and and public of consortium USAID-funded private sector institutions, provides support for scientists, and regulators, extension workers, farmers Support University-led Biotechnology Cornell Agricultural a The (ABSPII), overlooked. Project been have world resource-poor the and subsistence around to farmers importance of traits and crops many to biotechnology,related issues crop the of complexity and costs the to Due markets. international large occupy and value commercial high have that combinations crop/trait few a on primarily focusing are they but way, the leading been have companies expected sciences life is multi-national trend The continue. this to and countries developing adoption in been the has in crops growth genetically-engineered largest of the years, few last the Over sustainability. and productivity In the more developed countries, genetically-engineered crops contribute greatly to agricultural University F. Shotkoski,Director,AgriculturalBiotechnologySupportProject(ABSP)II,Cornell Agriculture biotechnology:ARoadMaptoCommercialization. Abstract Postdoctoral Research ofEntomology Associate,Department Wisconsin, 1992-1995 Research Associate/Senior Research Fellow, ofMedical Department Genetics University of University of Washington 1995–1998 Staff scientistIIacademicexperience Novartis AgribusinessBiotechnology Research Inc. 1998-2001 Cotton Biotechnology Crop Leader Global Cotton Traits Technical Manager Syngenta Plant Science2001-2004 Adjunct Professor ofPlant Department Breeding andGenetics Project II(ABSPII)Director Cornell University, 2005-present AgriculturalBiotechnology Support Professional experience BSc inAgronomy, University ofNebraska, Lincoln,1980-1984 MSc inEntomology, University ofNebraska, Lincoln,1986-1988 PhD inMolecular Entomology, University ofMinnesota, 1988-1992 University, USA Cornell II, (ABSP) Project Support Biotechnology Agricultural Director, SHOTKOSKI, Frank Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 and economicimpactsinasustainableway. health positive into know-how and capital, talent, indigenous translate help will infrastructure critical this creating into investment modest relatively a worldwide, networks similar with and and build on growing economic strengths in several African nations. By linking with each other marketplace, to laboratory the from ideas transferring in gap the tackle can centers these IFC, by proposed recently as fund, venture associated an with combination In entrepreneurs, needs. health local scientists, on focused services local and products health together affordable develop to investors bring and people, business will which facilities of network centers"; a for "convergence plan achievable yet ambitious, an provides presentation this Rwanda, and Ghana, Tanzania,in team our by conducted interviews in-depth one-hundred over of analysis economic value of their own domestic research? Based on background research and preliminary Saharan Africa tackle their own health problems, develop products and services, and capture the In Africa, there is more life sciences research than commercialization. How can countries in sub- Centre forBioethics P.Singer, SunLifeFinancialChairinBioethics&Director,UniversityofTorontoJoint "Accelerating HealthInnovationinAfrica" Abstract at Harvard Business School. Medical Ethics at the University of Chicago, Public Health at Yale University, and Management Universityof Toronto;the at MedicineInternal studied Singer30 newspapers. national than in op-eds more written and fellows, and students graduate 70 over trained grants, research in for Challenges Grand Foundation Global Health Initiative. He Gates has published over 240 research articles, received over Melinda $50 million and Bill the of Board Advisory Scientific the of member a and Canada of SocietyRoyal the and Sciences Health of the Academy Canadian of Fellow a is He Award. Research Medicine of Department and Award, TorontoDales Awardand Colleges Excellencefor from YaleUniversity Publicof School Health, University of Research Health of Nellie Institutes Westerman Prize Canadian in Ethics, Young the Educator Award received of the Association Distinguished Investigator Award has of and Michael Smith Award.Canadian Some of his main honors include Medical Singer bioethics. teaching and fair care, planning influenza pandemic end-of-life organizations, healthcare in setting quality priority in improvements included earlier contributions His world. developing the and entrepreneurship, sciences, life of nexus the at is research Singer's Professor Network. Health University at Centre McLaughlin-Rotman of Director Interim the is Singer Professor Joint Centre forBioethics, Canada Director, SunFinancialBioethicsand Life in Chair University of Toronto SINGER, Peter

137 BioVisionAlexandria 2008 138 BioVisionAlexandria 2008 eadd h Ntoa Aad n giutrl cecs 18; n oee te is Level First the offered and Medallion 1980; by Decree ofScienceandArt ofthePresident ofEgypt, 1981. Sciences, Agricultural on Award National the Rewarded Science Society ofAmerica;andEgyptian Society of Toxicology. Member, US Society of Toxicology; Society of Environmental Chemistry and Toxicology; Weed and UNorganizations. US other and USEPA by funded projects researchToxicology, through University Alexandria anumberofResearchConstructed ofPesticide LaboratoriesattheDepartment and Chemistry monitoring andmodeofactionspublishedmostlyininternationaljournals. a mr ta 7 sinic aes n ra o nuooiiy psiie ad ev metals heavy and pesticides neurotoxicity, of areas in papers scientific 70 than more Has Vice-Chairman, Steering Group onRiskAssessment(IPCS/SGRA, WHO), 1999–present. Member, Joint Meeting onPesticide Residues, WHO/FAO JMPR,since1999. (IPCS), Safety Chemical World Health since1992. Organization (WHO) on Program International (FRBs), Boards Review Final Member, Visiting Professor, KingSaud University, Saudi Arabia(1988–94). Texas, USA(1987–88). Visiting Professor, University of Texas Medical Branch (UTMB), Galveston, Park, North Carolina, USA(1979–82). Visiting Scientist, US Environmental Protection Agency, Research Triangle Faculty ofAgriculture, AlexandriaUniversity (1986–present). Toxicology,and Chemistry Pesticide of Professor Soliman, Ahmed Salah Faculty ofAgriculture, AlexandriaUniversity (Egypt) SOLIMAN, Salah Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 speaks English, French andSpanish. Christian Barcelona, in Based Columbia. British University,in Fraser Simon from Relations in degrees holds International in MA He an and Québec; Universityin Bishops from Political Europe.Science in Business, across entrepreneurs and agencies, development regional and national European, firms, consulting and legal funds, capital venture working leading with entrepreneurship, extensively and finance biotechnology of areas developing the in in activities particularly business development,new business Pan-European on focused and team sales the managed and trained created, he Development Business of Director as 1999, in joined he companies and entrepreneurship. Previously an Executive Director of Europe Unlimited, which investment and partnering initiatives in support of entrepreneurial technology and biotechnology initiatives, and to Europe Unlimited, the leading Pan-European provider of an independent venturesconsultant and adviser to new and biotechnology to his appointment as Secretary General of the sector EFB, in March 2005, he was biotechnology Prior development. business on and capital venture ventures, adviser new initiatives, strategic a and (EFB), of Federation Biotechnology European the of General Secretary is Suojanen Christian Secretary General, European Federation ofBiotechnology SUOJANEN, Christian

139 BioVisionAlexandria 2008 140 BioVisionAlexandria 2008 as thechallengesfacedby TB control programs, world-wide. status of development of diagnostics, new drugs and treatment strategies will be covered, Currentas well adherence. to related challenges and (IRIS) Syndrome Inflammatory Reconstitution Treatmenttrials. of HIV-TBIII and coinfection is II complex and I, associated with Phases overlapping drug in toxicities, risk now of areImmune many and vaccines and drugs TB new of development for push Recently,global BCG. major since a vaccine been new has thereno and years 40 past the in TB for introduced drugs new no been have There settings. resource-poor remoteand in use to easy but specific and sensitiverequired only areareurgently not tests that 100-year old technique and chest radiography, which has specificity problems. Newer diagnostic to the increased mortality observed. The diagnosis of TB is based on sputum smear microscopy, a Extremely Drug Resistant TB (XDRTB). These forms of TB are difficult to treat and contribute has been an increase in rates of drug resistant tuberculosis, including Multi-drug (MDRTB) and have which Furthermore,there TB, countries. these in programs of health public the for challenge huge rates a created increasing seen have Union Soviet former the and Europe Eastern severely unemployment and where intravenous drug abuse most is rampant. Countries in sub-Saharan Africa, countries in and poverty migration, turmoil, especially political facing those as well rise, as epidemic HIV the by affected to continues incidence TB stable, remained has prevalence TB While patients. HIV-infected were 195,000 which of 2005, in deaths related (TB) andHuman million TB- 1.6 and of TB cases new million 8.8 reports World (WHO) of Tuberculosis Organization Health dual epidemics The time. our of challenges health public major the of the converging one is (HIV) Virus Immunodeficiency of impact global The S. Swaminathan, Deputy Director, Tuberculosis Research Centre Tuberculosis: Comprehensive Overview andChallenges Abstract NACO. She hasover 90publicationsinnationalandinternationaljournals. national TB and AIDS Control programs and is a member of the Technical Resource Group of and pathogenesis as well as monitoring of HIV drug resistance. She has worked closely with the disease. She oversees the HIV laboratory, which is involved in studies of cell-mediated immunity of HIV-infected children and has initiated studies to identify better prognostic markers for this management the in pioneers the of one been has She patients. tuberculosis in use successful its to similar treatment, HIV Observed Treatmentfor Directly used of being strategy (DOT) the the for regimens prevention different and treatment of studying tuberculosis among HIV-infectedtrials patients. She is clinical also investigating several for investigator principal the is She scientists researchersand laboratory working on the interaction between HIV and tuberculosis. Division of HIV/AIDS at the Center. She heads a multi-disciplinary team of physicians, behavioral 16 years and is currently the Deputy-Director Sr Grade and Head of the of Head and Grade Sr Deputy-Director the currently is and years 16 the Tuberculosisat past worked the has Shefor Chennai Centre,Research Children’sthe USA. at Angeles, pulmonology Los pediatric of Hospitalin and All India Institute of Medical Sciences, New Delhi. She later specialized received her medical education at the Armed Forces Medical College, Pune Dr Soumya Swaminathan, MB,BS, MD is a pediatrician by training having Deputy Director, Tuberculosis Research Centre (India) SWAMINATHAN, Soumya Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 critical componentsforassuring thefullexploitationoftechnologiespotential benefits. as upon touché also are considerations infrastructure / trade / biosafety covering implications regulations and a seed industry, to be able to benefit from the technologies. Finally, other policy global benefits. Related to this aspect is the importance to of the contributed institutional evenframework, biosafety behavior this that and most, the benefited technologies the into on early adopter.early the came of that benefits countries the those on Itthat made clear is Emphasisis future. the for lessons as result issues important several experiences these of Out aspects. other among creation, employment and growth economic losses, productivity future potential and extraction nutrient including economy, wider the on effects indirect other and use resources natural for implications its as well as process this of aspects main the presentationanalyzes The farmers). to going benefits the of most with cotton, insect-resistantfrom million 20 about and years since past10 their the introduction for (19.7 billion billion originated 20 in USD soybeans, about than 500 more million be from to maize estimated benefits, economic significant and planted. Overall this process has resulted in more than doubling of grain and oilseed production Argentina has become the second largest producer of GM crops, with over 19.5 million hectares varieties GM present, the fromagricultural represented At commercially.over benefit 99% released of planted been soybeans, can 75% have of maize events and 80% additional for cotton. of howsocieties nine Along this then process, since and 1996, example in introduced were soybeans) aclear (herbicide-tolerant crops GM biotechnologies. is case Argentinean The Directorate forInternationalRelations,MinistryScience,TechnologyandInnovation E. J.Trigo,Director,GrupoCEOConsultoresS.A.andScientificAdviser, Soybeans inArgentina:BenefitsandLessonsfortheFuture Abstract published extensively. has he where sector, biotechnology and food agricultural, the in emphasis with organization, EnvironmentalInstitute FAO.and His areamain workand of policy technology and science is international organizations, including, among others, the OECD, IDB, EU, FAO the Stockholm work as a includes consultant to several Latin-American and the experience Caribbean national governments and professional to His National Holland. for Hague, Service the Internationalin ISNAR, the Research, at Agricultural Research of Director and Rica, Costa Jose San in IICA, Agriculture, on Cooperation for Institute Interamerican the of Transfer Program and TechnologyGeneration the of Director Argentina, in AgenINTA Fundación the of Director Executive was Previously,Food.he and Fisheries Livestock, Agriculture, for Secretariat the at Committee Advisory Policy Biotechnology the in Technologyand and Science of Promotion the for Agency National the of Directors of Board the at served has past, the and In fields. economics policy agricultural the in specializing firm consulting a CEO, Grupo of Director is also He and Aires. Buenos of of University Technologythe Council of Agronomy of Academic Faculty the Science, of the School Graduate the of of member as and Ministry Argentina, of the Innovation of Directorate the Relations from Economics Agricultural, in University PhD of Wisconsin and serves as a Scientific Adviser to the International holds Trigo, J. Eduardo and Innovation Directorate forInternational Relations, forScience, Ministry Technology Director, Grupo CEOConsultores S.A.andScientificAdviser, TRIGO ,EduardoJ.

141 BioVisionAlexandria 2008 142 BioVisionAlexandria 2008 session will briefly introduce PRRI and its activities and accomplishments, and will discuss in discuss will and accomplishments, and activities its and PRRI introduce briefly will session This COP9. and MOP4 of agenda the on topics the on input their seek to and Convention, Biodiversity and the and Protocol Cartagena America the to researchers North public introduce to Europe, America South Africa, in meetings regional organized has PRRI purpose, this Germany.For Bonn, May,in 12-30 back-to-back, held be will which COP9, and MOP4 in researchers public of participation the facilitate to are 2008 for activities main PRRI’s arena. international the in organization well-recognized a become has PRRI establishment, its Since world. the over all from scientists research public many with (CBD), Diversity Biological on in participated PRRI (MOPs). Convention the Partiesto the (COP8) of Conference CPB 8th the in as well as MOP3, and MOP2 the to Parties the of Meetings the as such discussions, public researchers a forum through which they are informed about and involved in offer international to objective the with 2004 in established was (PRRI) Initiative Regulation and Research way.organized an representedin The been Public not 2004 until has countries, developed and agreements, the public research sector, which counts tens of thousands researchers in developing international these of development the During (CPB). Biosafety Protocolon Cartagena the as able to contribute to these goals depends on, among other things, international agreements, be will such biotechnology modern which to extent The protection. environmental and care to health biotechnology modern in research conduct strengthen the world, sustainable the production over of all food, feed institutes, and fiber; sector to Public address water shortage; to improve Biodiversity the and Protocol P. VandeMeer,ExecutiveSecretary,PublicResearchandRegulationInitiative(PRRI) Cartagena the in Convention Researchers Public of Participation Abstract depth thetopicsonagenda ofMOP4andCOP9. at theDelft University of Technology, theNetherlands. pubresreg.org). Piet Vander Meer is a Guest Professor at the University of Ghent, Belgium, and www.see (PRRI, Initiative Regulation and ResearchPublic the to support provides Vanderalso Meer Piet organizations. international and governments are clients main Its development. agreements, national policies and legislation related to environmental protection and sustainable Belgium-based environmental international of fields the in the consulting offers Horizonswhich consultancy sprl, of principal the is Meer Vander Piet 2004, Since Frameworks. Biosafety National of Implementation on projects UNEP-GEF the of manager programme as served he Frameworks of the pre-accession countries Biosafety in Central National and Eastern of Europe”. From“Implementation 2002 project to 2004, capacity-building the managed Meer Vander aspects of biosafety regulations and risk assessment in many countries. From 1999 to 2002, Piet the Netherlands during which he was closely involved in many EU and international EU fora. many in He in also regulationsinvolved provided closely biosafety was regular he training of which on charge during the Netherlands legal in the and was scientific he 1999, to 1989 From law. in microbiology and ecology, as well as in environmental and international lawyer,a and Pietscientist Meervana der as trained is specializations with Netherlands ExecutiveSecretary, Publicthe RegulationInitiativeResearch(PRRI), and Vander MEER,Piet Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 Russia, France, andItaly) (USA, agriculture and engineering science, of academies several of member a is He Baron. of title the received he accomplishments, scientific his to due 1990, JapanPrize.In the including awards, numerous granted been has He CropDesign. and (PGS), Systems Genetic Plant offs, the most cited scientists in the field of plant and animal science. His laboratory raised two spin- of one is and biotechnology; to contributors existing top 100 the among ranks He flowering. and development growth, plant in involved genes of identification the in contributions major produced also He reactions. physiological plant several of basis molecular the discover to and regulation gene Montagu study Vanto technology genes. new his plant applied chimerical to first tumefaciens the constructed Agrobacterium and from plants, transfer DNA of mechanism the a discovered is Schell, Jeff colleague, biology.his molecular and Hein Belgium, pioneer University, Ghent at Professor Em. Montagu, Van Marc Elected andActing President, theEuropean Federation of Technology VAN MONTAGU,Marc

143 BioVisionAlexandria 2008 144 BioVisionAlexandria 2008 were obtainedinthefieldofaethnogenomicsandethnogeography. results fundamental The nature. structure multi-national a is peculiarity society Russian The pharmocologenomics and grounds for fundamental understanding of illnesses and pathologies. oncologenomics, cardiogenomics, of development for basis the are and results The genetic levels. on protein diseases for individuals of predispositions of analysis the on focuses research The others. and retroelements DNA DNA, ribosome enzymes, of polymorphism catalytic and proteins was analyzed for different and systems analysis) of (SNP human DNA organism, of including diversity the genetic, structural proteomic The Sciences. of Academy Russian of groups “Human project the Russia, researchMoscow Statekey Universityof and participation polymorphism” Inwith organized was condensate. air exalted of The analysis protein in biomacromolecules. obtained were of results interesting special The mass-spectrometry details. in discussed are methods research in trends amplification, and options genes DNA technologies, enzyme on based is individuals for proteins and DNA of analysis particularities structural of methodology Modern research. biomedical in area new the open chemistry post-genomic and MoscowSciences, Stateof UniversityAcademyRussian bioinformatics proteomics, Genomics, Physics, Biochemical of Institute Varfolomeev Sergey 2005-2007. project Russian of Results S. Varfolomeev,Director,InstituteofBiochemicalPhysics,RussianAcademySciences The PathwaytoIndividualMedicine. Human GeneticVariationasStructuralandFunctionalDiversityofBiomacromolecules. Abstract enzymes, biofuels. (iii) current research interests: enviromental biotechnology, biosensors, genetic engineering of engineering genetic biotechnology,biosensors, enviromental interests: research current (iii) chemical microbiology fields: biocatalysis, other (ii) biotechnology,biokinetics. biology; enzymology kinetics, biological and physico-chemical fields: main the (i) SPECIALIZATIONS Sciences; 2004-present of StateUniversity;AcademyDirector,Russian 1987-present Physics, Biochemical of Institute MoscowChemistry, of Faculty Department Enzymology Chemical of Professor,Head 1987. Chemistry,Bioorganic and MoscowBiologyMolecularUniversity;State 1978/ for Laboratory Interfaculty Belozersky A.N. Depart., Biokinetics of HeadProfessor, 1974/1978. University; State Moscow Chemistry, of Faculty Department, Enzymology Chemical researcher, Senior 1973/1974. University; State Moscow Chemistry, of Faculty Department Kinetics Chemical Professor,Assistant 1971/1973. University;StateChemistry, Moscow Bioorganic and Biology Junior researcher, Biokinetics Department, A.N.Belozersky Interfaculty Laboratory of Molecular Prize for Science and Technology;Professionalappointments: Science 1984 Prizefor 1974, TheNational 2000: andTechnology; for Science Prize Lomonosov The 1979 Member of the Russian Academy (Chemistry); of Sciences; 2006: Honors, awards: Science Department, of (Chemical Doctor 1971 degree Enzymology); Kinetics PhD Chemical Kinetics, 1968 Chemical (Moscow); University Chemistry, State Lomonosov of Faculty Education: Director, Institute ofBiochemical Physics, Russian Academy ofSciences. VARFOLOMEEV, Sergei Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 future. near the in more even and presently SOLiD 2 and Solexa 6 of sequencers next-generation the performance computer of 416 CPUs, a memory of 912G, and a storage of 300T, as required by high- new a with expanded been has capacity computing its and programmers, 100 than more advantages of the developing countries. BGI’s new Department of Informatics, in Shenzhen, has genome sequence. Bioinformatics is both labor-intensive and brain-intensive, which is one of the reach a number of important discoveries by identification of DNA functional elements from the to annotators sequence other and ReAS as well as genomes, of sequencing novo de for repeats by developing RePS and its improved version RePSII to overcome the obstacle of the unknown gained successfully was sequencing, shotgun genome whole by rice of map, sequence fine then draft, working the example, For years. past the in (BGI) Institute Genomics Beijing by made achievements the all to contributors major the of one been has Bioinformatics of Department bioinformatics. developing to given be biotechnology.should Prioritiesand sciences life of in up development the without made been have would bioinformatics. This forwards another historic opportunity for the developing countries to pick year the of science in discoveries nor technology in breakthrough However,neither sciences. life and genomics for Miracle Yearof andhave tools a as acknowledged been has 2007 year powerful The research. biological of practice the forever and supercomputers changed sequencers made have understandings These has two solid pillars based on two understandings of life “Life is of sequence” and “life is digital”. field of life sciences. Genomics, a new frontier and foundation of life Bioinformatics sciences is the and scientific biotechnologies, core and most important tools of genomics, as well as of the whole Huada GenomicsResearchCenter. H. Yang,Director,BeijingGenomicsInstitute,ChineseAcademyofSciencesand Countries Bioinformatics: EssentialInfrastructureandImportantToolsforGenomicsinDeveloping Abstract and anAcademician ofChineseAcademy ofSciencesin2007. 2006, in EMBO of member foreign a as elected was He 2006. in Sciences Worldof Academy Researchincluding Leader of the Yearhonors, by and Scientific American in 2002, and Awardawards in Biology bymany the Third received have team his and YangDr. Project. 1000 Genomes International the to contributing groups member major the of one also is BGI China. major genomics centers in the world with campuses in the Beijing, Hangzhou,of Shenzhen one and become has Tibet, now BGI 2007. Asian’sin first genome the as well as years, last the in domesticated silkworm (Bombyx mori). They also sequenced and analyzed many microorganisms 2002, a genetic variation map of the chicken genome in 2004, as well as a draft sequence of the in ssp.indica) L. sativa (Oryza genome rice the of sequence draft a produced also collaborators significant contribution to the final sequence and HapMap of the human genome. BGI and its a made China in collaborators his Dr.Yangand Consortium, HapMap International the and Consortium Sequencing Genome Human International Coordinator- the of As in-China USA. (1991–1994), UCLA and (1990–1991) School of University from afterwards Genetics at CIML, Marseilles, Medical France trainings (1988–1990), postdoctoral then his in received Harvard and Medical 1988; in PhD Denmark, Copenhagen, his earned Yang Dr. Director, Huada Genomics Research Center and Sciences of Academy Chinese Institute, Genomics Beijing Director, YANG, Huanming

145 BioVisionAlexandria 2008 146 BioVisionAlexandria 2008 new approach,new andsomepracticalconclusionswillbederived from thisspecificcasestudy. possible a illustrate to referred traded be of will case the Tunisia specific The in reasoning. the embedded in products) (water water virtual and soils) the in stored (rainwater water green include to necessary however is It resource. the as considered groundwater,is and lakes rivers, from water i.e. water, blue only approaches, classical the Inwater. of types all to concept the important challenge to overcome it is to change the an usual water that resources show paradigm and by crisis enlarging scarcity water current the of reasons the analyse will presentation The D. Zimmer,ExecutiveDirector,WorldWaterCouncil Water Resources:theNeedforIncreasedHydrosolidarity Abstract requiring attentiontobeidentifiedinorder particular toprogress. issues critical allow that the expertise collective of and knows stakeholders among dialogue of he importance environment, the on drainage of impacts the on instance for controversies, to Used it. unify to institutions new for need the of and sector water the of fragmentation the of drawbacks the of convinced Marseilles, in WorldWaterCouncil the of Director Executive of position the currentlyoccupies resourceshe human management, in experience good with and the Cemagref, with a great interest for the work in multicultural and projects,multidisciplinary and guiding several researchsupervising teams dealing with water issues. After these 15 years at Headon Department the Waterof Environmentalof and charge Engineering,in where was he Deputy became then He landfills. for systems lining and drainage combined with and systems irrigated in management salinity quality,with water and regimes flow on systems drainage of a researcher and became Head of a Research Unit dealing with the impacts and Agricultural French as started the he Centre, this In Centre. Research Cemagref, Engineering Environmental the at career his of part great spent a He VI. Paris University in He systems drainage on Engineering. PhD a completed Agricultural and Paris, in in d’Agronomie National Institut French background the from graduated a has Zimmer Daniel Executive Director, World Water Council ZIMME ,Daniel Speakers’ Biographies & Abstracts & Biographies Speakers’ BioVisionAlexandria April 2008 2008

Partners, Sponsors and Exhibitors BioVisionAlexandria BioVisionAlexandria

147 Partners, Sponsors and Exhibitors 2008 BioVisionAlexandria BioVisionAlexandria

148 BioVisionAlexandria April 2008 2008 BioVisionAlexandria BioVisionAlexandria

149 Partners, Sponsors and Exhibitors

Partners

The World Life Sciences - Biovision Set up on the initiative of the late Mr Raymond Barre, former Prime Minister, and the Académie

2008 des Sciences, the World Life Sciences Forum (WLSF) BioVision is a unique international platform specifically designed to chart the progress of Life Sciences, within a strict ethical framework. BioVision is an unprecedented event enabling constructive dialogue to take place among all stakeholders contributing to the understanding, acceptance and development of Life Sciences. BioVision’s mission is also to provide objective information to the public regarding the questions raised by progress in Life Sciences and their applications. The Forum gathers high-level representatives from science, society at large, and industry, politics and international organisations in order for them to work in collaboration. It deals simultaneously with all fundamental areas in Life Sciences, in particular health, agriculture and nutrition, environment and the interactions between them. BioVision’s objective is to facilitate the confrontation – at times heated – between these different approaches and to ensure that the expression of differences does not mean sterile confrontation. It is also about agreeing to move ahead together on concrete actions, step by step if necessary and without renouncing each other’s profound convictions, in the interests of the victims of disease, hunger or those who suffer from living in an unhealthy environment. These actions concern every country, as the problems also exist for some parts of the population in “developed” countries.

European Action on Global Life Sciences – EAGLES Addressing Europe’s responsibilities towards the developing world European Action on Global Life Sciences EAGLES was set up through the initiative of members of the European Federation of Biotechnology (EFB). EAGLES aims at enhancing the collaboration between European researchers and researchers in the developing world to ﬁght hunger and disease has been launched by the European Federation of Biotechnology (EFB). The project is being supported by the European Commission and is a collaboration between EFB and scientiﬁc partners in Europe, China, Egypt, Ghana, South Africa and the Philippines. Members of the Steering Committees include prominent scientists from China, Egypt, Ethiopia, Ghana, India, Kenya, Mexico, South Africa,

BioVisionAlexandria BioVisionAlexandria Syria and Thailand.

A number of EAGLES conferences and workshops is being organized in Europe and various developing countries (DEC). The topics illustre the need for much more effective European responses on the use of biology in combating problems in health and food supply in the DECs and in achieving the Millennium Development Goals. The first major EAGLES conference was held 26-29 April 2006 as part of BioVision at the New Library of Alexandria, Egypt. News about future conferences is published at the EAGLES website; http://www.efb-central.org/eagles/site 150 The Arab Fund for Economic and Social Development (AFESD) The Arab Fund for Economic and Social Development (AFESD) is an autonomous regional Pan-Arab development finance organization, (“the Fund”). Its membership consists of all states who are members of the League of Arab States. The AFESD is an Arab regional financial institution, having an independent juridical personality. Its function is to assist the economic and social development of Arab countries through (1) financing development projects, with preference given to overall Arab development and to joint Arab projects; (2) encouraging the investment of private and public funds in Arab projects; and (3) providing technical assistance services for Arab economic and social development. BioVisionAlexandria April 2008

The Academy of Sciences for the Developing World (TWAS) TWAS, the Academy of Sciences for the Developing World, represents the best of science in the developing world. Its principal aim is to promote scientiﬁc capacity and excellence for sustainable development in the South.

TWAS is an autonomous international organization, founded in Trieste, Italy in 1983 by a dis- 2008 tinguished group of scientists from the South under the leadership of the late Nobel laureate Abdus Salam of Pakistan. Originally named “Third World Academy of Sciences”, it was officially launched by the then-secretary general of the United Nations, Javier Perez de Cuellar, in 1985. Since its inception, TWAS’s operational expenses have largely been covered by generous contributions of the Italian government. The Academy’s more than 700 Fellows and Associate Fellows are elected from among the world’s most distinguished scientists. Fellows are citizens of the South; Associate Fellows are citizens of the North who either were born in the South or have made significant contributions to the advancement of science in the South. About 80 percent of TWAS’s membership are Fellows representing more than 70 countries in the South. (See TWAS Membership page for more information). A Council, elected by members every three years, is responsible for supervising all Academy affairs. A small secretariat headed by an Executive Director assists the Council in the administration and coordination of the programmes (contacts). The secretariat is located on the premises of The Abdus Salam International Centre for Theoretical Physics (ICTP) in Trieste, Italy. Since 1986, TWAS has supported scientific research in 100 countries in the South through a variety of program. More than 2,000 eminent scientists worldwide, including TWAS members, peer review proposals free-of-charge for research grants, fellowships and awards that are submitted to the Academy by scientists and institutions in developing countries.

The Organization of the Petroleum Exporting Countries (OPEC) The Organization of the Petroleum Exporting Countries (OPEC), is a permanent, intergovernmental organization, created at the Baghdad Conference on10–14 September, 1960, by Iran, Iraq, Kuwait, Saudi Arabia and Venezuela. The five Founding Members were later joined by nine other members. OPEC had its headquarters in Geneva, Switzerland, in the first five years of its existence; then moved to Vienna, Austria, on 1 September 1965. BioVisionAlexandria OPEC’s objective is to co-ordinate and unify petroleum policies among member countries, in order to secure fair and stable prices for petroleum producers; an efficient, economical and regular supply of petroleum to consuming nations; and a fair return on capital to those investing in the industry.

The International Development Research Center (IDRC) 151 IDRC is a Canadian Crown corporation that works in close collaboration with researchers from the developing world in their search for the means to build healthier, more equitable, and more prosperous societies.

Germany: A Global Player (not only) in Biotechnology

To present Germany internationally, abroad, the German Government in cooperation with commerce and industry is leading a campaign entitled “Germany-Land of Ideas”. The phrase sums up a wealth of positive arguments associated with Germany both within the country and abroad: a nation of science and culture; a land of poets and thinkers; innovative products made in Germany.

Germany is Europe’s number one research location. However, in a globalized world, scientiﬁc and technological progress has long since ceased to take place in isolation within national boundaries. Together, through interaction and exchange between the leading experts worldwide, we can shape the future.

To keep the quality of science and technology high, the German Academic Exchange Service (DAAD) helps to widen the skills of German students abroad as well as to extend foreign students’ skills in Germany.

The German Academic Exchange Service is one of the world’s largest and most respected intermediary organizations in its ﬁeld. For more than 75 years, the DAAD has been committed to advancing academic relations between Germany and other countries, as well as more generally, to promoting the ﬁelds of education, science, culture and research. Not least through these activities, the DAAD can base its work on an extensive range of expertise and experience.

More information: http://www.land-of-ideas.org http://www.daad.de http://cairo.daad.de

Supporters Partners, Sponsors and Exhibitors

Exhibitors Guide 2008 Senghor University

www.usenghor-francophonie.org Booth A1 Senghor University is a Francophone University acting for the OIF (International Organization of French-Sharing Countries). It delivers a master’s degree in the area of Development, specifically dedicated to the development of Africa. The University offers 7 different specialties within 4 areas: Environment, Cultural Heritage, Health and Management. It also offers several training sessions, either in Alexandria or in African countries, in collaboration with local, national or international partner institutions.

ICOM

www.icomgroup.org

Booth A2 We, at ICOM with more than 10 years of personnel and professional experiences in the ﬁeld of Organization and Marketing, are committed to serving our customers in this ﬁeld of business with value added experiences, providing complete reliable information and services for the success of all activities we are responsible of.

We believe that quality is the key to fulﬁll our commitments to: • Our customers and community, by providing the type of services that best suits their objectives through a better understanding of their needs.

BioVisionAlexandria BioVisionAlexandria • Our employees, by preserving and developing their abilities and productivity by continuously improving their skills.

Overview

We, at ICOM specialize in:

• Conferences and meetings organization • Medical marketing. 162 • Scientiﬁc and audiovisual equipments rent • Designing - Printing • Human resources • Marketing Research • Each business is a unique entity, we work closely with our customers to meet their speciﬁc needs, business issues, challenges and opportunities BioVisionAlexandria April 2008

Springer

www.springer.com Booth A3

Springer is the second-largest publisher of journals in the science, technology, and medicine 2008 (STM) sector and the largest publisher of STM books. It publishes on behalf of more than 300 academic associations and professional societies. Springer is part of Springer Science and Business Media, one of the world’s leading suppliers of scientiﬁc and specialist literature. The group publishes over 1,700 journals and more than 5,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in over 20 countries in Europe, the USA, and Asia, and some 5,000 employees. Taylor & Francis Group

www.informaworld.com Booth A4 Taylor & Francis Group is one of the leading international academic publishers, producing around 1,800 books and 1,200 journals annually under the imprints of Taylor & Francis, Rutledge and Psychology Press. Our innovative range of online products includes reference works, journals, abstracting databases and currently 17,000 eBooks. The electronic resources of Taylor & Francis Group are brought together in one searchable interface, inform world, which gives new and improved accessibility to our online products.

Nature

www.nature.com Booth A5 Nature Publishing Group (NPG) brings leading scientiﬁc and medical research to your desktop. The NPG portfolio combines the continued excellence of Nature and its associated research and review journals, over 42 leading academic and society journals and 8 Nature Clinical

Practice journals. NPG also provides news content through Nature News and scientiﬁc career BioVisionAlexandria information through Nature jobs.

Bibliotheca Alexandrina YESBU and LYM programs

www.bibalex.org/yesbu

Booth A6 163 YESBU (Youth for Environmental Sustainability and Better Understanding) is a special program operated by and directed to young students (13-18 years old) and LYM (League for Young Masters) is directed to young masters (19-25 years old). These programs aim to increase environmental awareness about local and global problems and promote preventative environmental management concept among youth. Also they seek to encourage scientiﬁc thinking and engage youth in activities and programs related to the environment. They try to develop scientiﬁc research, constructive crisis team work and personal and social skills of the youth. They encourage exchanging youth ideas and knowledge with their peers by engaging them in a dialogue and team work and promoting learning and knowledge activities by self learning and distance learning methods. Partners, Sponsors and Exhibitors

Novo Nordisk

www.novonordisk.com Booth A7 Novo Nordisk is a healthcare company and the world leader in diabetes care. The Company 2008 has the broadest diabetes product portfolio in the industry, including the most advanced products within the area, of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as homeostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a signiﬁcant diﬀerence to patients, the medical profession and society. Novo Nordisk’ s vision is to defeat diabetes by better methods of diabetes prevention, detection and treatment and to work actively to promote collaboration between all parties in the healthcare system in order to achieve common goals. With headquarters in Denmark, Novo Nordisk employs approximately 24,000 full-time employees in 79 countries, and markets its products in 179 countries.

EAGLES

www.efb-central.org/eagles Booth A8 European Action on Global Life Sciences (EAGLES) aims at enhancing the collaboration between European researchers and researchers in the developing world to ﬁght hunger and disease. EAGLES has been launched by the European Federation of Biotechnology (EFB). The project is being supported by the European Commission and is a collaboration between EFB and scientiﬁc partners in Europe, China, Egypt, Ghana, South Africa and the Philippines. Members of the Steering Committees include prominent scientists from China, Egypt, Ethiopia, Ghana, India, Kenya, Mexico, South Africa, Syria and Thailand.

The World Bank www.worldbank.org Booth A9 BioVisionAlexandria BioVisionAlexandria The World Bank is a vital source of financial and technical assistance to developing countries around the world. It is made up of two unique development institutions owned by 185 member countries—the International Bank for Reconstruction and Development (IBRD) and the International Development Association (IDA). Each institution plays a different but supportive role, in our mission of global poverty reduction and the improvement of living standards. The IBRD focuses on middle income and creditworthy poor countries, while IDA focuses on the poorest countries in the world. 164 The Bibliotheca Alexandrina is a Depository Library for World Bank publications. World Health Organization www.who.int Booth A9 The World Health Organization is the United Nations specialized agency for health. It was established on 7 April 1948. WHO’s objective, as set out in its Constitution, is the attainment by all peoples of the highest possible level of health. Health is defined in WHO’s Constitution as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. The Bibliotheca Alexandrina is a Depository Library for WHO publications. BioVisionAlexandria April 2008

United Nations Educational, Scientiﬁc and Cultural Organization

ww.unesco.org 2008 Booth A10 UNESCO was founded on 16 November 1945. UNESCO functions as a laboratory of ideas and a standard-setter to forge universal agreements on emerging ethical issues. UNESCO is working to create the conditions for genuine dialogue based upon respect for shared values and the dignity of each civilization and culture. The world urgently requires global visions of sustainable development based upon observance of human rights, mutual respect and the alleviation of poverty, all of which lie at the heart of UNESCO’s mission and activities. The Bibliotheca Alexandrina is a Depository Library for UNESCO publications. Food and Agriculture Organization

www.fao.org

Booth A10 The United Nations Food and Agriculture Organization was established in 1945 to lead international eﬀorts to defeat hunger. Serving both developed and developing countries, FAO acts as a neutral forum where all nations meet as equals to negotiate agreements and debate policy. FAO is also a source of knowledge and information. FAO assists developing countries and countries in transition to modernize and improve agriculture, forestry and ﬁsheries practices and ensure good nutrition for all. The Bibliotheca Alexandrina is a Depository Library for FAO publications.

Academic Bookshop

www.abcacademic.com

Booths A11, 12, 13 Academic Bookshop is an Egyptian joint stock company. It was established in 1977, and it BioVisionAlexandria has been renewed, and in its new shape became a glory of the international bookshops. It is considered the greatest bookshop in the foreign book fields as it contains 56,000 titles on all scientific fields. The bookshop is provided by the best research methods, such as computers and advanced international communication systems, so it is considered a permanent book fair for the scientific foreign books.

Pearson Education 165 www.pearsoned.co.uk

Booths A11, 12, 13 Pearson was founded by Samuel Pearson in 1844. Pearson’s publishing interests began in the 1920s. In 1998, Pearson Education was created. Pearson Education Europe, Middle East and Africa is the region’s leading educational publisher. Pearson Education is part of the global media and education group Pearson, and a sister company of Penguin and the Financial Times newspaper. Pearson aims at helping children and adults to learn, business people to make good decisions, and readers to wind down or wise up with a good book. The businesses fuel a growing demand for knowledge and share a common purpose: to help their customers live and learn. Partners, Sponsors and Exhibitors

ELSEVIER

www.elsevier.com

Booth A14 2008 As the world’s leading publisher of science and health information, Elsevier serves more than 30 million scientists, students, and health and information professionals worldwide. Elsevier are proud to play an essential role in the global science and health communities and to contribute to the advancement of these critical ﬁelds. By delivering world-class information and innovative tools to researchers, students, educators and practitioners worldwide, we help them increase their productivity and eﬀectiveness. Elsevier’s operations are organized in two divisions: Science & Technology and Health Sciences. Our products and services include electronic and print versions of journals, monographs, textbooks and reference works and cover the health, life, physical and social sciences.

Siemens

www.siemens.com Booth A15 Siemens is a global powerhouse in electrical engineering and electronics, active in 190 countries, with headquarters in Germany, Asia and America, that strives to position itself as a “local partner “ to all its customers. For 160 years, Siemens has been providing answers to the world’s toughest questions through technological innovations and comprehensive know-how. The Company has today 400,000 employees working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements, Siemens’ operations are divided into three sectors: Industry, Energy and Healthcare. The advanced activities are handled by Siemens IT Solutions and Services, Siemens Financial Services GmbH and Siemens Home and Oﬃce Communication Devices. Major aﬃliates include BSH Bosch und Siemens Hausgeräte GmbH, Fujitsu Siemens Computers (Holding) BV and Nokia Siemens Networks. Siemens has been active in Egypt since 1901, where it holds leading positions in Energy and Environmental Care/Automation and Control, Industrial and Public Infrastructures/

BioVisionAlexandria BioVisionAlexandria Healthcare; while Siemens IT Solutions and Services functions across all three ﬁelds. The Company embraces its social responsibility in Egypt by promoting employee development and supporting educational organizations. Siemens is totally committed to a business strategy that generates proﬁts while contributing to the well-being of people, the societies it serves and the world in general.

Research, Development and Innovation Programme 166 Booth A16 The European Commission and Egypt signed in June 2007 the Research, Development and Innovation (RDI) agreement with a grant of 11 million to support the Egyptian Government’s research, development and innovation initiatives. A Programme Implementing Oﬃce established by the Ministry of Higher Education and Scientiﬁc Research is responsible for implementing the Programme over a period of 3 years. The RDI overall objective is to contribute to the promotion of Egypt’s economic growth and international competitiveness by improving its research, development and innovation performance. BioVisionAlexandria April 2008

SCYNEXIS

www.scynexis.com Booth A17 SCYNEXIS is a drug discovery and development company headquartered in Research Triangle Park, North Carolina. SCYNEXIS’ mission is to deliver eﬀective and innovative drug pipeline 2008 solutions to its partners. SCYNEXIS research teams integrate medicinal chemistry, advanced biological screening, computational chemistry, bioanalysis and analytical chemistry and use powerful, proprietary technologies such as the HEOS® Software Suite, MEDCHEM-FACTORY® and KIT™ Kinase Inhibitor Technology to advance molecules to candidate selection. SCYNEXIS development teams have been tailored to be especially eﬀective in moving customer projects from the discovery phase to the clinic. SCYNEXIS process chemistry and bioanalytical DMPK departments operate under current GMP/GLP guidelines and have a strong track record of success

Monsanto

www.monsanto.com

Booth A18 Monsanto is an agricultural company with 17,000 employees worldwide. When farmers succeed, we succeed. Through the tools of modern biology, we support our commitment to agriculture and to the farmers that feed, clothe and fuel our growing world. We produce leading seed brands in large-acre crops such as corn, cotton and oilseeds (soybeans and canola), as well as small-acre crops such as vegetables. We also produce leading in-the-seed trait technologies to farmers who aim at protecting their yield, supporting their on-farm eﬃciency and reducing their on-farm costs. We are constantly seeking ways to maximize the potential of seed, both its yield potential and the technology used to protect it, so farmers can obtain more out of each seed. Today, farmers use our innovative seed-based products to help them protect their crops and produce healthier foods and better animal feed. As a company, we are committed to broadly licensing our seed and trait technologies to other companies throughout the world. This approach ensures that farmers can access our products in the varieties that are the most appropriate to their farm. In addition to our seeds and traits business, we also manufacture the world’s best-selling

herbicide, Roundup®, and other herbicides used by farmers, consumers and lawn-and-garden BioVisionAlexandria professionals. Our business is structured in two segments: Seeds and Genomics, and agricultural productivity. The Seeds and Genomics segment consists of the Company’s global seeds and traits business, and genetic technology platforms, including biotechnology, breeding and genomics and agricultural productivity. The agricultural productivity segment consists primarily of crop protection products, residential lawn-and-garden herbicide products, and the Company’s dairy business.

Fine Seeds International 167

Booth A19 Fine Seeds International SAE (FSI) is a private shareholders company established under Egyptian law in 1995. The company is active in breeding, multiplying, processing and selling corn to Egyptian agriculture. It also produces wheat and rice varieties. The Company exports to Europe high quality hybrid Brassica seeds and imports herbicides. Along with Monsanto, the Company is developing, since the year 2000, hybrid corn endowed with Bt to resist insects. FSI has 55 full-time employees and is an active member of the Egyptian Seed Industry Association (ESIA). Currently, the Chairman of FSI is the chairman of ESIA. Partners, Sponsors and Exhibitors

ACML-Egypt

www.acml-egypt.com

Booth A20 2008 ACML-EGYPT is an Egyptian Joint-Stock Company with an Egyptian-Arab capital, established in Alexandria, Egypt, in early 1995. ACML-EGYPT is your gateway to the information era, to provide for the Egyptian & Arab markets E-Books, E-Periodicals, E-Database, E-Journals, Library Automation Software, Library Furniture, Restoration Labs, Materials, CD ROMs and More ACML-EGYPT represents more than 25 international publishers, such as IEEE, ASME, ASCE, IHS, Proquest, CABI Our aims are to: • Promote high standards of provision and delivery of library and information services • Encourage widespread understanding of the value of good library and information services • Represent the interests of our Publishers and Vendors throughout Egypt and Arab World • Satisfy our clients in Egypt and the Arab World in ﬁelds of information industry resources • Developing the information infrastructure in Egypt, and strength the role of libraries and information centers in its community.

British Council

www.britishcouncil.org.eg Booth B1 We are the UK’s international organisation for educational opportunities and cultural relations. Our purpose is to build relationships between the UK and other countries to the benefit of all involved, and to increase appreciation of the UK’s creative ideas and achievements around the world. Incorporated by royal charter, we are registered as a charity (not-for-profit organisation) and operate as an executive non-departmental public body in the UK. The British Council has embarked on a five-year programme of strategic change, which we’re

BioVisionAlexandria BioVisionAlexandria calling Strategy 2010, to equip the organisation for the cultural relations challenges of the early 21st century. A major objective of Strategy 2010 is to increase the scale on which we operate. To do this, we are reorganising our international operations in 12 regions and developing a new range of products and services that will operate at the regional and global level.

168 KaSha

www.kashaonline.com Booth B3 KaSha is an international joint venture committed to providing world-class distribution services of books, periodicals, English Language Teaching and multimedia publication, in a cost-eﬀec- tive and timely manner, to customers in the Middle East, North Africa, Turkey and Islamic Republic of Iran. KaSha partners with international publishers, such as John Wiley & Sons, S. Karger AG, Express Publishing, Panpac Education, Black Cat, Cengage Learning and Pearson Education and holds an extensive stock range of the latest publications in its modern distribution facility in Jordan BioVisionAlexandria April 2008

Bibliotheca Alexandrina Library Sector Resources

www.bibalex.org Booth B4 2008 The Bibliotheca Alexandrina Library sector is a public-research library; established to revive the Ancient Library of Alexandria and to ensure an international center of excellence in Alexandria. It oﬀers services to its users through the Main Library and its Specialized Libraries: the Taha Hussein Library, the Children’s Library, the Young People’s Library, the Arts & Multimedia Library and the Nobel Section, with the objectives to improve awareness, knowledge and dialogue between cultures and attain standards of excellence in scientiﬁc research.

The Bibliotheca Alexandrina Bookshop

www.bibalex.org Booth B5 Our Bookshop contains a rich variety of books and gifts that reﬂect the wonders of our civilization and the uniqueness of our national heritage. It oﬀers a perfect reminder of the great history of the Ancient Library, as well as the fascinating building of the Bibliotheca Alexandrina and what it comprises.

TWAS-ARO

www.bibalex.org/twasaro Booth B6 To help disseminate and share TWAS, the Academy of Sciences for the Developing World, information about its activities throughout the developing world, the Academy has established five regional offices. The Academy’s Arab Regional Office (TWAS-ARO) was launched at the Bibliotheca BioVisionAlexandria Alexandrina, 2-3 June 2005, under the theme “Visions and Expectations”. TWAS-ARO aims to promote scientific capacity and excellence for sustainable development in the region. The overall objective of the TWAS-ARO is to promote the activities of TWAS and its affiliated organizations in the region, as recommended by the Academy’s current and future strategic plans.

DAAD

www.daad.org 169 Exhibition Area

The German Academic Exchange Service (DAAD) DAAD is one of the world’s largest and most respected intermediary organizations in its ﬁeld. Scores of students, teachers, researchers and scientists, supported by DAAD, have been able to gain valuable experience abroad. The 200 and more programs with which DAAD pursues these objectives range from short-term exchanges for research or teaching purposes to doctoral scholarships lasting several years for graduates from developing countries, from information visits by delegations of foreign university vice-chancellors to the long-term regional programs initiated to establish eﬃcient higher education systems in the Third World.